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ABSTRACT

In addition to their primary role in the maintenance and regulation of reproductive
capacity, ovarian steroid hormones acting through specific nuclear receptors influence
more general neurobiological functions, such as perceptual-spatial skills and learning and
memory. Estrogens act to alter certain aspects of cognitive performance and pathology
such as epileptic seizure activity and Alzheimer’s disease. Furthermore, ovarian steroids
act during development to alter the neuronal cytoarchitecture and synaptic connectivity.
These early influences of steroids on the brain are essentially permanent and in part
determine the steroid responsiveness of the adult brain. The mechanism and sites of action
for the effects of estradiol on cognitive performance and epileptic seizure activity have not
been established, but one probable site is the hippocampus, a steroid-responsive region of
the brain. Estrogen receptors have been found in cells of the hippocampus using a variety
of techniques. Furthermore, there is a transient increase in the expression of estrogen
receptors during the first postnatal week of life; a period that is active in neuronal
differentiation and synaptogenesis. During this time period estrogen has been shown to
have a number of transcriptional effects, mediated by steroid receptor coregulatory
proteins, on morphological and biochemical properties of hippocampal neurons that would
predict an excitatory action of this steroid on synaptic physiology in the hippocampus.

xii

Additionally, the neurotrophins, including brain-derived neurotrophic factor
(BDNF), also affect the long-term survival and differentiation of hippocampal cells during
development, and their viability in adulthood. Neurotrophins are widely expressed in the
CNS and are involved in complex and activity-dependent modulation of dendritic and
axonal growth. Moreover, the expression of neurotrophic factors has the ability to acutely
modulate synaptic transmission by presynaptic as well as postsynaptic mechanisms. In
addition to the modulation of synaptic transmission and plasticity, BDNF may also be
involved in hippocampal synaptogenesis.
In the adult rat, estrogen regulates mRNA levels of BDNF and its high affinity
receptor, trkB, in several regions of the rat brain. It follows, then, that estrogen induced
changes in neurotrophin synthesis is an important mediator of differentiation of the
brain, and specifically the hippocampus. Furthermore, hormonally mediated changes in
neurotrophin expression during development may be causally related to plasticity in the
adult hippocampus. The cellular mechanisms by which estrogen can influence the
developing hippocampus have not been examined and is the focus of this outline.
Information obtained will be contribute to a greater understanding of the hippocampus,
and may illuminate some of the cellular and molecular events involved in the
development, maintenance and decline of normal cognitive function.

xiii

CHAPTER 1
GENERAL INTRODUCTION

During development, estrogen has a variety of effects on the morphological,
biochemical, and electrophysiological characteristics of neurons in several regions of the
mammalian brain that result in sexually dimorphic brain structures in adulthood. The
hippocampus is an estrogen responsive brain structure that is involved in cognitive
functions such as spatial mapping, and learning and memory. In addition, it has been
demonstrated that estrogen exerts a profound influence on the differentiation and
plasticity of hippocampal neurons (Blanco et al., 1990; Gould et al., 1990). Gender
differences in hippocampal morphology may arise due to the presence of testosterone that
is aromatized to estrogen in nervous tissue by the enzyme aromatase (Naftolin et al.,
1971).
The hormonal influences on the rat brain occur at an early period of development
during late gestation and early postnatal life. This period has been defined as the “critical
period” of sexual differentiation (Jacobson and Gorski, 1981). The early influences of
steroids on the brain act to organize neural pathways, and these pathways are essentially
permanent. Later in adulthood, steroids act on these differentiated neural pathways to
activate behaviors and functions. This hypothesis was developed over forty years ago
and is known as the organizational-activational hypothesis of steroid action (Phoenix et
1
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al., 1959). It is during the critical period that the presence or absence of specific
hormones has their impact upon brain development (McEwen, 1983). However, the
mechanisms by which estrogen influences the developing brain, and specifically the
hippocampus, is essentially unknown and is the focus of this dissertation project.
Estrogen acts by binding to intracellular estrogen receptors (ERs), of which there
are two isoforms (alpha and beta; Greene et al., 1986; Tsai and O'Malley, 1994; Kuiper et
al., 1996). Estrogen receptors act directly as transcription factors and are located
predominantly in neurons. Moreover, both estrogen receptor isoforms (ER and ) have
been described in the neonatal hippocampus, implicating estrogen as an important
influence in hippocampal development.
In addition to normal wild-type estrogen receptors, multiple mRNA splice
variants of the estrogen receptor have been discovered in the normal rat brain, including
the hippocampus (Petersen et al., 1998; Price et al., 2000). When transcribed in vitro
these mRNA splice variants are functional proteins that exhibit altered ligand and DNA
binding interactions and have a unique pattern of cellular localization. Thus, estrogen
receptor mRNA splice variants add yet another facet to the possible molecular and
cellular actions of estrogen.
Upon binding ligand, the ER complex interacts with an estrogen response element
(ERE) in DNA where it regulates gene transcription and ultimately neuronal function.
Estrogen receptors also interact with other proteins, termed nuclear receptor co-activators
and co-repressors, that increase or decrease ER action at the ERE, respectively. In the
absence of hormone, several nuclear receptors actively repress transcription of target
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genes via interaction with nuclear receptor corepressors (NCoR). Upon binding of
hormone, however, these corepressors dissociate from the DNA-bound receptor, which
subsequently recruit a nuclear receptor coactivator (NCoA) complex. The coactivator
proteins function as signaling intermediates between the receptors and the general
transcriptional machinery to affect gene transcription (see Horwitz et al., 1996;
Katzenellenbogen et al., 1996). Coactivator proteins accomplish this by interacting
directly with the activation function (AF) domains of a nuclear receptor in an agonist
dependent manner, leading to enhancement of receptor mediated transcriptional
initiation. Over 30 potential coactivators have been identified by their ability to bind
various receptor domains and to alter the transcriptional activity of NRs (McKenna et al.,
1999a; Glass and Rosenfeld, 2000). Distinct classes of ligand-dependent transcriptional
cofactors have been described, including CBP/p300 and the p160 family (Xu et al.,
1999). At present, the p160 family contains three members including SRC-1/N-CoA1
(Onate et al., 1995; Kamei et al., 1996), SRC-2/GRIP-1/TIF2 (Hong et al., 1996; Voegel
et al., 1996; Torchia et al., 1997) and SRC-3/AIB1/p/CIP (Torchia et al., 1997, Li, 1997,
Suen, 1998). The temporal and spatial relationship of these regulatory proteins with the
ERs could determine the specificity in the depression or activation of gene expression.
Interestingly, neurons in the adult rat forebrain of both sexes co-express estrogen
and neurotrophins receptors and are the sites of estrogen action and neurotrophin
synthesis (Miranda et al., 1993a). It is not surprising then, that in the adult hippocampus
and hypothalamus, estrogen regulates several aspects of the neurotrophic system. For
instance, estrogen has been shown to alter messenger RNA levels of brain-derived

4
neurotrophic factor (BDNF) and its high affinity receptor, trkB (Toran-Allerand, 1996;
Gibbs, 1998). Brain-derived neurotrophic factor is a 14-kDa polypeptide that plays an
important role in the survival, differentiation, and outgrowth of peripheral and central
neurons during development and in adulthood (Barde, 1989; Davies, 1994). During
postnatal life, BDNF has been shown to accelerate the development of both excitatory
and inhibitory synapses in the hippocampus (Vicario-Abejon et al., 1998). BDNF exerts
its effects on the nervous system via signaling primarily through trkB, and to a lesser
extent through the low affinity pan neurotrophin receptor, p75NGFR. The activated trkB
receptors initiate local signaling at the membrane resulting in signaling cascades that
traverse the cytoplasm and culminate with transcriptional changes (Segal and Greenberg,
1996). Recent studies indicate that within minutes of application, BDNF can influence
synaptic transmission and plasticity in the hippocampus. It is possible then, that the
trophic effects of estrogen on the hippocampus are caused by enhanced expression of
neurotrophins and/or their receptors.
Considering these observations and data in the literature concerning estrogen’s
influence on the rat hippocampus, I hypothesized that during rat brain development,
estrogen acts on the hippocampus by modulating brain derived neurotrophic factor, its
receptor trkB, and/or the p160 coactivator proteins. The goal of this project was to
describe the localization of estrogen receptors and coactivator proteins in the developing
hippocampus, and further, to determine whether estrogen influenced the neurotrophic
system early in hippocampal development. The information obtained from this
dissertation may subsequently contribute to a greater understanding of estrogen’s
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organizational effects on brain structure and function. To achieve this goal, three specific
studies were performed that utilized neuroanatomical, biochemical, molecular biological
and in vitro cell culture techniques.
The purpose of Specific Aim 1 was to characterize the developmental expression
of estrogen receptors (ER  and ) in the developing rat hippocampus. This aim
employed Western blot analysis, receptor binding studies, immunocytochemistry and
quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR) to
determine the distribution and developmental expression of ER and  in the rat
hippocampus. Using immunocytochemistry, I analyzed the distribution of ER in the
developing male and female rat hippocampus at postnatal (P) days 0, 4, 7, 10, 15 and 20
and compared those ages with adults. The protein levels I observed in vivo were
confirmed semi-quantitatively with Western blot analysis. Next, I used conventional and
quantitative real-time PCR to analyze mRNA expression for ER splice variants in the
developing rat hippocampus. Other brain regions, including the medial basal
hypothalamus and cortex were also examined for comparison. Finally, I used an estrogen
receptor binding assay to determine if the different ERs have distinct ligand binding
affinities in the neonatal hippocampus. The data from this first specific aim are presented
in Chapters 3 and 4 of this dissertation.
Based on data demonstrating effects of estrogen on the neurotrophic system in the
adult, Specific Aim 2 was designed examine the hormonal regulation of BDNF and its
receptor, trkB, in the CA1 and CA3 subregions of the rat hippocampus during early
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postnatal development and is presented in chapter 5. This aim was accomplished by
surgically removing endogenous hormones shortly after birth by gonadectomy.
Immediately following gonadectomy, estrogen (or vehicle only) was replaced to mimic
the early hormonal surge normally observed in intact animals. First, to determine
whether estrogen receptors are colocalized with BDNF, or trkB, I used double-label
immunocytochemistry on normal tissues and primary hippocampal cells. Initially, to
determine if estrogen regulated BDNF mRNA levels in vitro, I treated hippocampal cells
with multiple doses of 17-estadiol benzoate, a long lasting estrogen receptor agonist. In
these studies, BDNF mRNA levels were determined using quantitative real-time PCR.
Subsequently, in the hippocampus and hypothalamus of hormone manipulated animals,
mRNA transcript levels for BDNF and trkB were examined using quantitative real-time
PCR. The last set of experiments for this aim examined whether estrogen alters protein
levels for BDNF and trkB in the developing hippocampus using Western blot analysis.
To further elucidate the mechanisms by which estrogen influences the developing
rat hippocampus, I designed a third series of experiments composing Specific Aim 3 to
examine the expression of the p160 coactivators (including SRC 1-3) in the developing
rat brain. These experiments were conducted to provide insight into the potential
mechanisms by which estrogen receptors influence transcriptional activation during
development. While the p160 coactivators likely play a significant role in gene
transcription by steroid receptors, their expression in brain tissue during development had
not been reported. Therefore, in the developing rat brain, I examined the mRNA
expression for the p160 coactivators in the medial basal hypothalamus, hippocampus
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regions CA1 and CA3, and the cortex using quantitative PCR. Additionally, I used
immunocytochemistry to determine if the protein expression followed a pattern similar to
the mRNA during development. Finally, I double-labeled hippocampal cells with ER
and SRC-1 to determine if these proteins we co-localized.
The overall conclusion from this dissertation project is that estrogen receptors (
and  are present in hippocampal neurons and may mediate the effects of estrogen early
in development by modulating brain derived neurotrophic factor. The effects of estrogen
might also involve interactions with p160 family of steroid receptor coactivators. The
influence of estrogen then, could have profound impacts on the developing hippocampus
to organize various morphological, biochemical, and electrophysiological parameters of
this brain structure.

CHAPTER 2
REVIEW OF RELATED LITERATURE

Structure of the hippocampus
The hippocampus is a limbic system brain structure that plays an important role in
cognitive functions including spatial mapping and learning and memory. As first shown
by (Anderson and Lomo, 1966), the hippocampus is composed of a tri-synaptic excitatory
circuit (Fig. 1). Accordingly, input identified as the perforant pathway is relayed from
the entorhinal cortex to the granule cells in the hilus of the dentate gyrus. The axons of
the granule cells form a bundle, termed the mossy fiber pathway, which in turn innervates
the pyramidal cells of the CA3 region. Finally, the CA3 pyramidal cells send excitatory
efferents, the Schaeffer collaterals, to the pyramidal cells of the CA1 region. The
hippocampal formation therefore consists of a complex of three main subfields, the
dentate gyrus, the CA3 subregion, and the CA1 subregion. The CA2 subfield is less well
defined in the rat and appears to lack specific features and therefore is largely ignored in
this outline. The granule cells of the dentate gyrus and the pyramidal cells of regions
CA1-3 (Fig.2) are considered the principal cells of the hippocampus. These principal
cells are excitatory, using the amino acid glutamate as a neurotransmitter.
Hippocampal outputs project to a variety of brain regions (Swanson et al., 1978)
and act in a general way to integrate interoceptive and exteroceptive data
8
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(Derryberry and Tucker, 1992). The output targets include the subiculum, entorhinal
cortex, lateral septal nucleus, olfactory bulb, nucleus accumbens, amygdala,
hypothalamus, and contralateral hippocampus.

CA1
Schaeffer
Collateral Pathway

CA3

Perforant
Pathway
Mossy Fiber
Pathway

Dentate
Gyrus

FIG 1: STRUCTURE OF THE HIPPOCAMPUS. This schematic diagram
demonstrates the pattern of neuronal connectivity in the hippocampus. It is
composed of a tri-synaptic excitatory network containing the dentate gyrus,
and regions CA1-3.
There is some controversy concerning the inclusion of the dentate gyrus in the
hippocampal formation. The dentate region has several morphologically distinct
structures, including granule cells and the hilar polymorph region, which would support
the view that this is a separate brain region altogether. However, the dentate gyrus sends
strong efferents through the mossy fiber pathway to Ammon’s horn, i.e., the CA
subfields. Furthermore, lesion studies demonstrate that disruption of the dentate gyrus
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results in the near abolishment of hippocampal function. Because of these anatomical
and physiological connections, the dentate region is included with the hippocampus in
this dissertation.
In contrast to the excitatory pyramidal and granule cells, the non-principal
hippocampal local circuit neurons synapse locally and project to the contralateral
hippocampus and subcortical structures. These are considered to be inhibitory
interneurons, which synapse primarily on the soma and proximal dendrites of pyramidal
cells (Ribak et al., 1978). Most inhibitory interneurons (~97%) in the brain use the amino
acid -amino butyric acid (GABA) as a neurotransmitter and are responsible for
modulating excitatory responses of pyramidal cells in the adult brain. Hippocampal
pyramidal cells, in contrast, excite postsynaptic neurons by liberating an excitatory amino
acid. Hippocampal inhibitory cells are diverse and are thought to fall into functionally
distinct subsets defined by a similar morphology and physiology. Those inhibitory cells
that innervate pyramidal cell somata or axon initial segments control the local generation
of Na+-dependent action potentials and inhibitory fibers terminating on dendrites can
suppress calcium-dependent spikes (Miles et al., 1996). Thus, distinct inhibitory cells may
differentially control dendritic electrogenesis and axonal output of hippocampal
pyramidal cells. In addition, the discovery that some inhibitory interneurons form
synapses that contact only other inhibitory cells (Gulyas et al., 1996) implies that local
inhibitory cell networks also exist. Hippocampal interneurons contain a variety of neuropeptides, which may act as co-transmitters, as well as several calcium binding proteins
(Freund and Buzaki, 1996). Calcium-binding proteins, including parvalbumin, calbindin
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28k, and calretinin, act to buffer the influx of calcium as a result of excitatory stimulation
and activation of L-type Ca2+ channels and can be used to differentiate the subsets of
hippocampal interneurons.

Principal cells of the hippocampus
Pyramidal cells are the excitatory projection neurons of the hippocampus and use
L-glutamate as a transmitter. In the major regions of the hippocampus (CA1-3), the

pyramidal cells are situated in a single continuous layer called the stratum pyramidale. In
contrast to other neuronal types, pyramidal cells have not one, but two dendritic trees
which emerge from opposite sides of the cell body (Fig. 2). The basal dendrites arise
from the side that gives rise to the axon, and the apical dendrites arise from the other side.
Excitatory input to CA1 pyramidal cells is extensive. About 5000 CA3 pyramidal
cell axons from the Schaffer collateral pathway converge to synapse on a single CA1 cell
(Kandel et al., 1991). These synapses form at all levels of the CA1’s dendritic tree, from
close to the cell body to more distant levels. Most of the synapses are excitatory upon
dendritic spines in area CA1. Because the neck of the dendritic spine restricts diffusion
between the head of the spine and the rest of the dendrite each spine may function as a
separate biochemical region (Harris and Stevens, 1989). This compartmentalization has
important implications for selectively altering the strength of synaptic connections during
learning and memory.
Extensive morphological studies have demonstrated that even within the
hippocampus there is some variation in the extent of pyramidal cell dendritic branching.
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FIG 2: PRINCIPAL CELLS OF THE HIPPOCAMPUS. Camera Lucida drawings of
biocytin-filled CA1 pyramidal cells demonstrate the elaborate apical and basal
dendritic arborizations. Adapted from Cannon (1998).

These studies indicate that dentate granule cells have dendritic trees that averaged
9,300m in total length. In contrast, CA1 and CA3 pyramidal cells have much more
elaborate dendritic trees, averaging 13,500 and 15,800m in total length respectively
(Ishizuka et al., 1995). However, many more characteristics may be used to identify
either similarities or differences between the classes of hippocampal pyramidal cells. For
example, van Pelt et al., (1997) hypothesized that the differences between pyramidal

13
neurons is that branching probabilities may decrease with distance from the soma more
rapidly in the simpler cells than in more complex cells.
During late embryonic and early postnatal development, hippocampal pyramidal
cells are undergoing synaptogenesis. It is at this time period that the structure of neurons
and their circuits are formed. Subsequently, the local environment plays a critical role in
the development and maturation of the neuronal circuitry of this system. For instance,
pyramidal, but not non-pyramidal, dendrites are influenced by chronic exposure to
neurotrophic factors during the neonatal period (Baker et al., 1998).

Non-Principal cells of the hippocampus
The pioneering Golgi stain studies of Ramon y Cajal (Cajal, 1893, 1911) and
Lorente de Nó (1934) have firmly established the notion of several heterogeneous classes
of non-principal neurons, generally referred to as interneurons. In the hippocampus,
interneurons are considerably less abundant (<10%) than spiny principal neurons, such as
granule and mossy cells of the dentate gyrus and pyramidal cells of regions CA1-3
(Olbrich and Braak, 1985). Moreover, following recent technical and conceptual
progress, an astonishing variety of interneuron classes have been identified (Freund and
Buzaki, 1996).
It has been established that there are at least 16 distinct morphological interneuron
phenotypes and 3 different modes of discharge (Parra et al., 1998) in the hippocampus.
Axons of different groups of inhibitory cells target precise and different zones of
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pyramidal cell membrane (Fig. 2; Buhl et al., 1994; Miles et al., 1996). These inhibitory
cells predominantly use the fast acting amino acid GABA as their

Feed-forw ard

Feedback

SL-M

SR
BS C

BC

SP

BC
AAC

HC

SO

FIGURE 3: GABAERGIC CELLS IN THE HIPPOCAMPUS. Principal cells
(black) are contacted by GABAergic interneurons (gray) via feed-forward (left) and
feedback (right) circuits. Interneurons can be divided into distinct classes
according to the input they receive and their output profiles (as defined by the
selective targeting of membrane domains of principal cells). AAC, axo-axonic
cells; BC, basket cells; BSC, bi-stratified cells; HC, horizontal cells; SL-M, stratum
lacunosum-moleculare; SR, stratum radiatum; SP, stratum pyramidale, SO, stratum
oriens.

neurotransmitter. Although interneurons have been viewed traditionally as subserving an
inhibitory function, recent anatomical studies indicate that those interneurons that
selectively innervate other interneurons may have a net disinhibitory activity without
direct effect on principal cells (Freund and Buzaki, 1996). Moreover, GABAergic
inhibitory post-synaptic potentials (IPSPs) are depolarizing during early development
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(Cherubini et al., 1991) and are instrumental in synchronizing population firing rates
(Cobb et al., 1995). The principal cells of the hippocampus are contacted by GABAergic
interneurons via feed-forward as well as feed back circuits (Fig. 3). The three main types
of GABAergic interneurons are the axo-axonic, basket, and bi-stratified cells. These
interneurons can be divided into distinct classes according to the input they receive, as
reflected by the layer-specific location of their dendrites; and their output profiles, as
defined by the selective targeting of membrane regions of principal cells. Basket cells
provide somatic and perisomatic inhibition (Buhl et al., 1994) whereas other types of
interneurons synapse primarily onto subdomains of the dendritic tree (Freund and Buzaki,
1996; Miles et al., 1996). It thus appears that interneurons are a very diverse population
acting in a variety of ways to influence the neurotransmission of cells in the
hippocampus.

Function of the hippocampus
The hippocampus projects to several brain regions and acts to facilitate cognitive
functions such as spatial mapping and learning and memory. Storage of information as
long-term memory is commonly assumed to involve modifications of the relevant
synapses. Studies have demonstrated that a brief high-frequency train of stimuli to any
one of the three afferent pathways of the hippocampus produces an increase in the
excitatory synaptic potential in the postsynaptic hippocampal neurons. This effect, which
can last for hours, days and even weeks (Bliss and Lomo, 1973), has been termed long
term potentiation (LTP). LTP, a use dependent increase in synaptic efficacy, is
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considered the major experimental model for learning and memory formation at the
synaptic level in mammals and, in the extreme, epileptic activity. Studies have shown
that LTPs at different synapses in the hippocampus are not identical. In the CA1 region,
LTP has three interesting properties: 1) cooperativity (more than one fiber must be
activated to obtain LTP), 2) associativity (the contributing fibers and the postsynaptic cell
need to be active together, in an associative way), and 3) specificity (LTP is specific to
the active pathway) (Kandel et al., 1991). Using spatial and visual water maze tasks,
Morris and colleagues (1986) have demonstrated that the associative LTP in CA1 is
important for spatial memory. The CA3 region, in contrast, has different properties and
is not associative. Additionally, LTP in the CA3 does not require an increase in
intracellular calcium levels. In fact, the CA3 region may not be involved in LTP at all.
Normal hippocampal function in the adult is dependent on precise interactions
between the excitatory glutamatergic pyramidal neurons and inhibitory GABAergic
neuronal systems. Pyramidal neuron firing rates reflect not just excitatory drive but the
balance between excitatory inputs received from other pyramidal neurons and inhibitory
inputs received from GABAergic interneurons. Supporting the role of the hippocampus
in learning and memory, administration of GABA agonists muscimol and baclofen impair
these functions, while antagonists facilitate memory retention in the adult rat
(Ammassari-Teule et al., 1991). Excess stimulation (Feldblum et al., 1990) or inhibition
(Houser, 1991) of GABA activation can result in epileptiform activity. The hippocampus
is particularly susceptible to the ischemic damage and trauma that has been associated
with increases in epileptiform activity and seizures.
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Electrophysiological studies of hippocampal “place” cells (O'Keefe and Conway,
1978) and hippocampal long-term potentiation support hypotheses of the important role
of the hippocampus in spatial memory processing. Furthermore, neurobehavioral studies
consistently show that hippocampal damage is associated with disruption of spatial
learning and memory processing for a variety of adult species including humans (Olton
and Papas, 1979).

Development of the hippocampus
The time course of hippocampal development is extensive. It begins

prenatally

and continues until well after birth. Examination of the postnatal development of
pyramidal neurons in rats shows extensive growth of the dendritic tree. However, not all
components develop simultaneously. The basal dendrites and the shaft and terminal
branches of the apical dendrites develop first (before postnatal day 15). These immature
neurons have a small soma and only short, simple, often bipolar processes (Cowan et al.,
1980). During the next few days, the apical dendrites elongate into the molecular layer as
the lateral and pre-terminal branches of the apical dendrites proliferate. These cells begin
forming synapses with the axons of cells in the tri-synaptic network, and as a result
dendritic spines increase in density and change shape to reach maximal numbers by
postnatal day 24 (Pokorny and Trojan, 1986).
The hippocampus is similar to the neocortex in that the GABAergic interneurons
are generated embryonically, between embryonic days 14 and 18. These interneurons
become postmitotic before the pyramidal and granule cells (Amaral and Kurtz, 1985;
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Lubbers et al., 1985). The interneuron’s circuitry is well developed and morphologically
mature by postnatal day 7 (Seay-Lowe and Claiborne, 1992) even as their target granule
and pyramidal cells excitatory connections are still being developed. Thus, the
GABAergic system is well developed at birth (Coyle and Enna, 1976; Rozenberg et al.,
1989). In contrast, the excitatory inputs begin developing after the first postnatal week
(Richter and Wolf, 1990). The principle and most numerous cells of the hippocampus are
the granule cells of the dentate gyrus and the pyramidal cells found in regions CA1 to
CA3. Granule cells are considerably smaller than pyramidal cells, and are subsequently
more numerous as well. Pyramidal cells begin development prenatally, in contrast to
cells of the dentate gyrus where 80% of cells are generated postnatally (Bayer, 1980). In
the subgranular zone of the dentate gyrus, neurogenesis continues for at least one year
(Schlessinger et al., 1975), and likely throughout the life of the organism (Gage et al.,
1998). This process of neurogenesis, which includes proliferation, survival, migration
and differentiation, can be regulated by a variety of stimuli. It appears that the total
granule cell number increases into midlife of rats and mice and then reaches a plateau,
but does not decline (Kempermann et al., 1998). Furthermore, there is little postnatal
neuronal death occurring in the hippocampus of the rat (Boss et al., 1987).
Fewer studies have examined the effects of hippocampal damage sustained during
infancy on the development of spatial learning and memory abilities. However, it has
been shown that neonatal hippocampal damage can result in long-lasting if not permanent
deficits in spatial memory (Altemus and Almli, 1997). These results showed that
behavior performance measures under the spatial conditions were significantly correlated
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with the total volume of hippocampal tissue damage. Accordingly, hippocampal integrity
is important for the normal development of spatial learning and memory functions, and
other brain structures do not assume hippocampal-spatial memory functions when the
hippocampus is damaged during the neonatal period. It is to be stated, above all, that
while the conditions for neonatal learning have not been elucidated, newborn animals are
able to learn and memorize a number of reactions, even several hours after delivery and
remember them for 24 hours (see Myslivecek, 1997).

Mechanisms of sexual differentiation
Testosterone (T) is not only a hormone but a prohormone, the precursor of
estradiol, resulting from aromatization, and of 5-dihydrotestosterone (DHT) via the 5reductase system. The enzyme aromatase was described in neuroendocrine tissues more
than 25 years ago (Naftolin et al., 1971), which created the foundation for the “brain
aromatization hypothesis” (Naftolin and Ryan, 1975). Subsequent experiments
demonstrated that treatment with DHT, the non-aromatizable androgen, was ineffective
in increasing masculinization of females (McDonald and Doughty, 1972; Gerall et al.,
1976) or restoring normal male mating behavior (McDonald et al., 1970; Baum et al.,
1982). The studies implying that regulation of male sexual behavior required the
conversion of androgen to estrogens, presumably through the aromatization, are reviewed
by Lephart (1996). Both T and DHT bind with high affinity to androgen receptor (AR)
whereas 17-estradiol will preferentially bind the estrogen receptor. The
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Fig 4: BIOCHEMICAL PATHWAY FOR THE METABOLISM OF
TESTOSTERONE. This diagram illustrates the conversion of testosterone to 17estradiol via aromatization, and Dihydrotestosterone (DHT) via the p450 enzyme
5-reductase.
findings of these early rat studies supported the hypothesis that many, if not most, of the
effects of androgens on neural cell differentiation are mediated by the local formation of
estrogens by the aromatase enzyme.

The adult hippocampus shows a response to estrogen
The hippocampus is one site in the brain that shows a robust responsive to
estrogen, and ER transcripts have been localized there as well (Register et al., 1998). The
hippocampus is not only involved in learning and memory functions, but has been
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implicated in some reproductive characteristics like female sexual behavior as well
(Cameron et al., 1979). In the adult, sex differences have been observed in the CA1 and
CA3 region where males and females differ in neuronal branching patterns and dendritic
spine densities (Gould et al., 1990) and synapses (Woolley and McEwen, 1992). When
ovariectomized rats are treated with estradiol, an increase in spine density occurs on the
apical dendrites of the pyramidal cell in the CA1 region (Gould et al., 1990; Woolley and
McEwen, 1993). It has been suggested that these effects on pyramidal cells are mediated
through a mechanism dependent on the activation of N-methyl-D-aspartate (NMDA)
receptors (Woolley and McEwen, 1994). These results are further supported by
experiments demonstrating that estradiol regulates mRNA and protein of the NMDAR1
subunit in the hippocampus of adult ovariectomized female rats (Gazzaley et al., 1996).
In addition, it has been shown that following estrogen treatment, the amplitude of both
sustained and transient Ca2+ currents, but not K+ currents, are significantly enhanced
when compared to non-treated OVX controls (Joels and Karst, 1995). Consistent with
the data of Woolley et al. (1997), the alteration of Ca2+ by the long-term modulation of
estrogen could be linked to steroid-induced morphological changes in dendrites of CA1
pyramidal cells.
The dentate gyrus is also different between the sexes. Pfaff (1966) originally
reported a greater cross sectional area in the dentate gyrus of adult male rats, and it is
heavier in adult male than female rats (Madeira and Paula-Barbosa, 1993). In this region,
males have a thicker granule cell layer (Juraska et al., 1988) and greater granule cell size,
number and density in comparison to females (Wimer and Wimer, 1989). Moreover,
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dendritic branching patterns of dentate granule cells have been reported to be different
between the sexes (Juraska et al., 1985), and more mossy fiber synapses are found in
males than females (Parducz and Garcia-Segura, 1993). These phenotypic sex
differences can be altered in females by postnatal exposure to testosterone (Roof and
Havens, 1992).
Inquiries into the functional consequences of these changes using intracellular
recording techniques have showed that estradiol administration increases synaptic
excitability and prolonged the EPSP in 20% of pyramidal neurons in the CA1 region
(Wong and Moss, 1992). This is consistent with the pioneering work by Terasawa and
Timiras, (1968) who showed that estradiol treatment decreases hippocampal seizure
threshold. This work has been extended to show that induction of long term potentiation
is maximal in female rats during the afternoon of proestrus when estrogen levels are high
(Warren et al., 1995; Cordoba Montoya and Carrer, 1997). These differences in the
hippocampus have also been demonstrated in different aspects of behavior.
Accumulating evidence from a variety of experimental human (Phillips and Sherwin,
1992; Kampen and Sherwin, 1994; Kimura, 1995) and animal (Luine and Rodriguez,
1994; Diaz-Veliz et al., 1995; Kampen and Sherwin, 1996; O'Neil et al., 1996; Packard et
al., 1996) data indicate that estradiol may affect learning and memory processes.

Sexual differentiation of the brain
Individual differences in brain function and behavior are shaped partly by the
effects of early experience and by hormones. Sexual differentiation of the brain is an
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example of a hormonally directed event in which the presence or absence of testosterone
during fetal and neonatal life causes brain development to diverge in two directions: male
or female. During normal development, the brain is exposed to high

FIG 5: TESTOSTERONE SURGES DURING LATE EMBRYONIC AND EARLY
POSTNATAL DEVELOPMENT IN THE MALE RAT. In the male rat, a priming
surge of testosterone is observed beginning on embryonic (E) day 17, and peaking at
E18-19. AT E18 the levels of testosterone peak, and are significantly greater than
females. A second surge of testosterone is observed at birth, which peak 2 hours
after delivery.
levels of gonadal steroids during a perinatal sensitive period. In rodents, males are
exposed to higher testosterone levels than females during the perinatal period (Weisz and
Ward, 1980; Rhoda et al., 1984). In males, the testes of the embryo begin testosterone
secretion with a priming surge on embryonic day 18 and at this point the levels are
significantly greater than observed in females (Weisz and Ward, 1980). Immediately
following birth, a second smaller testosterone surge is observed in males (Fig. 5;
Hoepfner and Ward, 1988). This period has been defined as the “critical period” of
sexual differentiation beginning in late gestation and ending in early neonatal life. The
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sensitive period for sexual differentiation of the rat hypothalamus is approximately E18
to postnatal days 7-10 (Jacobson and Gorski, 1981). Evidence for a critical period in
hypothalamic development comes from studies showing that steroidal effects are not seen
after about the tenth postnatal day in rats (Lobl and Gorski, 1974). It is during this period
that the presence or absence of specific hormones has their impact on development.
Testosterone exerts an organizational influence on a plastic CNS during this period
(McEwen, 1983).
It has generally been considered that the default pattern of the nervous system is
female (MacLusky and Naftolin, 1981), resulting from a lack of hormonal stimulation.
However, these suggestions were challenged by studies showing that endogenous serum e
subsequent studies (Nunez et al., 1971) demonstrestrogen levels are extremely high
during the postnatal period in both male and female rats (Weisz and Gunsalus, 1973;
Ojeda et al., 1975). Whilated that the estrogen binding protein, alpha feto-protein, binds
estrogen and prevents its entry into the brain, secretions from the ovaries may also be
important. For instance, because it acts as a transcription factor when bound to its
receptor, very little estrogen may be needed to have profound effects on neurons.
Alternatively, rather than preventing estrogen from entering the brain, -feto-protein may
act as a carrier, delivering estrogen to hormonally responsive tissues. Additional studies
showing that estrogen, secreted from the ovaries, has important developmental
consequences support this view. For instance, Gerall et al., (1972) and Hendricks and
Duffy, (1974) demonstrated that the presence of an ovary transplanted into neonatally
castrated male rats actively feminized their behavior. This effect is mimicked by
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estradiol benzoate treatment from 20 to 30 days after birth, given to males castrated on
day 1 (Hendricks and Gerall, 1970), suggesting that the effects of neonatal estrogen may
last longer than the first postnatal week. Even though the time frame for these studies is
quite variable, they underscore the importance of estrogen’s actions during development.
The early influences of steroids on the brain act to organize neural pathways
responsible for reproductive behavior, and these pathways are essentially permanent.
Later in adulthood steroids act on these differentiated neural pathways to activate
behaviors and functions. They in part determine the steroid responsiveness of the adult
brain. This paradigm is known as the organizational-activational hypothesis of steroid
action and was developed by Phoenix et al., (1959), who along with Barraclough and
Gorski, (1961) and Harris and Levine, (1962) were the first to propose that gonadal
steroids acted on the brain.
Furthermore, neurons of the developing brain have high levels of the P450
enzyme, aromatase, which converts significant amounts of gonadally derived testosterone
to estrogen in the brain. Aromatase mRNA levels increase dramatically before birth and
peak on postnatal days 3-4, after which they decline to adult levels (Harada and Yamada,
1992). Transiently high increases of aromatase have also been described in the
developing rat hippocampus (MacLusky et al., 1994). The aromatization of testosterone
is a necessary event in the “masculinization” of the rodent brain, and estrogen acting
through its receptor is the masculinizing hormone (Naftolin and Ryan, 1975). In the
absence of testis or the androgen surge during late gestation, the brain remains
“feminized” (Arnold and Gorski, 1984). Furthermore, testosterone facilitation of male
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sexual behavior can be blocked by a steroidal inhibitor of aromatization (Goy and
McEwen, 1980). So, in the rodent brain, it is the levels of estrogen that control
masculinization.
Steroidal modulation in the brain is important for a number of neurological
functions. Many of these functions are not directly associated with reproductive function.
For instance, levels of circulating estrogen influence neuroendocrine regulation, sexual
differentiation of the brain, mood, learning and memory, responses to stress, body
temperature, running activity, food ingestion, aggression and sensory sensitivity
(McEwen, 1994). While many components of this process are well established, the
cellular mechanisms mediating hormonally induced sexual differentiation of the brain
remain largely unknown.

Evidence for estrogen’s action on the neonatal hippocampus
As described above, estrogen has been shown to induce synapse formation in
hippocampal CA1 neurons in adult rats, which is thought to be determined by the
neonatal actions of testosterone during development. Estrogen treatment of adult males
fails to produce the same increase in synaptogenesis as in females. If the aromatization
of testosterone to estradiol is blocked during development, however, males demonstrate a
female-like response to estradiol treatment in adulthood with similar increases in spine
synapses (Lewis et al., 1995). In a recent study examining the hippocampal volume and
neuron number of food caching squirrels it was determined that seasonal variation of sex
differences in the morphology of the hippocampal complex previously reported in short-
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lived rodents might not reflect true adult plasticity, but rather results from organizational
or activational effects of gonadal hormones during development (Lavenex et al., 2000).
This study used modern stereological techniques to determine that seasonal changes in
behavior associated with increases spatial memory processing do not correlate with
morphological changes, such as variations in volume or neuron number.
Organizational effects on hippocampal mediated behaviors are suggested by the
ability of castration in neonatal male rats to produce female learning patterns in adults,
and estradiol treatment of neonatal females to produce male-typical learning patterns
(Williams and Meck, 1991). Additionally, it has been shown that males perform better
than females using spatial cues (Williams et al., 1990; Williams and Meck, 1991),
generally considered a hippocampus mediated behavior, and these differences can arise
as a result of the neonatal exposure of males to endogenous testosterone (Williams et al.,
1990; Williams and Meck, 1991; Roof and Havens, 1992). More recent data in mice
lacking ER suggest that this receptor may mediate the effects of steroid hormones in a
spatial learning task (Fugger et al., 1998). Similarly, humans females demonstrated
significantly enhanced spatial ability when exposed to excessive androgens during
development as compared to normal male relatives (Nass and Baker, 1991).

The Estrogen Receptor
Many of the actions of estrogen are exerted via the estrogen receptor (ER). The
ER is an intracellular receptor that is a member of a large nuclear receptor superfamily of
proteins. Estrogen receptors function directly as ligand-dependent transcription factors
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regulating the synthesis of specific RNAs and proteins. These receptors have a highly
conserved DNA-binding domain and a less conserved C-terminal ligand-binding domain
(Evans, 1988). The primary role of ER is to regulate the expression of specific target
genes by binding DNA directly through estrogen response elements (ERE), often located
in the 5’ flanking region of estrogen responsive genes. The ER may also affect
transcription indirectly through interactions with transcription factors such as the
activator protein 1 (AP-1). The actions of estrogens are antagonized by antiestrogens,
which bind to the ER in a manner that is competitive with estrogen; but antiestrogens
usually fail to effectively activate gene transcription (Katzenellenbogen, 1996). The
estrogen receptors are similar to most other steroid hormone receptors (Fig. 6), in that
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FIG 6: GENERAL STRUCTURE AND FUNCTIONAL ORGANIZATION OF
NUCLEAR RECEPTORS-This diagram represents a linearized steroid hormone
receptor and its domains. The modulator domain (A/B) mediates protein-protein
interactions with other transcription factors. The DNA binding domain (C) is highly
homologous across members of the steroid family and contains two zinc finger motifs.
The 15mer DNA consensus sequence for ER binding is AGGTCAnnnTGACCT. The
ligand binding domain (E) is located at the C-terminus and contains amino acid
residues necessary for hormone binding.
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they exhibit a variable N-terminal region, a short and well-conserved cysteine-rich DNA
binding central domain, and a relatively well-conserved ligand binding C-terminal half
(Kumar et al., 1987). The carboxyl terminal domain is both structurally and functionally
complex. In addition to its hormone binding and nuclear translocation roles, the ER
contains trans-activation and dimerization functions.
The central domain contains a cysteine rich region compatible with the formation
of DNA binding zinc fingers (Miller et al., 1985). This domain of 66-68 amino acids
binds to a specific region of DNA sequence termed the hormone response element
(HRE). These response elements are short, palindromic sequences of DNA that enable
the hormone receptor to bind with high affinity (Klein-Hitpass et al., 1988). The Nterminal domain is less well defined and may have a modulatory effect on transactivation. It may also provide gene specificity for transcriptional activation by
mediating protein-protein interactions with other general transcription factors. Although
the precise mechanism by which ER regulates transcription remains to be determined,
considerable progress has been made in defining the domains within ER required for its
activity. Specifically, it has been demonstrated that the transcriptional activity of ER is
mediated by two activation functions (AFs) located in the amino-terminal (AF-1) and
carboxyl-terminal (AF-2) regions. AF-1 in the N-terminal domain, whose activity is
regulated by phosphorylation in response to growth factors (Kato et al., 1995; Bunone et
al., 1996), and AF-2 in the hormone-binding domain (HBD), whose activity is strictly
dependent on the presence of ligand. Although both of these AFs function in a
synergistic manner in most circumstances, they can also function independently in a cell-
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and promotor-specific manner, an activity that may explain the tissue-selective agonist
activity of some ER ligands (Berry et al., 1990; Tzukerman et al., 1994). The activity of
estrogen receptor function is highly dependent on its conformation. The ER can exist in
ligand bound and unbound states, and are predominantly located in the cell nucleus,
irrespective of whether they are bound to estradiol (Greene et al., 1984). Furthermore, it
has been demonstrated that different heat shock proteins, including hsp70 and hsp90, can
bind to the ER, and after doing so, maintain the receptor in a receptive but
transcriptionally inactive state (Pratt, 1990). The heat shock proteins likely assist in the
folding of the receptor protein and/or transport across membranes (Smith and Toft, 1993)
in addition to maintaining the receptor’s structure. Upon hormone binding, the hsp90
protein dissociates and the ER dimerizes with itself. Following dimerization, the
estrogen receptor binds with high affinity to DNA at the estrogen response element
(ERE) and transcription is initiated (Fig 7).
Previous studies have shown that estrogen treatment of neonatal rats can cause the
transformation of the hippocampal ERs from the cytoplasmic to the nuclear form and that
bound ER can bind DNA (O'Keefe and Handa, 1990). In the juvenile (Orikasa et al.,
2000) and adult (Weiland et al., 1997) hippocampus the ER’s are found in the greatest
concentration predominantly in interneurons in the hilar polymorph region of the dentate
as well as in interneurons of the radiatum of CA3. In contrast, in the neonate, ER mRNA
(O'Keefe et al., 1995) and protein (Solum and Handa, 2001) is highly concentrated
throughout the pyramidal cell layer of CA3, and to a lesser extent in CA1, demonstrating
a presence in pyramidal cells and interneurons.
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FIG 7: A SCHEMATIC DIAGRAM DEMONSTRATING THE CLASSICAL
ESTROGEN RECEPTOR ACTIVATION PATHWAY 1) The steroid
hormone passes through the cell membrane and 2) binds to the receptor.
Binding of E to its receptor displaces the hsp and transforms the receptor. 3)
The transformed receptor dimerizes and binds DNA at the HRE to 4) initiate
transcription of estrogen responsive genes.

Non-classical actions of estrogen
Although modification of gene expression as a consequence of estrogen liganding
to DNA-binding receptors is the traditional framework for interpreting underling
mechanisms, an increasing number of reports document effects of acute application of
estrogenic steroids that are too rapid (occurring within 10 minutes) to be accounted for by
a genomic pathway. A novel pathway for the action of estrogen on the nervous system
has been demonstrated by studies producing rapid (2-3 minute) and reversible changes in
membrane excitability after steroid application (Fig. 8; Moss et al., 1997). Effects of
estrogen on the electrophysiological activity of rodent hippocampal neurons was first
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reported by (Teyler et al., 1980), who found that 17-estradiol treatment induced a rapid
enhancement of glutamatergic synaptic transmission in the CA1 region of in vitro
hippocampal slices. While little is known about the molecular identity of the binding site
for the rapid action, there is evidence that some rapid action may involve membrane or
intracellular receptors that are coupled to ion channels and transmitter receptors by
second messengers (Mermelstein et al., 1996). Early studies have shown that estrogen
can alter cyclic nucleotide levels in the cell (Guanaga et al., 1974; Weissman et al.,
1975), and act on potassium channels via a second messenger system involving cAMP to

FIG 8: NONGENOMIC EFFECTS OF ESTROGEN. Possible nongenomic effects
mediated by estrogen involve the MAP Kinase and cAMP cascades. These effects
might be mediated by a classical intracellular ER (solid arrows) or via a novel
membrane receptor (dashed arrows). Following signal transduction, gene
modulate
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(Minami
al., 1990).
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modulate the membrane potential (Minami et al., 1990). It appears then, that estrogen
may also act through non-transcriptional mechanisms to function in a neuromodulatory
role. For instance, estrogen treatment of ovariectomized rats rapidly increases
immunoreactivity for the phosphorylated form of the cAMP response element binding
protein (CREB). This has been demonstrated in neurons of the preoptic area, the bed
nucleus of the stria terminalis (Zhou et al., 1996) and the anteroventral periventricular
nucleus (Gu et al., 1996). Recently, the involvement of cAMP and protein kinase A
(PKA) has been noted in estradiol-induced dendritic spine outgrowth in cultured
hippocampal neurons (Murphy et al., 1998b). Estrogen also upregulates protein kinase C,
and PKC-induced phosphorylation influences Ca2+ currents and exocytosis (Drouva et al.,
1988; Drouva et al., 1990; Fomina and Levitan, 1997). Estradiol has likewise been
shown to elevate PKC catalytic activity in the preoptic area of female rats (Ansonoff and
Etgen, 1998). Thus, Ca2+ currents might be jointly regulated by estrogenic influences on
transcription and phosphorylation.
Furthermore, experiments investigating the rapid effect of estrogen have
demonstrated that estrogen can potentiate kainate-induced currents via activation of the
cAMP cascade in vivo (Gu and Moss, 1996) and in vitro (Gu and Moss, 1998). These
experiments have subsequently been completed in isolated hippocampal neurons of the
estrogen receptor knock-out (ERKO) mouse (Gu et al., 1999). The data suggest that the
potentiation of kainate-induced currents by 17-estradiol was likely a G-protein coupled,
cAMP-dependent phosphorylation event. In other experiments, estrogen dramatically
enhanced expression of the neurotensin/neuromedin gene in preoptic neurons, even
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though its promoter lacks an estrogen response element (Alexander and Leeman, 1994).
This is the first experiment to show that estrogen has a direct effect on a neurotransmitter.
More recently, it has been shown that estrogen regulates Neurotensin gene transcription
by interactions with the cAMP/PKA cascade in SK-N-SH cells, a neuronal cell line
(Watters and Dorsa, 1998). Neurotensin, a 13-amino acid peptide containing CREB and
AP-1 recognition sites, is involved in stimulation of prolactin release and may participate
in the preovulatory leutenizing hormone surge (Alexander and Leeman, 1994). It thus
appears that estrogen has non-transcriptional roles in neuroendocrine function by
modulating the expression of a neurotransmitter gene. These non-transcriptional effects,
detected within seconds or minutes of estrogen exposure, are much too rapid for a
genomic mechanism of action and indicate that estrogen may act on membrane receptors
or other cellular components to alter neuronal events.

The Estrogen receptor is expressed in two forms, ER and ER
Recently, a novel estrogen receptor, called ERwas cloned (Kuiper et al., 1996)
which is highly homologous to the original ER receptor, now termed ER. The DNAbinding domain is 95% identical and the C-terminal ligand-binding domain is 55%
identical (fig. 9). Like ER67kDa)ER~54kDa) has a high affinity for estradiol and
is capable of activating the transcription of an estrogen response element reporter gene
construct (Kuiper et al., 1996) Studies of the regional distribution of ER and ER
indicate areas of overlap as well as some considerable differences. In some brain regions,
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ER appears to compose a significant portion of total ER, and as such may play an
important role in estrogen action. Differences exist in the ligand binding affinity and the
ligand specificity of the ER subtypes, thus creating the potential for regional variations in
activity. Estradiol has been shown to induce differential neuronal phenotypes by
activating estrogen receptors  or  as well (Patrone et al., 2000). In this study,
following transient transfection in neuroblastoma cells, ER activation resulted in an
increased length and number of neurites, whereas ER activation modulated only neurite
elongation. Similarly, the hippocampus responds robustly to estrogen, and ER and ER
mRNA transcripts have been detected in the rat hippocampus (Shughrue et al., 1997) and
the hippocampus of an ovariectomized female
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FIG 9: COMPARISON BETWEEN THE ER AND ER SEQUENCES
Percentage amino acid identity in the domains A/B (N-terminus), C (DNA
binding), D (hinge region), E ( ligand binding domain), and F (ligand
dependent transactivation) are depicted.

monkey at a relatively high ER/ER ratio (Register et al., 1998). Additionally, it has
been demonstrated that some hippocampal pyramidal cells may express ER(Li et al.,
1997b). These results suggest that ER may also play a role in mediating estrogen
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effects in the mammalian hippocampus. The existence of at least two ERs and their
possible co-localization in some brain regions and differential effects on gene expression
expands the potential signaling pathways that could be involved in mediating genomic
effects of estradiol. Finally, the functional impact of estrogen receptor localization in the
hippocampus may prove relevant to the emerging role for estrogen as a protective factor
in neurodegenerative injury. This potential role is further highlighted by the recent
findings that the expression of ER and ER changes following ischemic brain injury
and that these changes correlate with the hormonal modulation of neuroprotection (Dubal
et al., 1999).

Estrogen receptor  and  messenger RNAs are variably spliced
Analysis of mRNA prepared from a variety of estrogen-responsive cell lines,
breast tumor specimens, and normal breast tissue have established that estrogen receptor
 mRNA is typically expressed as a mixture of transcripts (Miksicek et al., 1993;
Gotteland et al., 1995; Poolaab et al., 2000). Analysis of these transcripts have revealed
that the heterogeneity is largely a result of an imprecise pattern of mRNA splicing that
gives rise to a family of correctly processed and exon-skipped transcripts. Although it
has been proposed that the alternative spliced forms of ER might be clinically
significant in the progression of breast cancer and the resistance to therapy (Pfeffer et al.,
1996), their existence in brain tissue is still debated. Similarly, ER mRNA has been
reported to be variably spliced (Fig 10). The wild-type form has been designated ER1,
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an 18 amino acid insert between exon 5 and 6 in the ligand binding domain (LBD) has
been termed ER2, and a deletion of the second zinc finger domain of exon 3 has been

FIG 10:SCHEMATIC DIAGRAM OF ER mRNA SPLICE VARIANTS.
Messenger RNA for ER is variably spliced resulting in proteins with altered
function. The major variants are shown here along with the wildtype ER1 form.
Each of these variants can also exist in combination with the others, producing a
large combination of isoforms.

termed ER13. A combination of these two variants, then, produces ER23.
Furthermore, recent work in our lab has resulted in the identification of a novel, naturally
occurring ER mRNA splice variant that is missing exon 4 and has been designated
ER14 (Price et al., 2000). It also appears that all of these variants can be translated
into functional proteins, each of which has altered pharmacological properties. Therefore,
splice variation of steroid receptor mRNA can lead to alteration of receptor function
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depending on which portion of the receptor is altered by the insertion or deletion. Given
that many ER mRNA splice variants are expressed in various normal rat tissues at levels
equal to those of the wild type form, these variants should be considered in addition to
ER and ER when describing the effects estrogen.

Co-activators and co-repressors influence estrogen receptor transcriptional activation
The nuclear hormone receptors are transcriptional regulators that activate gene
transcription upon binding of their respective ligands. While there is considerable
evidence that nuclear receptors can contact some of the basal factors of the preinitiation
complex directly, without the need for intermediary coregulatory proteins, evidence for
additional factors is supported by observations that different classes of receptors can
interfere with one another’s transcriptional activity by squelching limiting factors that are
not components of the basal transcription machinery (Meyer et al., 1989).
Recent data show that nuclear receptors enhance or inhibit transcription by
recruiting an array of proteins to the transcription complex. These have been termed
coregulatory proteins collectively, and can be subdivided into coactivators, corepressors,
and integrators. Coactivator proteins interact directly with the activation domain of a
nuclear receptor in an agonist-dependent manner (but not in the presence of an
antagonist), leading to enhancement of the receptor activator function. A number of
biochemical and yeast two-hybrid studies have identified proteins capable of interacting
with NRs and influencing their transcriptional activity. Transcriptional activation by both
AF-1 and AF-2 of the estrogen receptor is cell type specific and relies on the promotor
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context of the hormone response element (Tora et al., 1989). This suggests the existence
of different mediating or coactivating proteins, several of which have been identified to
date.
Two distinct steps in target gene activation appear to be regulated by coactivators.
First, they play a role in remodeling chromatin, a process that involves the destabilization
of histone-DNA contacts to allow the binding of other transcription factors (Kadonaga,
1998). Second, coactivators are required to recruit the transcription machinery,
ultimately RNA polymerase II, to transcribe target genes. This involves the recruitment
of a protein complex that interacts with one or more subunits of the polymerase and is
essential for transcriptional initiation.
Over 30 potential coactivators have been identified by their ability to bind various
receptor domains and to alter the transcriptional activity of nuclear receptors (McKenna
et al., 1999a; Glass and Rosenfeld, 2000). These coactivator proteins function as
signaling intermediates between the receptors and the general transcriptional machinery
to affect gene transcription (see Horwitz et al., 1996; Katzenellenbogen et al., 1996).
Distinct classes of ligand-dependent transcriptional cofactors have been described,
including CBP/p300 and the p160 family (Xu et al., 1999). At present, the p160 family
contains three members including SRC-1/N-CoA1 (Onate et al., 1995; Kamei et al.,
1996), SRC-2/GRIP-1/TIF2 (Hong et al., 1996; Voegel et al., 1996) and SRC3/AIB1/p/CIP (Torchia et al., 1997, Li, 1997, Suen, 1998). The p160 proteins contain a
short conserved nuclear receptor interaction motif (NR box), which has the core sequence
LXXLL (L = leucine and X = any amino acid) (Heery et al., 1997; Torchia et al., 1997).
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All of the p160 coactivators have a core NR interaction domain that contains three of
these NR boxes arranged in tandem. A unique fourth NR box has been characterized at
the extreme carboxyl terminus of an alternatively spliced variant of SRC-1, SRC-1a
(Takeshita et al., 1996). Moreover, the p160 family is defined by an overall sequence
similarity of 40% between the three proteins, distinguishing its members from other
coregulator classes. The highest degree of homology is in the N-terminal domains, where
the basic helix-loop-helix (bHLH) domain exhibits a high degree of similarity. This
bHLH domain is responsible for mediating protein-protein interactions with other
transcriptional machinery.
How these proteins function as coactivators is currently speculative, but attention
centers on their interactions with the basal transcription machinery and on their
associated histone acetyltransferase (HAT) activity. Both CBP and SRC-1 bind to
TATA-binding protein (TBP) (Abraham et al., 1993; Takeshita et al., 1996), and the
TBP-binding site of CBP serves as an independent activation domain when brought to
DNA (Swope et al., 1996). These mediators interact with the LBD and some are capable
of increasing the AF-2 response in a ligand-dependent manner. On certain promoters,
AF-1 and AF-2 must synergize to reach efficient activation. Additionally, while
coactivators interact with components of the basal transcription machinery they don’t
enhance the basal transcriptional activity by their own. Coactivators may mediate
interactions with other transcription factors and play a role in the assembly and
stabilization of the transcriptional preinitiation complex.
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ERAP160

Cofactor
GRIP-170, p160

Alternative
Designations

TIF2/
hSRC-2/
mSRC-3
hSRC-3

ERAP-140

Related
Factors

Interacts with and coactivates nuclear receptors; interacts with
CBP/p300; contacts basal transcription factors; possesses
acetyltransferase activity, intareacts with PCAF; contains autonomous
activation domains; targeted deletion causes hormone insensitivity

ERAPs bind ER in ligand-dependent manner; mammalian cellular
fraction enriched in GRIP-170; coactivates GR

Notes

(Onate et al., 1995;
Kamei et al., 1996)

(Halachmi et al.,
1994)

References

TABLE 1

SRC-1

hSRC-1
NcoA-1/
mSRC-1
P160

Interacts with and coactivates nuclear receptors; interacts with CBP

(Hong et al., 1996;
Voegel et al., 1996;
Torchia et al., 1997)

(Torchia et al., 1997;
Xu et al., 2000)

hSRC-1
mSRC-3/
hSRC-3

P/CIP coactivates CBP-mediated signaling pathways
AIB-1 interacts with, coactivates ER; overexpressed in breast tumors
TRAM-1 interacts with and coactivates TR
SRC-3 preferentially coactivates ERover ER

(Yeh and Chang,
1996)

GRIP-1/
mSRC-2
NcoA-2, p160

ARA-70 interacts with and coactivates AR in prostate cells

(Chakravarti et al.,
1996; Kamei et al.,
1996)

TIF2/
hSRC-2

p300

Interacts with and coactivates multiple activators, including nuclear
receptors; acetyltransferase; interacts with PCAF, SRC-1,
TIF2/hSRC-2 and p/CIP mSRC-3

(Kwok et al., 1994)

p/CIP/
mSRC-3

CBP

Broad functional similarity to CBP; interacts with and coactivates
nuclear receptors; possesses acetyltransferase activity; interacts with
PCAF, SRC-1 and p/CIP/mSRC-3

SRC-1
TIF2/
hSRC-2
GRIP-1

hGCN5

(Blanco et al., 1998;
Kotani et al., 1998;
Krumm et al., 1998)

ACTR/RAC3
AIB-1/TRAM-1
hSRC-3/p160

ARA-70
CBP

p300

PCAF

Possesses intrinsic acetyltransferase activity; interacts with PR and
SRC-1; interacts with TR and ACTR
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Originally, it was considered that the inhibitory activity of steroid receptor
antagonists was due simply to the competition between agonists and antagonists for
binding to the receptor. However, there is increasing evidence that suggests that
antagonists activity results from an active process which involves the recruitment of
transcriptional corepressors (Horwitz et al., 1996; Xu et al., 1996; Webb et al., 1999).
Two corepressors have recently been identified: a 270-kDa mouse protein termed N-CoR
(nuclear receptor corepressor; (Horlein et al., 1995) and a 168-kDa human protein termed
SMRT (silencing mediator for retinoid and thyroid hormone receptors; (Chen et al.,
2001), both of which have similar properties. SMRT, N-CoR, and their homologs
represent a new class of transcriptional mediators for nuclear receptors that actively
silence basal transcription. As with coactivators, the receptor/corepressor dyad may be a
subunit of an even larger inhibitory complex, since there is evidence that the repressive
effects of unliganded steroid receptors result not only from binding a corepressor, but
also from the ability to interact with and sequester or inactivate TFIIB directly
(Baniahmad et al., 1993).
Therefore, in the absence of hormone, unliganded receptors interact with a family
of transcriptional corepressors, including SMRT and N-CoR, which target histone
deacetylases to establish a condensed and repressed chromatin structure. Upon hormone
binding, the corepressor complex is replaced by a coactivator complex containing SRC1,
CBP and/or GRIP or SRC-2, and this is followed by transcriptional initiation.
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ERs are transiently expressed in the hippocampus during development
The classical intracellular estrogen receptor has been identified in the rat
hippocampus by several different methods, including in situ hybridization and
immunocytochemistry (Pfaff and Keiner, 1973; Loy et al., 1988; Pelletier et al., 1988;
Maggi et al., 1989). Work in our laboratory has shown that ER and ER mRNA are found
at high levels in the hippocampus during the first postnatal week of development, with a
subsequent decline to the adult level (O'Keefe and Handa, 1990; O'Keefe et al., 1995;
Solum and Handa, 2001). Within the adult hippocampus, estrogen receptors are primarily
found in interneurons (Weiland et al., 1997), although recent studies have demonstrated the
presence of ERs in pyramidal cells as well (Shughrue and Merchenthaler, 2000). In
contrast, in the neonate, ER is predominantly distributed throughout the pyramidal cell
layer (Solum and Handa, 2001), suggesting its presence in pyramidal cells as well as
interneurons. Within the pyramidal cell layer, the highest density is found in the CA3
region, intermediate levels are found in CA1, and lower levels are found in the dentate
gyrus (O'Keefe et al., 1995; Solum and Handa, 2001). Furthermore, other investigators
have demonstrated the presence of ERs in hippocampal cells in vitro (Murphy et al.,
1998b). Preliminary data from our laboratory have shown transient increases in both ER

and ER mRNA in the developing brain as well (Price Jr. and Handa, 1997).
Unfortunately, most studies of the effects of estrogen in the hippocampus have been
conducted in the adult, not the neonate.
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Functional Significance of ER in adulthood
Estrogen has been shown to influence a variety of processes associated with
hippocampal function. In addition to altering learning behavior (O'Neil et al., 1996)
estrogen facilitates kindled seizures in the hippocampus (Buterbaugh and Hudson, 1991)
and has the ability to decrease seizure threshold in the hippocampus (Terasawa and
Timiras, 1968). Studies have shown that while transynaptic responses of pyramidal cells

in CA1 are not affected by changes in circulating estrogen following low-frequency
stimulation, synaptic plasticity, which is at the basis of Hebbian associative memory, is
facilitated by estrogen treatment (Cordoba Montoya and Carrer, 1997). Research by Warren
(Warren et al., 1995) has found that induction of long-term potentiation (LTP), which

depends on synaptic plasticity, is maximal in female rats during the afternoon of
proestrus. It has been known for some time that synaptic plasticity and LTP in CA1
depend on the availability of NMDA type glutamate receptors (Collingridge and Singer,
1990), and coincidentally in the adult, estrogen increases the number of NMDA type
binding sties in CA1 (Weiland, 1992a). Woolley and colleagues (Woolley et al., 1997)
recently confirmed this finding and proposed that this increased affinity may be explained
by the greater concentration of the NMDAR1 receptor protein that is regulated by
estradiol. These changes in NMDA binding result in greater sensitivity to NMDA
receptor–mediated synaptic input. This effect was demonstrated in slices taken from
estrogen treated rats in which responses to AMPA receptor-mediated synaptic input and
GABA-mediated inhibition were blocked (Woolley et al., 1997). An inquiry into the
functional consequences of these changes using intracellular recording showed that
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estradiol administration increases synaptic excitability and prolonged the EPSP in 20% of
CA1 pyramidal neurons (Wong and Moss, 1992) and markedly increased the amplitude
of NMDA mediated EPSPs (Foy et al., 1999). In extracellular recording experiments,
slices perfused with 100pM of 17-estradiol exhibited a pronounced, persistant, and
significant enhancement of LTP of both the fEPSP slope and amplitude compared to
controls 30 minutes after high frequency stimulation (Foy et al., 1999). The dynamic
regulation of plasticity by estrogen may also be operative in the ventromedial
hypothalamic nucleus (Frankfurt et al., 1990), arcuate nucleus (Matsumoto and Arai,
1979), lateral septal nucleus (Miyakawa and Arai, 1987), and preoptic area (Langub et
al., 1994) where the steroid has been shown to modulate the number or size of synaptic
contacts.
Ovarian hormones also regulate the synaptic connectivity of hippocampal
neurons. The hippocampal synapses regulated by estradiol are excitatory synapses
formed on dendritic spines. Experiments have demonstrated that dissociated
hippocampal neurons grown in culture can double their dendritic spine density in
response to estradiol (Murphy and Segal, 1996), confirming earlier in vivo experiments
(Gould et al., 1990; Woolley and McEwen, 1992). As glutamate is the primary

neurotransmitter at CA1 pyramidal cell dendritic spine synapses, it follows that glutamate
receptor numbers increase in parallel with spine synapses (Weiland, 1992b; Woolley et
al., 1997). The combined morphological and electrophysiological analysis of estradiol’s
effect on CA1 pyramidal cells suggests that estradiol-induced spine synapses are a
structural substrate of the estradiol induced increase in synaptic sensitivity to NMDA
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receptor-mediated input. An alternative explanation is derived from data showing that
estrogen is acting by altering levels of GABA neurotransmission (Murphy et al., 1998b).
This work demonstrated in vitro that estrogen decreases the levels of glutamic acid
decarboxylase (GAD), the GABA synthesizing enzyme. The resulting effect is a
decreased inhibition suggesting that in the adult synaptic excitability is facilitated by
disinhibition of pyramidal cells instrumented through the action of estradiol on inhibitory
interneurons, since estrogen is preferentially taken up by interneurons (Loy et al., 1988). It
has been suggested that the mechanism for this estradiol induced increase in dendritic
spine density in vitro is through the phosphorylation of cAMP response element binding
protein (CREB); (Murphy and Segal, 1997). More recent in vivo experiments showed that
ovariectomy decreases GAD levels and estrogen protects against this decrease (Hart et
al., 1999). In a further attempt to determine which hippocampal neuronal populations are
activated by estradiol, (Rudick and Woolley, 1999) analyzed the induction of c-Fos
immunoreactivity following estrogen treatment. This study found that the density of cFos nuclei in pyramidal cells, but not interneurons, is increased within 2 hours of
estradiol treatment, suggesting a direct effect on pyramidal cells. Estrogen also increases
the expression of the transcription factor c-fos in the CA1 region (Jennes, 1990), further
indicating that estrogen has activational effects on hippocampal physiology.

Effects of Estrogen on Memory and Cognition
Accumulating evidence from a variety of experimental human (Phillips and
Sherwin, 1992; Kampen and Sherwin, 1994; Kimura, 1995), and animal (Luine and Rodriguez,
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1994; Diaz-Veliz et al., 1995; Kampen and Sherwin, 1996; O'Neil et al., 1996; Packard et al.,
1996) data indicate that estradiol may affect aspects of brain chemistry and morphology

known to be important for memory functions. Prospective, controlled studies of
surgically and naturally menopausal women demonstrated that exogenous estrogen
enhanced short- and long-term memory and the capacity for learning new associations,
whereas visual memory was unaffected. The hormonal influences on memory processes
appear to involve action on brain structures such as the hippocampus and basal forebrain.
Animal studies have suggested that estradiol influences performance on various
learning and memory tests. In male rats, acquisition of radial maze behavior is impaired
by neonatal gonadectomy or administration of the aromatase inhibitor androst-1,4, 6triene-3,17-dione, indicating an organizational effect on spatial behavior exerted by the
aromatization of testosterone to estradiol (Williams et al., 1990).
In humans, a role for estrogen in memory is suggested from studies examining the
effects of hormone replacement therapy in postmenopausal women. For example,
estrogen replacement therapy enhances immediate and delayed verbal recall in both
naturally and surgically menopausal women (Sherwin, 1994).

Estrogen and Neuroprotection
A significant number of studies have clearly established that estradiol is a potent
neuroprotective and neurotrophic factor for neurons. It is no surprise then, that the
decline of ovarian activity after surgical and natural menopause appears to affect a
number of brain structures, including mood and certain types of memory.
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Epidemiological evidence suggests that estrogen replacement therapy for postmenopausal
women is associated with an improvement of some measures of cognitive performance,
protection against cognitive deterioration, and decreased incidence of Alzheimer’s
disease (Paganini-Hill and Henderson, 1994; Tang et al., 1996; Sherwin, 1997; Costa et
al., 1999). Additionally, beneficial effects of estrogen on the mortality and morbidity
associated with cerebral stroke have been demonstrated (Lafferty and Fiske, 1994;
Grodstein et al., 1996; Hurn and Macrae, 2000). .
The protective effects of estrogen on different cell damaging factors have been
described in vitro and in vivo (see (Wise et al., 2000; Garcia-Segura et al., 2001). The
first studies of the neuroprotective effects of estradiol were detailed in relation to the
effects of serum deprivation on neuronal survival in cell culture (Arimatsu and Hatanaka,
1986). Since then, protective effects of estradiol have been reported in 12 different types
of neuronal cells against 14 different toxicities including serum deprivation (Bishop and
Simpkins, 1994; Green et al., 1997; Gollapudi and Oblinger, 1999), oxidative stress (Behl
et al., 1995; Goodman et al., 1996; Sawada et al., 1998), amyloid  pepdtide (A)
induced toxicity (Goodman et al., 1996; Green et al., 1996; Mattson et al., 1997) and
excitotoxicity (Singer et al., 1996; Regan and Guo, 1997; Weaver et al., 1997). These
studies demonstrated that physiological and pharmacological doses of 17-estradiol
profoundly attenuate the extent of injury and decrease neuronal cell death.
However, fewer studies have examined the neuroprotective effects of estrogen
with animal models (see McEwen and Alves, 1999; Garcia-Segura et al., 2001). Of these
it has been demonstrated that in the female rat, physiological levels of estradiol protect
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against ischemic damage induced by middle cerebral artery occlusion (Simpkins et al.,
1997; Alkayed et al., 1998; Dubal et al., 1998). Moreover, in estrogen receptor  knockout mice, estradiol did not protect the brain against ischemic injury, indicating that ER
is a critical link in estradiol-mediated neuroprotection (Dubal et al., 2001). The discovery
that ER mediated protection of the brain carries far-reaching implications for the
selective targeting of ERs in the treatment and prevention of neural degeneration.
Although estrogen is a well-described neuroprotective agent, the mechanism by
which estrogens exert their neuroprotective actions is less clear. Recent studies
attempting to determine estrogen’s mechanism of action in neuroprotection revealed that
in response to injury, estrogen modulates critical factors such as bcl-2 (Singer et al.,
1998; Dubal et al., 1999; Pike, 1999) and immediate early genes.
It appears that estradiol can act via mechanisms that require classical intracellular
receptors (estrogen receptor alpha or beta) that affect transcription, via mechanisms that
include cross-talk between estrogen receptors and second messenger pathways, and/or via
mechanisms that may involve membrane receptors or channels. Additionally, estrogens
exert protective effects on neuronal cells in culture that may be mediated, at least in part,
by their ability to alter free radical production and/or free radical action on cells or by
suppressing oxidative stress in neurons (Behl et al., 1995; Mattson et al., 1997). Finally,
the neuroprotective actions of estrogen could be mediated, at least in part, through
interactions with the previously described neurotrophins. By influencing the expression
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of these trophic factors and/or their receptors, estrogen could profoundly influence the
survival of neurons in both the developing and adult brain.

Estrogen Receptors are Co-expressed with the Neurotrophins
The neurotrophins are a family of growth factors including BDNF, NGF, NT-3,
NT-4/5 and the fish neurotrophin, NT-6. Like estrogen, the neurotrophins have important
influences on the development, survival, plasticity, and aging of neurons in mammalian
brain regions that subserve reproductive, cognitive, and various other functions. The
biological activities of the neurotrophins are mediated by two structurally distinct classes
of cell membrane receptors that are preferentially expressed in neural tissues (Chao,
1992; Raffioni et al., 1993; Chao and Hempstead, 1995). One class consists of members
of the tropomyosin-related kinase (trk) family of receptor tyrosine kinases (trkA, trkB,
and trkC), each of which mediate neurotrophin signaling through increased tyrosine
autophosphorylation of its cognate receptor. NGF binds trkA; BDNF binds to trkB, as
does NT-4/5 but with lower affinity; and NT-3 binds primarily to trkC. The second
receptor, p75NTR, is a pan-neurotrophin receptor that binds all neurotrophins with low
affinity. The trks can mediate responses to the neurotrophins with or without the
participation of p75NTR. Neurotrophin binding to Trk receptors induces receptor
dimerization, autophosphorylation and generation of a signaling cascade resulting in
neuronal differentiation and survival. Interestingly, neurons in forebrain regions of both
sexes in the rat coexpress estrogen and neurotrophin receptors and are the sites of
estrogen and neurotrophin synthesis (Toran-Allerand et al., 1992; Miranda et al., 1993b),
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suggesting a potential interaction between these two receptor systems. In addition,
estrogen receptor and neurotrophin receptor co-expression leads to convergence or crosscoupling of their signaling pathways (Toran-Allerand et al., 1999). However, an
important and unanswered question

NGF

BDNF

NT-4

NT-3

p75

TrkA

TrkB

TrkC

Figure 11: INTERACTIONS BETWEEN NEUROTROPHINS AND THEIR
RECEPTORS. All Neurotrophins bind to the low affinity p75 receptor, whereas
binding to the high-affinity Trks is specific to the different neurotrophins. NGF
binds to TrkA, BDNF and NT-4 to TrkB, and NT-3 to TrkC.
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is whether the developmental actions of estrogen on neurite growth and differentiation
are mediated directly or result from intermediate steps via modulator interactions with
endogenous growth factors and their signaling pathways.
The neurotrophic effects of gonadal hormones appear to play some role in the
developmental determination of sex differences as well. For example, a role for nerve
growth factor (NGF) in the sexual differentiation of the brain is suggested by evidence
that the administration of NGF antibodies to neonatal rats prevented testosteronemediated defeminization of sexually dimorphic reproductive behavior and excitability of
VMN-midbrain projections (Yanase et al., 1988). Similarly, anti-NGF attenuated the
estrogen-mediated defeminization of lordosis (Hasegawa et al., 1991).

Function of the Neurotrophins
According to the classic mechanisms of neurotrophin action, neurotrophins are
released constitutively and influence the development and survival of certain populations
of neurons, depending on the specific Trk receptors they express. Such mechanisms
operate in almost all regions of the nervous system and have been studied extensively
during the past few decades (Barde, 1989; Davies, 1994). It also appears that
neurotrophins can influence synaptic transmission at both developing and adult synapses.
In addition to their specific patterns of expression in the adult CNS, the neurotrophins
and their receptors are developmentally regulated (reviewed by (Davies, 1994). BDNF,
NT-3, and NT-4/5 mRNA levels increase in abundance with postnatal age (Friedman et
al., 1991; Timmusk et al., 1993), and in rats, mRNA levels for TrkB and TrkC transiently
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peak between postnatal day (P1) and P14 in several different brain regions, correlating
with maximal neuronal growth, differentiation, and synaptogenesis (Ringstedt et al.,
1993; Altar et al., 1994; Knusel et al., 1994). Furthermore, McKay and colleagues
(Vicario-Abejon et al., 1998) have shown that neurotrophins can speed up the
development of both excitatory and inhibitory synaptic transmission in cultured
hippocampal neurons. Moreover, neurotrophins have been shown to promote neuronal
survival during development and after various brain insults (Lindvall et al., 1994). In fact
it has been suggested that the trophic support provided by the neurotrophins is required
for nerve growth during development (Tucker et al., 2001).
Additionally, a further function can be assigned to neurotrophins. Recent
evidence has accumulated that neurotrophins might serve as feedback regulators for the
efficacy of synaptic transmission in the mammalian CNS. It was shown that
neurotrophins are synthesized in an activity dependent manner by neurons and are
released upon depolarization (Thoenen, 1995; McAllister et al., 1999), making them
ideally suited to influence the neuronal activity in an autocrine fashion. In the
hippocampus, changes in BDNF mRNA levels are particularly dramatic, increasing by
over six fold in dentate granule cells within 30 minutes after seizure induction (Ernfors et
al., 1991). Additionally, in the developing brain, kainic acid or pilocarpine induced
seizures resulted in dramatic increases of BDNF mRNA in the hippocampus and cortex
as early as postnatal day 7 (Kornblum et al., 1997). Similarly, manipulations meant to
mimic neuronal activity are particularly effective in regulating neurotrophin mRNA
levels in dissociated neuron cultures. Depolarization of cultured hippocampal neurons

54
and cerebellar granule cells with glutamate receptor agonists or high potassium, for
example, dramatically increases the levels of mRNAs encoding BDNF and NGF (Bessho
et al., 1993; Lindholm et al., 1994; Berninger et al., 1995). Conversely, BDNF and NGF
levels are down regulated in the presence of GABA through activation of GABAA
receptors (Zafra et al., 1991; Berninger et al., 1995). This specific spatial and temporal
distribution of the neurotrophin and Trk receptors indicates that they are likely to be in
the right place at the right time to be involved in both developmental and adult plasticity.
Additionally, these studies suggest that brain derived neurotrophic factor acting through
its receptor trkB may be involved in protection mechanisms after damage during seizures
as well as in sprouting responses.

Brain-Derived Neurotrophic Factor
Brain-derived neurotrophic factor (BDNF) is a 27-kDa polypeptide that is
recognized to play an important role in the survival, differentiation, and outgrowth of
select peripheral and central neurons during development and in adulthood (Conover and
Yancopoulos, 1997; Lu and Figurov, 1997). The rat BDNF gene gives rise to four major
transcript forms, and each contains a unique 5’ exon (I-IV) and a common 3’ exon (V)
that codes for the mature BDNF protein (Timmusk et al., 1993). BDNF binds with high
affinity to a specific receptor tyrosine kinase, TrkB (Klein et al., 1991), both of which are
widely expressed in the central nervous system. In particular, the hippocampus expresses
high levels of mRNA for BDNF (Hofer et al., 1990) and the mRNA for TrkB is found on
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factors are functionally similar to retrogradely acting growth factors such as nerve
limiting quantities and promotes neuron survival through its retrograde transport and
signaling to the cell body. Recent studies have shown that the endogenous neurotrophins,
BDNF and NT-3, are transported anterogradely by central and peripheral neurons. The
supply of BDNF by afferents is consistent with their presynaptic growth factor (see LeviMontalcini, 1987). BDNF has also been shown to play an tissues, where they function as
trophic factors and act similar to neurotransmitters (Altar et al., 1997). This suggests that
these anterogradely transported and released trophic synthesis, vesicular storage release
and postsynaptic actions (Fig. 8). Anterograde axonal transport provides an afferent
supply of BDNF and NT-3 to neurons and target important role in activity-dependent
synaptic plasticity in the hippocampus (Kang and Schuman, 1995; Korte et al., 1995;
Korte et al., 1996; Patterson et al., 1996), to produce a lasting potentiation of synaptic
efficacy in the dentate gyrus (Messaoudi et al., 1998), and to enhance glutamatergic
synaptic transmission in hippocampal cultures through a presynaptic mechanism (Li et
al., 1998). In addition, TrkB ligands play a role in the visual cortex to regulate
development of ocular dominance columns (Cabelli et al., 1997), in sculpting the
dendritic morphology of pyramidal neurons, and in enhancing synaptic transmission
(Akaneya et al., 1997). Similar effects have been demonstrated in hippocampal cell
cultures, where BDNF has been shown to enhance growth and synaptic activity (Bartrup
et al., 1997). BDNF also induces the formation of excitatory and inhibitory synapses
(Vicario-Abejon et al., 1998; Bolton et al., 2000) and enhances the release of
neurotransmitters (Li et al., 1998). In slices from the developing hippocampus several
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studies have found that the application of BDNF influenced paired-pulse facilitation
(Kang and Schuman, 1995; Gottschalk et al., 1998).
The production of BDNF has also been shown to be regulated by synaptic
activity. Induction of hippocampal long-term potentiation (LTP), for example, rapidly
and selectively increases BDNF mRNA levels, with little or no effect on the other
neurotrophins (Castren et al., 1993; Dragunow et al., 1993). More recently, it has been
demonstrated that BDNF is upregulated during declarative memory formation in primates
(Tokuyama et al., 2000) suggesting that BDNF contributes to reorganization of neuronal
circuits for long-term memory formation. Furthermore, experiments have shown that
BDNF is rapidly and selectively induced in the hippocampus during contextual learning
(Hall et al., 2000) and spatial memory formation and maintenance (Mizuno et al., 2000).
The increase in hippocampal BDNF expression during contextual learning further
supports the suggestion that BDNF is involved in synaptic plasticity of the brain.
Together, these studies indicate that BDNF can have an effect on established synaptic
contacts that gives rise to the possibility that it can influence synaptic plasticity (Thoenen,
1995; Figurov et al., 1996).

Effect of Gonadal Hormones on BDNF
As recently been reported in adult rats, relative levels of BDNF mRNA within
specific regions of the hippocampus can fluctuate significantly over the course of the
estrous cycle with lowest levels detected in CA1 and CA3 on the afternoon of proestrus
(Gibbs, 1998). In addition, relative levels of BDNF mRNA in regions CA1, CA3 and the
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dentate gyrus were significantly increased in ovariectomized rats treated with estrogen
and progesterone relative to ovariectomized controls. Evidence for increased
hippocampal levels of BDNF mRNA following long-term continuous estrogen treatment
has also been reported (Singh et al., 1995). In addition, recent evidence demonstrates that
soy phytoestrogens can regulate levels of BDNF (Pan et al., 1999). In this study, it was
shown that following ovariectomy, levels of BDNF mRNA decreased in the frontal
cortex and a diet with added soybean estrogens returned the levels to that of intact
controls. Murphy et al. (1998a) recently demonstrated that short-term treatment with
estradiol produces a significant decrease in BDNF protein in primary rat hippocampal
cultures, and that the decrease in BDNF plays an important role in estrogen-mediated
increases in spine density on CA1 pyramidal cells. One possibility for the observed
down-regulation of BDNF by estrogen may actually be a result of increased transport of
the neurotrophin as recently suggested (Gibbs, 1999). Modulation of BDNF levels by
estradiol may operate at the transcriptional level because of the sequence homology
existing between the nuclear estrogen response element (ERE) and regions within exon V
of the BDNF gene (Sohrabji et al., 1995). Estrogen-bound receptor may bind to these
regions to directly regulate BDNF expression levels. Alternatively, estrogens could
affect BDNF expression indirectly through the activation of neurons that regulate BDNF
or estrogen-responsive afferents to the target region.
Steroid hormones have been shown to affect the levels of BDNF in avians as well.
For instance, testosterone treatment increases the levels of BDNF protein in the high
vocal center (HVc) of the adult female canary (Rasika et al., 1999). These effects could
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be mediated by estradiol, a metabolite of testosterone. In a similar system, it has been
shown that the expression of BDNF mRNA is increased significantly with the HVc of
male but not female zebra finches during development (Dittrich et al., 1999).
Furthermore, premature stimulation on the normal increase of the BDNF mRNA
expression in juvenile male zebra finches occurred after treatment with 17-estradiol.
Given the increasing evidence for effects of BDNF on neuronal connectivity and
activity-dependent synaptic plasticity in the adult brain, it is reasonable to hypothesize
that hormonal effects on BDNF expression can contribute to effects on brain structure
and function. In the hippocampus specifically, the up-regulation of BDNF expression
could be a mechanism by which estrogen triggers the differentiation of cells within and
connected to this brain region. It is possible then, that these effects will contribute to the
effects of estrogen on cognitive processes and neuronal morphology.

Summary and Hypothesis
The hippocampus is a tri-synaptic circuit in the brain that is involved in many
functions, including spatial mapping, and learning and memory. Its development begins
prenatally and follows a discrete timeline that continues well after birth. The
development of the hippocampus may be influenced by estrogen, as suggested by
morphological differences between males and females. It is currently unknown how
estrogen mediates these effects on the developing hippocampus, but one possible way is
by altering synaptic physiology. The developmental actions of estrogens may be
mediated directly or indirectly through autocrine responses or local paracrine
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mechanisms involving interactions with growth factors or steroid receptor coregulatory
proteins. Through these interactions, estrogen may act to enhance the excitatory
environment of the developing hippocampus. This enhanced level of excitation during
development is thought to provide trophic support and alter intracellular calcium levels.
The inability of steroids to exert an organizing effect on the brain after the critical period
of sexual differentiation may be functionally related to hormonally mediated changes in
neurotrophin expression during development.
Furthermore, the mechanisms of estrogen signaling have become increasing
complex with the recent cloning of ERand the realization that ERs may interact with
coregulatory proteins to affect transcription. Our preliminary data showing alterations in
the expression of BDNF mRNA and protein in the hippocampus following early
hormonal manipulations lead me to hypothesize that during rat brain development,
estrogen acts on the hippocampus by modulating brain derived neurotrophic factor, its
receptor trkB, and/or the p160 coactivator proteins. Based on the nuclear expression of
ER in neurons of the developing hippocampus, I believe that estrogen is having direct
transcriptional effects to alter morphological and biochemical properties of the rat
hippocampus.

CHAPTER 3
LOCALIZATION OF ESTROGEN RECEPTOR ALPHA (ER) IN PYRAMIDAL
NEURONS OF THE DEVELOPING RAT HIPPOCAMPUS

Abstract
During development, estrogen has a variety of effects on morphological,
biochemical and electrophysiological properties of hippocampal neurons.
Correspondingly, estrogen receptor (ER) binding and mRNA increase transiently in the
developing hippocampus. In this study, we used immunocytochemistry to determine the
localization of the ER subtype in the developing rat hippocampus. Nuclear staining was
present in pyramidal cells and some interneurons of the CA1 and CA3 regions of the
developing rat hippocampus. Little or no immunoreactivity was observed in postnatal
day (P)0 animals (day of birth = P0), however, beginning on P4, ERimmunoreactivity
(ER-ir) was visible and reached maximal levels by P10. These levels subsequently
declined to low levels so that by P15, levels approximated those of adult females.
Western blot analysis confirmed that this antibody recognized a 67kd protein,
characteristic of the full length ER protein, in the hippocampus and pituitary.
Furthermore, most of the ER immunopositive cells in the hippocampus were located in
the pyramidal cell layer, and did not co-localize appreciably with -amino butyric acid
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(GABA) at any age examined. We conclude, based on the immunocytochemical
localization of ER, that the effects of estrogen on biochemistry and morphology of the
developing hippocampus may be direct through the ER subtype in hippocampal
pyramidal cells.

Introduction
In addition to their primary role in the maintenance and regulation of reproductive
capacity, estrogens influence more general neurobiological functions, such as perceptualspatial skills and learning and memory (McEwen, 1983; Luine, 1997; Packard and
Teather, 1997; Sherwin, 1997). Estrogens can also act to alter certain pathologies such as
epileptic seizure activity (Terasawa and Timiras, 1968; Saberi et al., 2001) and perhaps
Alzheimer’s disease (Henderson et al., 1996) and Parkinson’s disease (Leranth et al.,
2000). The mechanism and sites of action for the effects of estradiol on cognitive
performance and epileptic seizure activity have not been established, but one probable
site is the hippocampus, a sexually dimorphic, steroid-responsive brain region (Juraska et
al., 1989; Roof and Havens, 1992; Woolley and McEwen, 1992).
In the adult, it has been demonstrated that the hippocampus displays a robust
response to estrogen treatment and to fluctuations in ovarian hormones across the estrous
cycle (Gould et al., 1990; Woolley and McEwen, 1992). Sex differences are seen in the
CA1 and CA3 regions where males and females differ in dendritic branching patterns and
dendritic spine densities (Gould et al., 1990) and synapses (Woolley and McEwen, 1992).
When ovariectomized rats are treated with estradiol, an increase in spine density occurs

63
on the apical dendrites of the pyramidal cells in the CA1 region (Woolley and McEwen,
1993). Furthermore, the existence of low levels of estrogen receptors has been shown in
the pyramidal cell layer of Ammon’s horn, dentate gyrus, and subiculum of the adult rat
(Pfaff and Keiner, 1973; Rainbow et al., 1982; Loy et al., 1988).
The developing brain is also affected by exposure to gonadal steroids resulting in
sexual differentiation of the brain, which is characterized by sex-specific anatomical and
physiological features of the adult animal (Harris and Levine, 1962). Ovarian steroids act
during a perinatal sensitive period of development to alter the patterns of neuronal cell
death, neuronal cytoarchitecture and synaptic connectivity of the hypothalamus
(McEwen, 1983). Gender-related differences in hippocampal dendritic plasticity of the
Ammon’s horn (Juraska et al., 1989; Isgor and Sengelaub, 1998) and dentate gyrus
(Juraska et al., 1985) during development have been reported. These early influences of
steroids on the brain are essentially permanent and in part determine the steroid
responsiveness of the adult brain (MacLusky and Naftolin, 1981). Consistent with this,
estrogen receptor binding and aromatase enzyme levels have been reported to be elevated
during this developmental period (O'Keefe and Handa, 1990; MacLusky et al., 1994).
However, the anatomical distribution of ER’s in the neonatal hippocampus has not been
reported.
Until recently, the effects of estrogen were thought to be mediated by a single
estrogen receptor. The cloning of ER in 1996 (Kuiper et al., 1996) has suggested new
complexities in estrogen signaling. While both subtypes are present in the adult
hippocampus (Li et al., 1997b; Shughrue et al., 1997) it is unclear which receptor is
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involved in modifying hippocampal morphology and physiology in development. Early
studies have demonstrated a transient elevation of ER mRNA and estrogen binding in the
neonatal rat hippocampus (O'Keefe and Handa, 1990; O'Keefe et al., 1995). However,
these studies were conducted before the cloning of ER, and do not necessarily
discriminate between ER and isoforms or provide a careful examination of the
anatomical distribution of each isoform To further elucidate the developmental profile of
estrogen receptors in the brain, we examined the distribution of ER containing cells in
the hippocampus of the male and female rat. We have demonstrated the presence of ER
in regions CA1 and CA3 of the developing rat hippocampus using immunocytochemistry
and Western blot analysis, and have shown that they are found predominantly in
pyramidal neurons.

Materials and Methods

Animals
Neonatal male and female rats of various ages from timed-pregnant Sprague-Dawley
dams and female adult rats were used in these studies (Charles River Laboratories,
Wilmington, MA). Animals were housed under a 12/12 h light dark cycle (lights on at
07.00 h) with food and water available ad libitum. Upon parturition, litters were sexed
and thinned to 8 pups (4 males and 4 females). Animals of both sexes were sacrificed at
postnatal (P) days 0, 4, 7, 10 and 15 (day of birth = P0) and females at 2-4 months
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(adults). All animal protocols were previously approved by the Animal Care and Use
Committee at Colorado State University.

ER Immunocytochemistry
Neonatal rat pups were anesthetized with Halothane and sacrificed by perfusion
with 10-20mL of 0.01M ice-cold phosphate buffered saline (PBS) followed by 10-20mL
of freshly prepared ice-cold 4% paraformaldehyde in 0.01M PBS. Adult animals were
anesthetized and sacrificed similarly, but were perfused with approximately 200mL of
0.01M PBS and 200mL 4% paraformaldehyde. Brains were post-fixed in 4%
paraformaldehyde overnight at 4ºC and subsequently removed and placed into 30%
sucrose in 0.01M PBS at 4°C until permeated. Brains were sectioned 30m thick on a
cryostat and placed into 0.01M PBS with 0.1% Triton X-100 (PBS-TX) and 0.1%
Sodium Azide. The tissue was processed for immunocytochemistry (ICC) as described
previously (Kerr et al., 1995). Briefly, the tissue was first incubated with 0.3% H2O2 in
0.01M PBS to quench any nonspecific reaction with endogenous peroxidases.
Subsequently, non-specific antibody binding was blocked by incubation with 4% normal
goat serum (NGS) in 0.01 M PBS. Tissue was then incubated for 48 hours at 4ºC with
ER antiserum (C1355, 1:10,000; M. Shupnik, U. of VA) in the presence of 2% NGS.
This antibody was raised against the 14 most carboxyl-terminal amino acids of the rat
ER, and has been described previously (Friend et al., 1997). Following primary
antibody incubation, the tissue was washed (3 x 15 min. in 0.01M PBS-TX at room
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temperature) and incubated for 2 hours at room temperature with a biotinylated goat antirabbit IgG (1:500; Vector Labs, Burlingame, CA). Tissue was washed as before and
incubated with an avidin-biotin-horseradish peroxidase complex (1:500; Vector Labs) for
1 hour. Staining was visualized with a tris-buffered saline solution containing
diaminobenzadine (DAB, 0.5mg/ml; Sigma) and hydrogen peroxide (0.01%) for 6-10
minutes. After developing, the tissue was rinsed and mounted on glass slides. The
mounted sections were allowed to air dry overnight at room temperature and were
subsequently dehydrated in graded ethanols, cleared in xylene and coverslipped with
Permount (Fisher Scientific, Fair Lawn, NJ) for analysis.
To determine immunoreactive specificity, we pre-adsorbed the antibody with the
immunoreactive peptide, which was the same amino acid sequence the antibody was
raised against. The antibody was incubated with 0.5ng/ml of the peptide in 0.01M PBS
overnight at 4ºC. Tissue was then incubated with either a normal antibody solution, or an
antibody + peptide solution for 48 hours at 4ºC. The tissue was then processed as
described above for immunocytochemistry.

Double-label immunocytochemistry
For the co-localization studies, tissue from three P10 females was first processed for
ER immunoreactivity which was visualized with nickel intensified DAB. Briefly, 0.3
mg/mL of nickel ammonium sulfate was added to the DAB solution resulting in a dark
blue stain. Subsequently, the tissue was washed in 0.01M PBS (3 x 15 min. at room
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temperature). The tissue was then processed for -amino butyric acid (GABA)
immunoreactivity using anti GABA serum (1:10,000, Sigma, St. Louis, MO).
Essentially, the tissue was processed as above, except that after incubating with 0.3%
H2O2 the tissue was blocked for 2 hours in 6% NGS. Tissue was then washed (3 x 15
min. in 0.01M PBS-TX) before the secondary antibody incubation as described above.
Following a final washing step as before, this reaction was developed with normal DAB
(0.5mg/mL + 0.01% H2O2) to produce a brown reaction product. After developing, the
tissue was rinsed in 0.01M PBS and mounted on glass slides. The mounted sections were
air-dried overnight at room temperature and subsequently the slides were processed
through a series of increasing alcohols, cleared with xylene, and coverslipped with
Permount (Fisher Scientific). Double-labeled cells were visualized by microscopy as
cells containing a dark blue nucleus and a brown cytoplasm. The percentage of doublelabeled cells was determined by taking a ratio of the number of ER+/GABA+ cells to the
number of ER+/GABA- cells in four separate coronal sections from each animal which
spanned the hippocampus from dorsal to ventral. Cell counts were made using a 40X
objective in three randomly chosen areas of each hippocampal subfield. Cells with a dark
blue nucleus and a brown cytoplasm were considered double labeled, whereas those cells
which did not contain a brown cytoplasm were considered ER positive only.
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Western Blot Analysis
Male and female animals were sacrificed at various ages and the brains were quickly
removed. The hippocampi were dissected on ice and individually homogenized in 200l
of 50mM Tris buffer (pH 7.2, 4ºC) containing 1mM EDTA, 1 mM phenylmethylsulfonyl
fluoride (PMSF), 1mM leupeptin, 1 g/ml antipain, and 1 g/ml aprotinin. Homogenates
were then centrifuged (105,000 x g) for 30 minutes at 4ºC in a Beckman L765
Ultracentrifuge and the membrane and cytosolic fractions were collected. Protein
concentrations were determined using the BCA protein assay (Pierce, Rockford, IL).
Protein samples were mixed 1:1 with sample buffer containing 10% glycerol, 2% SDS,
5% -mercaptoethanol, and 0.05% bromphenol blue and boiled for 5 minutes. The
samples (100g/hippocampus, 60g/pituitary) were separated by SDS polyacrylamide
gel electrophoresis along with biotinylated molecular weight standards (Bio-Rad,
Hercules, CA). The stacking gel contained 4% acrylamide while the resolving gel
contained 12% acrylamide. Following electrophoresis the proteins were electrically
transferred to nitrocellulose in 49.6 mM Tris, 384 mM glycine, 0.01% SDS at 30V
overnight followed by 80V for 1 hour at 4ºC. The gels then were stained with Coomassie
blue to confirm equal protein loading per lane. After transfer, blots were incubated in
tris-buffered saline with 0.1% Tween-20 (TBST) containing 5% non-fat milk, 2% bovine
serum albumin, and 0.1% sodium azide. Subsequently, blots were incubated with
ERantiserum (C1355, 1:10,000) for 48 hours at 4ºC in TBST containing 2% non-fat
milk and 0.1% sodium azide. To serve as controls, blots were also processed without
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primary antibodies or with antibodies pre-adsorbed with the immunoreactive peptide.
Following primary antibody incubation, the blots were washed (three times, 15 minutes
each in TBST at 25ºC) and incubated with horseradish peroxidase conjugated goat antirabbit antibodies (1, Vector Labs, Burlingame, CA). Immunoreactive bands were
visualized with an enhanced chemiluminescence system (ECL, Amersham, Arlington
Heights, IL) according to manufacturers directions. To ensure that each lane was loaded
with an equivalent amount of protein, the blots were stripped with 0.2M NaOH and reprobed with anti-actin serum (1:10,000; Chemicon, Temecula, CA) as described above.
Following immunoblotting, digitized images of immunoreactive bands for target (ER)
and control (actin) products were imported into NIH Image software (v. 1.62) and the
average OD of each band was measured (based on a grayscale of 0-256 arbitrary units).
Additional background measurements were taken from each film and subtracted from
these values. A ratio of ER/actin was then determined and these values were compared
across development for statistical significance using a one-way analysis of variance
(StatView, SAS Institute Inc.).

Results
ER immunoreactivity in the developing rat hippocampus
The developmental profile of ER in regions CA1 and CA3 of the rat
hippocampus as determined by immunocytochemistry are shown in Fig. 13. ER
immunoreactivity (ER-ir) is concentrated to the nucleus of cells in the pyramidal layer
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of these subregions, although a few cells throughout stratum oriens and radiatum were
immunopositive as well. Immunoreactivity was consistently highest in the CA3
subregion, where not only the number of ER-ir cells was the greatest, but the number of
darkly stained cells as well. Lower levels of immunoreactivity (number of cells and
darkly stained cells) were observed in CA1 with very few cells stained in the hilus and
dentate gyrus. In CA1 and CA3, ER-ir increased from postnatal (P) day 0 to P10, at
which age the largest number of immunoreactive positive cells were observed.
Moreover, at P10, the number of darkly stained cells was also the greatest. These levels
subsequently declined, so that by P15, levels approximated those of the adult.
At early stages in development (P0-P4) no obvious anterior to posterior
differences were observed in ER-ir. However, at later stages (P7-P10) less staining was
generally observed in both CA1 and CA3 of the extreme anterior pole of the
hippocampus (corresponding to -2.1 mm from bregma, adult coordinate) and increased in
more caudal sections (corresponding to -3.8 from bregma, adult; Fig.14).
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Figure 13 Legend: Ontogeny of ER immunoreactivity in pyramidal cells of the rat
hippocampus. Coronal (30m) sections were taken from postnatal and adult female rat
brains and immunostained with a polyclonal ER antiserum followed by nickel
intensified peroxidase-DAB for detection. Staining is primarily concentrated to the
nucleus of pyramidal cells in regions CA1 and CA3 (arrowheads) although some
immunoreactive cells can be seen in stratum radiatum (arrows). Little to no
immunoreactivity is observed on postnatal day (P) 0. Staining subsequently increases
from P4 to P7 and reaches the highest intensity by P10. ER immunoreactivity then
declines to levels seen in the adult. Immunostaining in the hippocampus is compared to
that of the preoptic area, a brain region known to express high levels of ER. Staining in
the preoptic area is intense at P0, and remains strong throughout adulthood. SO, stratum
oriens; SP, stratum pyramidale; SR, stratum radiatum.
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Figure 133
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Immunoreactivity remained relatively constant from this point caudally to the posterior
pole (corresponding to –5.6 from bregma, adult), where the level number of ER-ir cells
was the highest. In the adult, the highest concentration of immunoreactive cells were
located –4.3 to –5.6 from bregma. Additionally, in the adult, a relatively large number of
ER-ir cells were located in the ventral hippocampus. The ventral hippocampus of the
neonate, in contrast, is less defined, making it difficult to make comparisons.
Similar to earlier developmental stages, we observed a few ER-ir cells scattered
in the stratum radiatum and oriens of the adult as well. There was no significant
difference in the level of ER immunoreactivity between males and females at any age
examined, where the number of immunopositive neurons appeared the same. A similar
ontogenetic profile was observed in the neocortex as has been previously demonstrated
(Yokosuka et al., 1995). Additionally, we compared immunostaining in the hippocampus
to that of the preoptic area, a brain region known to express high levels of ER. While
ER immunoreactivity is attenuated with maturation in the hippocampus, in the preoptic
area, ER-ir was strong at P0 and remained relatively high through adulthood (Fig. 13).
To determine if the staining we observed was specific for ER, we pre-adsorbed
the antibody with the immunoreactive peptide. The peptide was made corresponding to
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Figure 14 Legend: Schematic drawings representing the immunohistochemical
distribution of ER in three coronal sections of the postnatal day 10 rat brain. Relative
numbers of immunoreactive cells are represented by black circles; where the highest
numbers of cells are represented by the largest circles, intermediate numbers are
represented by medium sized circles, and the lowest numbers are represented by the
smallest circles. CA1-3, fields CA1-3 of Ammon’s horn; cg, cingulum; DG, dentate
gyrus; Ent, entorhinal cortex; ic, internal capsule; LV, lateral ventricle; ml, medial
lemniscus; S, subiculum. Drawings modified from the atlas of (Paxinos and Watson,
1986).
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Figure 144
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the last 14 amino acids of ER. Pre-incubation of the antibody with an 0.5ng/mL of the
immunoreactive peptide completely abolished all staining in the hippocampus and other
ER immunoreactive brain regions, such as the preoptic area (data not shown).

Western blot analysis
Using Western blot analysis, we determined that the ER expressed in the
developing male and female rat hippocampus is a full-length protein (Fig. 15A). The
antibody used in this experiment recognized a protein of approximately 67 kDa, which is
the size for the full length ER as previously reported (Furlow et al., 1990). Initial
experiments were conducted to investigate the presence of ER in both membrane and
cytosolic fractions following centrifugation. These experiments demonstrated that nearly
all ER was recovered in the cytosolic fraction (Fig. 15A), and no immunoreactive bands
were detectable in the membrane fraction (not shown).
The protein recognized in hippocampus correlates with a protein of the same size
in the pituitary (Fig. 15A), a tissue known to express high levels of ER. We were also
able to detect an intense band of the same size in the hypothalamus and uterus (data not
shown). In addition, the ontogenetic expression profile for ER by Western blot closely
matched that of ER-ir in the hippocampus. That is, immunoreactivity levels increased
from P0 to P10, where the level of expression is higher than all other ages examined
(p<0.005), with a subsequent decline to levels observed in the adult (Fig 15B).
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Figure 15 Legend: Western blot analysis of ER protein in the developing rat
hippocampus. (A) A single band of approximately 67 kDa detected by Western blotting
of cytosolic protein from the hippocampus of various days during postnatal (P)
development. Relative levels of hippocampal cytosolic protein (100g) are compared to
that of adult pituitary cytosolic protein (60g), which expresses abundant levels of ER.
The protein detected in the hippocampus is of the same molecular weight as full length
ER, which is the predominant form found in the pituitary. (B) Following Western blot
analysis of ER and actin in the developing hippocampus, mean optical densities were
determined of immunoreactive bands. Background levels were subtracted from these
measurements and a ratio of ER/actin was determined to give a net mean density for
each age. Each bar represents the mean ± S.E.M. of 3 independent experiments. (*)
Significantly higher than all other ages examined (p < 0.005).
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Figure 155
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When immunoblots from males and females were compared, it was determined that there
was no significant difference in the level of ER expression between the sexes at any age
examined. Furthermore, pre-adsorption of the antibody with the immunoreactive peptide
completely eliminated the 67 kDa band (data not shown).

ER/GABA double label immunocytochemistry
To assess whether ER is localized to pyramidal cells or interneurons of the
developing rat hippocampus, we used double label immunocytochemistry for ER and
GABA, a marker of interneurons. Postnatal day 10 females were used in these studies
because the level of ER immunoreactivity is highest at this age. We have demonstrated
that while ER and GABA are co-localized in a few cells of the neonatal hippocampus,
the majority of ER-ir neurons are GABA negative (Fig. 16). This is especially the case
in the CA3 subregion, where 96% ± 0.8% of ER-ir cells are not GABA-ir (92% ± 2.1%
in CA1), implying that they are pyramidal cells, rather than GABAergic interneurons.
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Figure 16 Legend: Double label immunocytochemistry of ER and GABA in the
pyramidal cell layer of the P10 rat hippocampus. Cells in the CA1 region of a P10 (A, B)
and adult (C-E) rat hippocampus were immunostained for ER and GABA. Cells
immunoreactive (ir) for ER contain a dark blue nucleus, while cells which are
immunoreactive for GABA contain a brown cytoplasm. Low power (A) and high power
(B) photomicrographs of the CA1 region of a P10 female hippocampus demonstrating
ER and GABA immunoreactivity. Cells in stratum pyramidale tend to be either ER-ir
(black arrowheads) or GABA-ir (white arrows) but not both. Some ER-ir cells can be
seen in stratum radiatum as well (black arrows). Less ER-ir is observed in the CA1
region (C) of the adult compared to the CA1 region of the P10 animal (A). A few
scattered ER-ir cells can be seen in the granule cell layer (D; black arrowheads) and
stratum radiatum (E; black arrows) of the adult as well. GABA-ir cells can also been
seen in these subregions, but these are not ER-ir. SO; stratum oriens, SP; stratum
pyramidale, SR; stratum radiatum.
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Figure 16
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Discussion

In the present study, using a specific antibody that detects full length ER, we
examined the ontogeny and distribution of ER containing cells in the developing male
and female rat hippocampus. Our results demonstrate that the ERphenotype is
transiently expressed in the developing rat hippocampus. At postnatal day 0, there is very
little expression of ER in the rat hippocampus. ER can be detected by P4 and reaches
its maximum levels by P10. ER-ir then decreases, so that by P15 the levels observed
approximate those of the adult. Moreover, expression of ER is concentrated to the
nucleus of pyramidal cells in the CA1 and CA3 regions of the developing rat
hippocampus, although some immunoreactive interneurons were also detected.
Our results also show a distribution pattern that is consistent with previous reports
of ER mRNA levels, where within the pyramidal cell layer, the highest density is found
in the CA3 region, intermediate levels are found in the CA1, and lower levels are found
in the dentate gyrus (O'Keefe and Handa, 1990). However, the ontogenetic pattern of
expression that we observed differs somewhat from that previously reported using RNase
protection assay (O'Keefe et al., 1995) and receptor binding techniques (O'Keefe and
Handa, 1990). In those studies, the peak of ERs in the neonatal hippocampus was
approximately postnatal day 7, while the peak we have observed for ER is on postnatal
day 10. The earlier studies were conducted prior to the identification of ER though, and
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did not differentiate between the two receptor isoforms. The presence of ER could
create the discrepancy between those studies and this one.
A recent report has demonstrated the presence of ER mRNA in the neonatal
mouse hippocampus (Ivanova and Beyer, 2000). In this report it was demonstrated using
semi-quantitative RT-PCR that male mice have transiently higher levels of ER and 
mRNA than females at P7. While previous work in our laboratory has shown a similar
ontogenetic profile for ER message levels in the hippocampus using in situ hybridization
(O'Keefe et al., 1995), we have not observed a sex difference in either ER mRNA
(O'Keefe et al., 1995) or protein levels (current study and O'Keefe and Handa, 1990).
The use of different species (mouse vs. rat) in these studies could explain this
discrepancy. Furthermore, Ivanova and Beyer (Ivanova and Beyer, 2000) did not
examine levels of ER protein and it is possible that variations in either ER message
stability or degradation could account for the differences they report. Finally, we have
observed developmental differences in hippocampal subregions (CA1 vs. CA3) that
would have been missed if the entire hippocampus, including the dentate gyrus and
subiculum were homogenized together. In these brain regions we have observed very
little ER staining.
The data presented in this study also raise another interesting question concerning
the time frame for organizational effects of steroid hormones in different brain regions.
For instance, extensive studies examining the hypothalamus have demonstrated that in
rats, gonadal hormones influence sexual differentiation of the hypothalamus from
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gestational day 18 through about the second week after birth (MacLusky and Naftolin,
1981), and these effects are likely mediated through the estrogen receptor. Our results,
showing the peak of ER expression at P10 in the hippocampus, which is relatively late
in relationship to the “critical period” of the hypothalamus, could suggest that the
hippocampus possesses a critical period that is later or prolonged compared to that for the
hypothalamus. This is consistent with the fact that the hippocampus finishes developing
at a later age than the hypothalamus (Bayer, 1980; Jacobson and Gorski, 1981a; Seress,
1985), and studies in the hypothalamus have shown that different critical periods exist for
different functions (Handa et al., 1985). Alternatively, it may be that the transient
expression of ER in the hippocampus is not related to sexual differentiation at all.
Based on the morphology and localization of immunoreactive cells, it appears that
ER is localized predominantly to hippocampal pyramidal neurons, rather than non-spiny
interneurons. This is consistent with data demonstrating the localization of ER
messenger RNA in the developing hippocampus using in situ hybridization (O'Keefe et
al., 1995). However, early reports suggested that, in the adult, ERs are concentrated to
interneurons rather than pyramidal cells (Weiland et al., 1997), even though most
morphological and physiological effects of estrogen have been demonstrated in
pyramidal cells (Woolley and McEwen, 1992; Lavenex et al., 2000). For instance, it has
been shown that following treatment with estradiol, it is primarily pyramidal cells that
become activated when using c-Fos as an indicator (Rudick and Woolley, 2000). Our
study, in contrast to earlier reports, further demonstrates that the ER-ir cells are
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pyramidal neurons, although the staining in the adult is much lighter than earlier periods
in development. While we detected a few scattered ER-ir cells in stratum radiatum and
oriens, nearly all immunoreactivity was observed in stratum pyramidale, supporting our
conclusion that the ER-ir cells are pyramidal neurons. Moreover, it is unlikely that the
ER-ir cells are interneurons based on their number, considering that interneurons
constitute a relatively small percentage of all neurons in the hippocampus (Olbrich and
Braak, 1985). A recent report supports the suggestion that ER is only localized to nonspiny interneurons in the developing hippocampus (Orikasa et al., 2000). However, the
earliest age examined in that study was postnatal day 14, a time point where we have not
observed any difference from adults, and the levels of ER expression are relatively low.
Additionally, the report of Orikasa et al. (2000) used in situ hybridization histochemistry
with digoxigenin-labeled probes to assess mRNA levels and a different ER antiserum.
Therefore, while the data from Orikasa et al. (2000) are not inconsistent with the results
presented here, differences in methodologies could explain the discrepancies. Additional
evidence that ER is primarily localized to pyramidal cells comes from our colocalization studies where, in the developing rat hippocampus, very few ER-ir cells are
also immunoreactive for GABA, thus, strongly suggesting that the ER-ir cells are
pyramidal cells rather than interneurons. Unfortunately, no specific marker of all
pyramidal cells exists to our knowledge, and thus we are unable to make an absolute
determination of ER-ir neuron type.
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While the number of immunoreactive cells in the adult was less than that
observed at P10, the number of ER positive cells visualized was much greater than
originally reported (Weiland et al., 1997). The distribution we observed in the adult more
closely resembled the recent report of Shughrue and Merchenthaler (Shughrue and
Merchenthaler, 2000), where pyramidal cells of regions CA1-3 were highly labeled,
especially in the ventral hippocampus. The report by Shughrue and Merchenthaler
(Shughrue and Merchenthaler, 2000) provides additional anatomical evidence of the
presence of ERs in pyramidal cells of the adult hippocampus, supporting our results in
the developing and adult animal as well. Similar to our findings, this article has
challenged the notion that ERs are only found in non-spiny interneurons as was originally
reported. Our observations, and those of Shughrue and Merchenthaler (Shughrue and
Merchenthaler, 2000), fit with the majority of physiological data showing direct effects of
estrogen on pyramidal cells.
The recent discovery of ER raised the possibility that many of the effects of
estrogen could be mediated by this receptor. While messenger RNAs for ER and to a
lesser extent ER have been detected in the adult hippocampus (Simerly et al., 1990;
Shughrue et al., 1997), it has not been demonstrated whether ER protein exists or not.
Furthermore, all of the previous estrogen binding studies have either been conducted in
the adult or do not discriminate between the two receptor types. Our data suggest that the
receptor responsible for mediating estrogens actions in the hippocampus is ER, but does
not rule out a similar role for ER. Considering the important role that ER potentially
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plays in the hippocampus, studies examining the anatomical distribution of both message
and protein for this receptor during development should to be conducted. Such data are
currently missing from the literature and would provide additional insight into the
complexity of ER signaling mechanisms.
The identification of multiple splice variants of ER mRNA (Petersen et al.,
1998) in the normal rat brain has suggested an additional level of complexity in estrogen
signaling. Recently, it has been suggested that the major splice variant of ER in adult
hippocampus is one that lacks the fourth exon (Price et al., 2000). This 4 variant does
not bind estrogen. Similarly, splice variants of ER have been identified (Pfeffer et al.,
1996; Pasqualini et al., 1999). An ER variant mRNA, lacking exon four, has been
isolated from the adult rat brain (Skipper et al., 1993), but does not appear to be present
in hippocampus (Price et al., 2000). Most of the ER variant mRNAs have only been
isolated in cancer tissues, cell lines or non-brain tissues. In this study we have
demonstrated that the ER protein detected in the hippocampus is consistent with the size
for the functional full-length ER subtype previously described (Furlow et al., 1990).
During normal development, the male brain is exposed to high levels of gonadal
steroids during a perinatal sensitive period. These steroids act to organize the brain in a
male direction resulting in permanent morphological and physiological changes. It has
been proposed that the organizational effects of estrogen seen early in development create
a hormonally responsive brain in adulthood (Phoenix et al., 1959). The transient
expression of ER in the rat brain implicates it in mediating the effects of estrogen
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during development. Furthermore, during the second postnatal week, a time when we
observe the highest concentration of ER, the plasma levels of estradiol are also high
(Meijs-Roelofs et al., 1973; Dohler and Wuttke, 1975). It follows then, that estrogen
acting on the ER receptor in the hippocampus around the tenth postnatal day of
development could be responsible for creating a hippocampus that has an altered
responsiveness to gonadal hormones in adulthood. For instance, although castration of
male rats reduces spine density in adulthood, estrogen treatment of adult gonadectomized
males has no effect on spine density in contrast to the effect of estrogen in females
(Lewis et al., 1995). It is also possible that estrogen is acting during the neonatal period
to sculpt the morphology or connectivity of the hippocampus in a male (or female)
direction and to function differently in adulthood, regardless of the adult steroid
environment. Unfortunately, most studies of the effects of estrogen in the hippocampus
have been conducted in the adult, and have overlooked the neonatal period when the
organizational effects of steroid hormones occur.
The classical role of ER in neurobiology is to regulate the expression of specific
target genes by binding DNA directly through estrogen response elements (Beato et al.,
1989). Previous work in this laboratory has shown that in the neonatal hippocampus, ER
can bind DNA (O'Keefe and Handa, 1990). In this study, we have demonstrated a
transient increase of ER immunoreactivity in the nucleus of pyramidal cells of the
developing rat hippocampus. The fact that ER immunoreactivity is concentrated to the
nucleus is consistent with a genomic form of action that has been extensively described.
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Until recently, based on studies in adult rat brain, it was believed that ERs only existed in
non-pyramidal neurons. This created speculations that estrogen was acting though sparse
interneurons or non-genomic mechanisms to alter hippocampal morphology. Based on
our data, it appears that in the neonate, the effects of estrogen to developmentally
organize the hippocampus are mediated directly through hippocampal pyramidal cells,
rather than GABAergic interneurons. It is also possible that activation of ER in
development results in transcriptional changes that alter the morphology and physiology
of developing hippocampal pyramidal neurons. These findings may contribute to our
understanding of the cellular mechanisms by which estrogen modulates hippocampal
related behaviors.

CHAPTER 4
EXPRESSION OF ESTROGEN RECEPTOR BETA (ER) mRNA SPLICE
VARIANTS IN THE DEVELOPING RAT HIPPOCAMPUS

Abstract
During development, estrogen has been shown to have a variety of effects on
hippocampal neurons. In the brain, the actions of estrogen are mediated by two different
estrogen receptors (ER);  and . ER mRNA has been has been shown to be variably
spliced in brain tissue, resulting in proteins with different functional properties. Wild
type ER has been designated 1, an insert between exon 5 and 6 in the ligand binding
domain (LBD) has been termed 2, and a deletion of exon 3 or 4 has been termed 3 or
4 respectively. In this study, we examined the expression and regulation of ER
mRNA splice variants (with and without 3 together) in the hippocampus, hypothalamus
and cortex throughout early postnatal development using quantitative real-time RT-PCR.
These results were compared to data obtained using conventional PCR methods.
Additionally, because 2 variants have been reported to have a lower affinity for estradiol
than 1, we used an estrogen receptor binding assay to assess whether the pattern of
estrogen binding during development was consistent with the mRNA isoforms expressed
at the same period. Our results suggest a development change in the levels of ER
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mRNA isoforms. From postnatal day (P) 0-4, the 2 variants are expressed at very low
levels in the hippocampus. Based on the changes in amino acid structure, it is likely that
this isoform does not contain a functional LBD. At P7 a significant change in the pattern
of ER splice variants occurs in the hippocampus such that the 2 variants are expressed
significantly higher. Conventional PCR studies suggest wild type and 4 variants are also
present in the developing hippocampus. Beginning on postnatal day 15 and continuing
through adulthood, there is a gradual decrease in the level of expression for the ER
splice variants. In contrast to the hippocampus, in the prefrontal cortex and
hypothalamus ER2 variants do not change significantly over development.
Conventional PCR methods suggest that the wildtype form is predominantly expressed in
these brain regions during development. Next, to determine if ERsplicing might be
hormone regulated during development, we gonadectomized male rat pups at P0 and
subsequently treated them with a single injection of 10g of estradiol benzoate or oil
vehicle. Gonadectomy caused a change in the expression pattern of ER mRNA
isoforms, where ER1 was expressed at the highest levels at early ages. Estrogen
treatment results in a pattern of expression similar to that of intact males. These data
suggest that different ER mRNA isoforms are present during development, including
ER2 which has an 18 amino acid insertion in the ligand binding domain.

92
Introduction
Estrogen signal transduction is mediated by two estrogen receptors,  and 
(see Katzenellenbogen, 1996) which are encoded by different genes. These receptors are
members of the nuclear receptor family of transcription factors (Tsai and O'Malley,
1994). All members of the nuclear receptor superfamily share characteristic structural
and functional domains able to act relatively independently of each other. These domains
include the ligand-binding domain located at the C-terminal half of the protein, the DNAbinding domain located centrally, and a variable transactivation domain located at the Nterminal end (Evans, 1988).
Additionally, for ER and ER, a number of messenger RNA variants have been
described (Fuqua et al., 1993; Pfeffer et al., 1996) which are generally the result of an
imprecise pattern of mRNA splicing that gives rise to a family of correctly processed and
exon-skipped transcripts that disrupt the normal domain structure of the receptor. While
most of the ER splice variants have been described in cancer cell lines or tumors, a few
reports have demonstrated their presence in normal tissues such as the pituitary (Friend et
al., 1997; Fasco et al., 2000; Pasqualini et al., 2001). Several ER mRNA splice variants
have also been described, many of which are endogenously expressed at relatively high
levels in normal tissues (Petersen et al., 1998; Raab et al., 1999; Inoue et al., 2000; Price
and Handa, 2000; Price et al., 2000).
There are currently at least five ER mRNA variants that have been described to
date including the wildtype form which has been designated ER1. ER2 has an in-
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frame insertion of 54 nucleotides between exon 5 and 6 that composes 18 amino acids
within the ligand-binding domain (Petersen et al., 1998). As predicted, this hormone
binds estrogen with a much lower affinity than the wildtype receptor and requires 1001000 times more estrogen to fully activate transcription (Petersen et al., 1998; Hanstein et
al., 1999). The 3 variant encodes an isoform resulting from an in-frame loss of 117 base
pairs in the DNA binding domain. As a result, this splice variant does not bind DNA
efficiently, but rather appears to enhance transcriptional activation through an activator
protein-1 (AP-1) response element in the promotor (Price et al., 2001). Lastly, a 4
variant results from the deletion of the fourth exon encoding the nuclear localization
signal (Price et al., 2000). As a result, this receptor variant appears to localize to the
cytoplasm. These ER mRNA splice variants modify the organization of the structural
domains, subsequently resulting in proteins with different cellular and subcelluar
localizations and altered functional properties (Hanstein et al., 1999; Inoue et al., 2000;
Price et al., 2001). For instance, it has been demonstrated using transient transfection
experiments with green fluorescent protein tagged splice variants that the subnuclear
distribution is highly dependent upon the ER splice variant expressed (Price et al.,
2001).
In this study, we used conventional and quantitative real-time PCR to examine the
expression of ER mRNA splice variants in several regions of the developing rat brain,
including the hippocampus, medial basal hypothalamus, and cortex. Our results
demonstrate that all ER variants are expressed in brain tissue, and in some cases the
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expression levels of variants were equal or near wildtype levels. Additionally, the
expression pattern was unique for the ER splice variants depending on the brain region
examined. This was particularly the case for the hippocampus, which expressed high
levels 2 variants during development. In contrast, the medial basal hypothalamus and
cortex did not show significant changes in ERb mRNA splice variants during
development.

Materials and Methods

Animals.
Timed-pregnant Sprague-Dawley females and adult male and female adult rats were
obtained from Charles River Laboratories (Portage, MI). Animals were housed under a
12/12 h light dark cycle (lights on at 07.00 h) with food and water available ad libitum.
Upon parturition, litters were sexed and thinned to 8 pups (4 males and 4 females).
Shortly after birth (4-6 hours), some pups were gonadectomized under hypothermia
anesthesia. Of these, half received a single subcutaneous injection of 10g estradiol
benzoate in 50l sesame oil, while the other half received oil alone. This protocol has
been shown to result in a decrease in plasma testosterone levels, an increase in estrogen
receptor levels and the abolishment of male sexual behavior (Ulibarri et al., 1990;
Kuhnemann et al., 1995; McCormick et al., 1998; Atanassova et al., 1999), presumably
by overcoming the ability of circulating alpha-fetoprotein to sequester circulating
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estrogen from the brain. Animals were subsequently sacrificed at postnatal (P) days 4, 7,
10, 15, 20 and 25 (day of birth = P0). Adult males and females were sacrificed at 3-4
months of age. An additional group of intact animals were sacrificed on P0. All animal
protocols were previously approved by the Animal Care and Use Committee at Colorado
State University.

Total RNA isolation and reverse transcription.
Neonatal rat pups were decapitated, and the brains quickly removed and the
medial basal hypothalamus and hippocampal regions CA1 and CA3 were dissected.
Total RNA was isolated according to the protocol of (Chomczynski and Sacchi, 1987).
Briefly, brain tissue was homogenized in 250l of GIT buffer (4M guanidinium
isothiocyanate/25mM NaCitrate, pH 7.0/0.5%sarcosyl/0.1M -mercaptoethanol) on ice.
Subsequently, 25l of 2M NaOAc (pH 4.0), 250l of buffer-saturated phenol (pH 4.3)
and 50l of chloroform/isoamyl alcohol (49:1) was added and the mixture vortexed. The
samples were then centrifuged at 14,000 x g for 20 minutes at 4ºC. The aqueous phase
was recovered and the RNA was ethanol precipitated. The resulting RNA was washed
with ice-cold 70% ethanol, and reconstituted in 50l RNAse free water. The RNA
content was measured with a spectrophotometer and only those samples with a 260/280
ratio above 1.6 were used.
2 g of total RNA was reverse transcribed with Superscript II reverse
transcriptase (RT; Gibco/BRL, Rockville, MD) using oligo-dT primers,
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deoxyribonucleotides (dNTPs; 100 mM each), 1st strand buffer (100 mM Tris-Cl/900 mM
KCl/1 mM MgCl2) and 2.5 mM dithiothreitol (DTT). The reaction was carried out at
room temperature for 10 minutes followed by 50 minutes at 42ºC. The RT was then
denatured at 95ºC for 10 minutes and stored at –80ºC until used.

Real-time quantitative polymerase chain reaction (PCR).
Real-time quantitative PCR was performed using the LightCycler System (Roche
Molecular Biochemicals, Indianapolis, IN). In this system, PCR occurs in borosilicate
glass capillaries that have a high surface-to-volume ratio to ensure rapid equilibration
between the air and the reaction components. A highly specific double-stranded (ds)
DNA binding dye, SYBR Green I (Molecular Probes, Eugene, OR), which only
fluoresces when bound to dsDNA, is used to determine the concentration of amplified
products. SYBR Green I binds to the minor groove of dsDNA and fluorescence is greatly
enhanced by binding. During the various stages of PCR, different intensities of
fluorescence signals can be detected, depending the amount of dsDNA that is present.
The 530 nm fluorescence is recorded at the end of the elongation phase, and increasing
amounts of PCR product are monitored from cycle to cycle. By comparing the amount of
unknown cDNA to a curve of amounts of a given cDNA amplified concurrently, realtime PCR eliminates the need for competitive in-tube standards with identical primer sets
as targets (Morrison et al., 1998).
To prevent nonspecific amplification we used hot-start PCR with dNTPs, specific
primers, PCR buffer (100 mM Tris-Cl, 1.5 mM MgCl2), 0.5 units Taq polymerase, 0.5
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units Taq antibody (Gibco/BRL) and 2 l of 10X stock SYBR Green I. Specific primers
for ER2 were: Forward-GGATGCTCACTTCTGCGCCGTCT and ReverseCTTCATCTGCGCAACGTGCCAGT from 5’ to 3’. Primers were developed using
OLIGO software (v. 6.51; Molecular Biology Insights, Cascade, CO). All samples were
amplified at 40 cycles that is approximately five to ten cycles beyond the beginning of
the linear phase of amplification. Specifically, an initial melting step was done at 95ºC
for 2 minutes followed for 40 cycles of 95ºC melting step for 1s, an annealing step (60ºC)
for 5s, and a 72ºC elongation step for 13s. In all experiments, samples containing no
template were included to serve as negative controls. To ensure that the standard and
unknown samples amplified equivalently additional control experiments were conducted
in which a known amount of target cDNA (from the standard curve) was added to the
unknown samples. These results were then compared to the sum of those obtained from
the known and unknown samples amplified independently and were not significantly
different (p = 0.797).

Construction of the ER2 standard curve.
To determine the absolute concentration of the target transcript, conventional
PCR for ER2 was used to generate a cDNA. Conventional PCR was performed on full
length ER2 that had been excised from an expression vector containing this splice
variant and was a gift from Dr. T. Brown (Pfizer, Inc., Groton, CT). The amplified
cDNA was purified using the Qiagen PCR purification kit (Qiagen, Valencia, CA)
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according to the manufacture’s directions. The purified PCR products were serially
diluted at a range of 10ng-10fg and this curve was run in duplicate alongside the
unknown samples.

[3H] Estrogen Binding Assay.
Cytosols from P7 and adult hippocampi were subject to an in vitro binding assay
to determine if there were developmental differences in the ability of ERs to bind 17estradiol (E2). The results were compared to those from P7 hypothalamus and cortex and
adult hippocampus and hypothalamus. Tissue samples were homogenized in 300l of
ice-cold TEGMD buffer (10mM Tris-Cl, 1.5mM EDTA, 10% glycerol, 25mM molybdate,
and 1mM dithiothreitol, pH 7.4) in Dounce tissue grinders (Dounce Co., Vineland, NJ).
The homogenates were transferred to 9 x 50mm polyethylene tubes and centrifuged at
105,000 x g for 30 minutes at 4°C in an ultracentrifuge (Beckman Coulter, Inc., Palo
Alto, CA) with a fixed angle rotor to separate the extract from the nuclear and membrane
fractions. Aliquots (100l) of the supernatant cytosols were incubated with increasing
amounts of [3H] E2 (0.01-50nM) for fours hours at room temperature in a total incubation
volume of 150l. Parallel incubations containing a 200-fold excess of Diethylstilbestrol
(DES) in addition to [3H] E2 were used to assess nonspecific binding. After four hours,
bound and unbound [3H] E2 were separated by passing the incubation reaction through a
1mL lipophilic Sephadex LH-20 column. The columns were re-equilibrated with 100l
TEGMD buffer and the incubation reactions were added to each column and allowed to
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incubate on the column at 4°C for 30 minutes. Next, the columns were washed with
600l TEGMD and the flow through was collected. To these samples, 4ml of
scintillation fluid was added and the samples were counted for 5 minutes in a scintillation
counter.

Statistical analyses.
All analyses were performed using an analysis of variance (ANOVA, StatView,
SAS Institute Inc.). Significant values were subsequently verified with the TukeyKramer post hoc analysis.

Results

Expression of ER mRNA splice variants in the developing rat hippocampus
Using quantitative and conventional PCR methods we examined the expression of
ER mRNA isoforms in the neonatal rat hippocampus during development (Fig 17). Our
results using conventional PCR demonstrate that, in the hippocampus, ER mRNA splice
variants are expressed a throughout development at different relative intensities
depending on the age. Initially, using conventional PCR with primers that span all
known splice variants, we were able to examine the relative distribution of each of these
ER variants during development (Fig 17A). On postnatal day 0, the ER23 and 4
variants are expressed at the highest concentration in the hippocampus. On postnatal day
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7, the ER23 isoform is expressed at the highest level, with lower levels of the other
variants (including wildtype and 4) present. Notably, because the 3 variants lack the
carboxyl terminal end of the DNA binding domain, they doesn’t bind estrogen response
elements efficiently, but rather act to enhance transcription through an activator protein-1
(AP-1) site (Price et. al., 2001). The pattern of expression observed on postnatal days 10
and 15 are very similar to that observed on P7 with ER23 expressed at the highest
level. In adult samples, the wildtype ER1 form is expressed at the highest levels.
Additionally, while expressed at lower levels than 1, the 3 (both 1 and 2) and 4
variants are detectable in adults. Due to the variability associated with these conventional
RT-PCR experiments, we were unable to make definitive claims concerning changes in
expression of ER splice variants over development. Because of this, we employed a
quantitative real-time PCR approach that allowed us to examine the 2 variants (with and
without the3 component) across development.

With this approach we used specific

PCR primers that were located in exon 2 and the 2 insert. With these primers we
simultaneously amplified cDNA samples from hippocampal regions CA1 or CA3
alongside samples containing a known concentration of ER2 cDNA and these data are
presented in figure 17B. These results demonstrate that a general trend of increasing
expression for ER2 mRNA over the first two weeks of development, such that, by P7
the level of expression was significantly greater than at birth (p < 0.02). While this
approach is unable to discriminate between the ER2
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Figure 17
Figure 17 legend: Expression of ER mRNA splice variants in the developing rat
hippocampus. Expression of ER mRNA splice variants in the hippocampus were
examined using conventional (A) and quantitative real-time (B) PCR. A) At most ages
examined, ER23 was expressed at the highest levels relative to the other variants. A
notable exception was the adult, where the wildtype form predominated. B) Across
development, ER2 levels are very low from P0-4, then increase to their peak at P10 then
drop slightly to levels observed in adults. (*) Significantly less than all other ages (p <
0.02). (#) Significant greater than adults (p < 0.04)
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and ER23 variants, it does provide quantitative evidence demonstrating a transient
increase in ER2 mRNA splice variants during early hippocampal development.

Expression of ER mRNA splice variants in the hypothalamus and cortex do not change
over development.
To determine if the differential expression of ER mRNA splice variants was
brain region specific, we also examined their expression in the medial basal
hypothalamus (Fig. 18) and cortex (Fig. 19) of the developing rat. These brain regions
have been shown to express wildtype ER mRNA in adulthood (Shughrue et. al., 1997).
Our results using conventional RT-PCR suggest that in adults and every age examined
during development, ER was expressed at the highest levels relative to the other
variants. Moreover, in each of these cases, ER2 was expressed at the next highest
relative intensity with lower levels of 3 and 4 detected in the hypothalamus and
hippocampus respectively. Next, using real-time PCR, we demonstrated that ER2 splice
variants in the developing hypothalamus (Fig. 18B) and cortex (Fig 19B) do not change
significantly over development. In the medial basal hypothalamus, we did observe a
general trend towards decreasing levels of the 2 isoforms with increasing age.
However, the decreases in expression with increasing age were not statistically
significant (p > 0.45), and it is unclear whether the gradual decline has any physiological
relevance.
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Figure 18
Figure 18 Legend: Expression of ER mRNA splice variants in the medial basal
hypothalamus during development. Expression of ER mRNA splice variants in the
hypothalamus was examined using conventional (A) and quantitative real-time (B) PCR.
A) The wildtype ER1 isoform is predominantly expressed at all ages examined with
lower levels of 2 also observed consistently. While their expression is quite variable, 3
variants are sometimes detectable. B) Quantitation of ER2 variants did not reveal a
significant developmental change in expression (p > 0.85). A trend is observed where the
levels of 2 expression gradually decline with increasing age.
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Figure 19
Figure 19 legend: Expression of ER mRNA splice variants in the cortex during
development. Expression of ER mRNA splice variants in the cortex was examined
using conventional (A) and quantitative real-time (B) PCR. A) The wildtype ER1
isoform is predominantly expressed at all ages examined with lower levels of ER2 also
consistently detected. While observed only sporadically, we were able to detect 4
variants in the cortex at early ages. B) Quantitation of ER2 (including 2 and 23)
variants did not reveal a significant change in expression over development (p > 0.92).

105
In these experiments it was not uncommon to see very low levels of 3 variants in the
hypothalamus, although the expression of these variants (ER13 and 23) was variable
and inconsistent. Interestingly, unlike the hippocampus, the 4 variant is undetectable
with conventional PCR methods at all ages examined.

ER mRNA splice variants are regulated by estrogen in the developing hippocampus
To determine if ER mRNA splice variants are regulated by estrogen in the
developing rat hippocampus, we gonadectomized rat pups shortly after birth.
Immediately following the surgery we treated them with a single injection of 10g
estradiol benzoate in 50l sesame oil, or oil alone. Following gonadectomy, there is a
change in the expression of ER mRNA isoforms. On P0, ER1 is expressed at the
highest relative level, with b1d3 also detected. On postnatal day 7, The pattern of
expression of very similar to that at birth with ERb1 expressed at the highest levels. On
P15, b1 is still expressed at the highest levels, but at this age following gonadectomy,
other ERb splice variants are very low. One exception is the 4 variant, which is
expressed at levels similar to that of the 1 variant.
Following estrogen treatment, the pattern of expression at any given age more
closely resembles that of the intact animal such that ER14 is expressed at the highest
levels early, with 3 variants increased shortly thereafter. On P10, ER23 is expressed
at the highest levels, with similar levels of the wildtype form also present.
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Figure 20

Figure 20 legend: Expression of ER mRNA splice variants is altered by estrogen in the
developing hippocampus. To determine if ER mRNA splice variants are regulated by
estrogen in the developing hippocampus, we gonadectomized male rat pups shortly after
birth. Immediately following the surgery we treated them with a single injection of 10g
estradiol benzoate. Following gonadectomy, there is a change in the expression levels of
ER mRNA isoforms, where ER1 is expressed higher relative to all other isoforms.
Following estrogen treatment, the pattern of expression more closely resembles that of
the intact animal. ER14 is expressed at high levels early, with 3 variants expressed at
high levels shortly thereafter.
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gonadectomized animals returns the pattern to one that more closely resembles the intact
animal.

Estrogen receptor binding studies demonstrate two binding sites for estrogen in the
developing hippocampus, one with high affinity, and one with low affinity
Scatchard analysis with tritiated estradiol ([3H] E2) was performed to determine if
estrogen binding during development was consistent with the binding affinities predicted
for the mRNA isoforms expressed at same period. Our results presented in figure 21A, B
demonstrate that two estrogen binding sites in the neonatal hippocampus exist; one with a
low affinity (Kd ~ 5 nM, presumably ER2) and one with a much higher affinity (Kd =
0.1nM, presumably ER, 1). It is unlikely that the change in estrogen binding affinity
observed during development is due to alterations in the DNA binding domain present in
the 3 variants, as it has been previously reported that this disruption does not alter the
receptor’s affinity for estrogen (Petersen et. al., 1998). For these binding studies, we
examined [3H] E2 binding in the hippocampus and hypothalamus of P7 and P10 rats.
Following analysis, we did not observe a significant difference between these two age
groups. Additionally, we did not observe a significant difference between males and
females, which were also analyzed separately. We have presented data from P7 males in
figure 21A, B.
For comparison, we examined [3H] E2 binding in the hippocampus and
hypothalamus of adult females (not shown). There is very little estrogen binding in the
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Figure 21 legend: Estradiol binding in the P7 hippocampus. Ligand binding affinity for
tritiated estradiol in cytosolic extracts from the hippocampus and hypothalamus of P7
animals was examined. Affinity constants were calculated by nonlinear regression of
bound vs. free ligand. Analysis of [3H]E2 binding revealed the presence of two different
binding affinities in the P7 hippocampus; one with a low affinity (A; Kd ~ 5 nM, light
blue lines) and one with a much higher affinity (B; Kd ~ 0.1nM, dark blue lines). The
high affinity binding presumable represents ER and ER1, while the lower affinity
binding presumably represents ER2. C) Linear transformation of the data by Scatchard
analysis is presented for illustrative purposes. Hypothalamic data are presented in the
Scatchard analysis for comparison (red line)
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adult hippocampus compared to the adult hypothalamus and neonatal hippocampus. This
could be due to the fact that we used the entire hippocampus from the adult, and based on
recent publications, it appears that estrogen receptors are predominantly located in the
ventral hippocampus (Shughrue and Merchenthaler, 2000). It is possible then, that our
samples were slightly diluted and thus we didn’t observe a very significant level of
estrogen binding in the adult hippocampus.

Discussion
In the brain the actions of estrogen are mediated by two different estrogen
receptors (ERs);  and . ER mRNA is variably spliced in brain tissue; the protein
products of which have been shown to have altered functional properties when expressed
in vitro (Petersen et al., 1998; Price et. al., 2001). In this study, we examined the
expression of ER mRNA splice variants in the medial basal hypothalamus, cortex, and
hippocampus during early postnatal development. Our results confirm that multiple
mRNA variants of ER exist in the brain, and that the expression pattern for these
variants depends on the brain region and developmental period examined. Interestingly,
in the hippocampus there is a developmental change in the levels of ER mRNA
isoforms, where shortly after birth the 2 variants are expressed at very low levels. At P7
there is a dramatic increase in expression, which peaks at P10, then gradually drops to the
levels observed in adulthood. Based on conventional PCR methods, we believe the
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prominent 2 isoform is the ER23 variant also lacking the C-terminal end of the DNA
binding domain. Therefore, this variant does not bind DNA or ligand efficiently.
In the hippocampus, gonadectomy at birth results in the expression of ER1 at the
highest relative levels in each age examined. Following estrogen treatment, the pattern of
expression is similar to that of intact animals suggesting that gonadal hormones may
regulate the expression of ER mRNA splice variants. This has a variety of implications
on the developing hippocampus at a period when hormone mediated organizational
effects on morphology and physiology are taking place (McEwen, 1983). Interestingly,
in both the estrogen and oil treated animals, the levels of all mRNA splice variants
gradually decrease over the first two weeks, which could be due to the fact that we only
gave a single injection of estrogen. It should also be noted that while the hormone
regulation experiments of ER splice variants were repeated several times, the results
were not always perfectly consistent. Nevertheless, it generally appears that
gonadectomy at birth alters the expression pattern of ER mRNA variants and estrogen
treatment results in an expression pattern similar to intact animals.
In the cortex and hypothalamus, the pattern of expression we observed in the
developing animal was similar to that of published reports in the adult (Price et. al.,
2000). In these brain regions the wildtype ER1 was expressed at the highest relative
level at every age examined. In contrast to the hippocampus, we did not observe a
significant developmental change in the expression of 2 isoforms, although in the
hypothalamus a trend of decreasing 2 expression with increasing age was observed.
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However, in the hypothalamus and cortex, we did observe low levels of 3 and 4
variants, respectively. Taken together, these data demonstrate that different ER mRNA
isoforms are present during development in brain tissue and raise interesting questions
concerning the physiological significance of ER splice variants during development.
In the neonatal hippocampus, the ER23 isoform is generally expressed at the
highest level. This isoform contains a 54 nucleotide insert in the ligand-binding domain
and a deletion of the second zinc finger of the DNA binding domain. Not surprising then,
this variant binds ligand with a much lower affinity that the wildtype form (Petersen et.
al., 1998; Price et. al., 2001). Our results in the developing hippocampus suggest that an
estrogen receptor with altered affinity for estradiol is indeed present. This is observed the
first postnatal week using an estrogen binding assay, where two distinct binding affinities
are observed; one with a high affinity (Kd ~ 0.1nM) suggestive of the ER and 1 types,
and one with a low affinity (Kd ~ 5nM) suggestive of the 2 isoform. The physiological
role of the 2 isoforms are not known. It is possible that estradiol is not the only
important ligand for ER2. For instance a number of studies have demonstrated that a
variety of estrogenic compounds exist which act as agonists with different affinities for
the estrogen receptor (Sun et. al., 1999; Petersen et al., 1998). Whether or not this is the
case in vivo or not remains unclear. Studies to examine the specific expression of ER
splice variants in vivo will require highly specific antibodies that are currently
unavailable. Additionally, experiments will be required to determine if some ligands act
differentially to regulate the action of estrogen receptors during brain development.
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In the past few years, a number of studies have described the presence of
alternatively spliced forms of the ER receptor (Fasco et al., 2000; Pasqualini et al.,
2001). However, the majority of these isoforms have only been described in cancer
tissues and cell lines (Fugua et. al., 1993; Pfeffer et. al., 1996). Interestingly, the ER23
variant that we have shown to be highly expressed in the developing hippocampus, is
directly analogous to an ER exon 3 deletion detected by several investigators (Pfeffer
et. al., 1996, Zhang et. al., 1996) and has a similar deletion that truncates the DNA
binding domain. The 3 variants do retain the ability to interact with coactivator proteins
such as SRC-1 (Bollig and Miksicek, 2000), suggesting 3 variants may still may be able
to influence DNA transcription through protein protein interactions. This ER variant has
been shown to possess dominant negative activity by inhibiting DNA transcriptional
activation by wildtype ERMiksicek et. al., 1993). While it is unknown whether the
ER23 possess dominant negative activity, it is interesting to speculate that this receptor
variant could modulate the actions of the wildtype ER receptor. Moreover, because
ER and ER have been shown to form heterodimers (Cowley et al., 1997), it is even
possible that this ER23 could influence estrogens actions mediated by the initially
described ER receptor. Considering that ER mRNA splice variants are expressed in
brain tissue equal to or greater than wildtype ER, we believe that these variants should
be considered in addition to ER1 and ER when examining the effects of estrogenic
agonists and antagonists in nervous tissue.
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The biological relevance for the expression of the ER isoforms in normal tissues
is not well established. It may be that the expression of ER mRNA splice variants in the
developing rat hippocampus acts to alter estrogen regulated gene expression, creating a
highly complex pattern of estrogen signaling. The expression of ER variants with
altered ligand or DNA binding properties may functionally act to repress or enhance
transcriptional activation by forming dimers with the wildtype receptors. It is also
possible that the LBD alterations resulting from mRNA splicing results in receptors that
bind ligands with different affinities. These ligands, then, might have either agonistic or
antagonistic properties depending on the receptor. At the same time, the ability of splice
variants to interact productively with coactivators or other transcription factors gives
these variants the potential to stimulate or otherwise modulate gene expression through
AP-1 motifs or other DNA binding sites. Further studies will have to be conducted to
determine whether the effect of ER mRNA splice variants has a functional relevance to
the effects of estrogen on the developing brain.

CHAPTER 5
ESTROGEN REGULATES THE DEVELOPMENT OF BRAIN-DERIVED
NEUROTROPHIC FACTOR (BDNF) mRNA AND PROTEIN IN THE RAT
HIPPOCAMPUS

Abstract
During development, estrogen has a variety of effects on morphological and
electrophysiological properties of hippocampal neurons. Brain-derived neurotrophic
factor (BDNF) also plays an important role in the survival and differentiation of neurons
during development. We examined the effects of gonadectomy with and without
estrogen replacement on the mRNA and protein of BDNF and its receptor, trkB, during
early postnatal development of the rat hippocampus. We used immunocytochemistry to
demonstrate that estrogen receptor alpha (ER) and BDNF were localized to the same
cells within the developing hippocampus. BDNF and ER were co-localized in
pyramidal cells of the CA3 subregion, and to a lesser extent in CA1. To determine if
BDNF mRNA was regulated by estrogen during development, we gonadectomized
(GDX) male rat pups at postnatal day (P)0 and examined mRNA and protein levels from
P0 to P25 using real-time RT-PCR and Western blot analysis. Following gonadectomy,
BDNF mRNA levels are significantly reduced on P7, but after treatment of GDX animals
with estradiol benzoate on P0, levels at all ages were similar to intact animals. BDNF
mRNA changes following GDX are accompanied by an increase in the levels of BDNF
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protein which were reduced by estrogen treatment at P0. We also examined the effect of
postnatal estrogen treatment on trkB. There were no significant changes in trkB mRNA
or protein in GDX or estrogen replaced animals. These results suggest that a direct
interaction may exist between ER and BDNF to alter hippocampal physiology during
development in the rat.

Introduction
It is well established that estrogen is involved in the differentiation and plasticity
of hippocampal neurons. For instance, estrogens influence general neurobiological
functions such as perceptual-spatial skills and learning and memory (McEwen, 1983;
Smith, 1994; Luine, 1997). Estrogens may also act to alter certain specific pathologies
such as epileptic seizure threshold (Terasawa and Timiras, 1968; Buterbaugh and
Hudson, 1991) and perhaps Alzheimer’s disease (Henderson et al., 1996) and Parkinson’s
disease (Leranth et al., 2000). The sites of action for the effects of estradiol on cognitive
performance and pathology have not been established, but one probable site is the
hippocampus, a sexually dimorphic, steroid-responsive brain region (Juraska et al., 1989;
Roof and Havens, 1992; Woolley and McEwen, 1992).
In the adult rat, it has been demonstrated that hippocampal pyramidal neurons
express mRNA for both isoforms ( and ) of the estrogen receptor (Shughrue and
Merchenthaler, 2000). Moreover, ovarian steroids act during a perinatal sensitive period
to alter the patterns of neuronal cell death and synaptic connectivity (McEwen, 1983).
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Additionally, we have demonstrated that ER is transiently expressed in developing
hippocampal pyramidal neurons (Solum and Handa, 2001a). Their biological roles in
such processes, however, remain uncertain.
Brain-derived neurotrophic factor (BDNF) is emerging as an important mediator
of activity-dependent modifications in synaptic strength (Lohof et al., 1993; Levine et al.,
1995) and plays important roles in the survival and growth of neurons (Barde, 1989;
Davies, 1994). For instance, BDNF regulates dendritic and axonal growth (Cohen-Cory
and Fraser, 1995; McAllister et al., 1995) and the efficacy of synaptic transmission at
excitatory synapses on hippocampal neurons (Vicario-Abejon et al., 1998; Sherwood and
Lo, 1999).
Interestingly, neurons in the adult rat forebrain of both sexes co-express estrogen
and neurotrophin receptors and are the sites of estrogen and neurotrophin synthesis
(Toran-Allerand et al., 1992; Miranda et al., 1994). Consistent with this, the relative
levels of BDNF mRNA within specific regions of the hippocampus fluctuate significantly
over the course of the estrous cycle (Gibbs, 1998) and increased levels of BDNF mRNA
following long-term estrogen treatment have been reported in this brain region (Singh et
al., 1995). It has also been shown that estrogen and neurotrophin receptor co-expression
leads to convergence of their signaling pathways (Toran-Allerand et al., 1999). However,
whether estrogen influences BDNF or trkB expression in the developing hippocampus in
vivo and whether the developmental actions of estrogen on neurons are mediated directly
or indirectly via interactions with growth factors and their signaling pathways is unclear.
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Given the increasing evidence for effects of BDNF on neuronal connectivity and
activity dependent synaptic plasticity in the adult brain, we hypothesized that estrogen
could similarly effect BDNF expression during development. This may subsequently
contribute to estrogen’s organizational effects on brain structure and function. In this
study, we examined the effect of gonadectomy and estrogen treatment on the
developmental expression of mRNAs and protein for BDNF and its receptor, trkB, using
immunocytochemistry, real-time quantitative RT-PCR and western blot analysis.

Materials and Methods
Animals. Neonatal male and female rats of various ages from timed-pregnant SpragueDawley females and adult male and female adult rats were obtained from Charles River
Laboratories (Portage, MI). Animals were housed under a 12/12 h light dark cycle (lights
on at 07.00 h) with food and water available ad libitum. Upon parturition, litters were
sexed and thinned to 8 pups (4 males and 4 females). Shortly after birth (4-6 hours),
some pups were gonadectomized under hypothermia anesthesia. Of these, half received a
single subcutaneous injection of 10g estradiol benzoate in 50l sesame oil, while the
other half received oil alone. This protocol has been shown to result in a decrease in
plasma testosterone levels, an increase in estrogen receptor levels and the abolishment of
male sexual behavior (Ulibarri et al., 1990; Kuhnemann et al., 1995; McCormick et al.,
1998; Atanassova et al., 1999), presumably by overcoming the sequestering ability of
circulating alpha-fetoprotein. Animals were subsequently sacrificed at postnatal (P) days
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4, 7, 10, 15, 20 and 25 (day of birth = P0). Adult males and females were sacrificed at 3-4
months of age. An additional group of intact animals were sacrificed on P0. All animal
protocols were previously approved by the Animal Care and Use Committee at Colorado
State University.
Hippocampal cultures. Neuronal cultures were prepared from rat embryonic
hippocampus at embryonic day (E)18. Embryos were recovered following maternal csection under halothane anesthetic and the hippocampi were dissected from the brain and
minced. Individual cells were isolated by trituration in Hanks’ Balanced Salt Solution
(HBSS; Gibco BRL, Rockville, MD) without Ca++ and Mg++. After allowing
nondispersed tissues to settle for 3 min, the supernate was transferred to a sterile 15mL
tube and centrifuged for 1 min at 200 x g. The pellet was gently resuspended in charcoal
stripped media without phenol red and an aliquot added to trypan blue stain for a
haemocytometer count. Cells were then plated on poly-D-lysine (0.05mg/ml; Sigma, St.
Louis, MO) coated coverslips at a density of 50,000 cell/cm2 and incubated at 37°C in
5% CO2 atmosphere. After four days in culture, one half of the media was replaced and
the cultures were treated with estradiol benzoate (0.01, 0.1, 1.0, 10 and 100nM) or
vehicle for 24 hours before processing.
Antibodies. Anti-ER antibodies, raised against the 14 most carboxyl terminal amino
acids, were purchased from Upstate Biotech (C1355; Lake Placid, NY); anti-ER
antibodies were from Zymed Laboratories and were raised against amino acids 468-485
of the ER protein (Z8P; San Francisco, CA); gamma amino butyric acid (GABA;

120
A2052) antiserum was obtained from Sigma; BDNF (sc-546) and trkB (sc-12) antiserum
were from Santa Cruz Biotech (Santa Cruz, CA) and map to the amino and carboxyl
terminal regions, respectively. To ensure immunoreactive specificity, competition
experiments were performed using the immunoreactive peptides for BDNF (sc-546P) and
trkB (sc-12P).
Double-label immunocytochemistry. Neonatal rat pups were anesthetized with
Halothane and sacrificed by perfusion with 10-30mL of 0.1M ice-cold phosphate buffered
saline (PBS) followed by 10-30mL of freshly prepared ice-cold 4% paraformaldehyde in
0.1M PBS. Adult animals were anesthetized and sacrificed similarly, but were perfused
with approximately 200mL of 0.1M PBS followed by 200mL of freshly prepared 4%
paraformaldehyde in 0.1M PBS. Brains were removed and placed into 30% sucrose in
0.1M PBS at 4°C until permeated. Next, the brains were sectioned 30m thick on a
cryostat and placed into 0.1M PBS containing 0.1% Sodium Azide. The tissue was
processed for immunocytochemistry (ICC) as described previously (Kerr et al., 1995).
Briefly, tissue from three P10 males was incubated with 0.3% H2O2 in 0.1M PBS to
quench any nonspecific reaction with endogenous peroxidases. Subsequently, nonspecific antibody binding was blocked by incubation with 4% normal goat serum (NGS)
in 0.1 M PBS. Tissue was then incubated for 48 hours at 4ºC with ER (1:10,000) or
ER (1:1,500) antiserum in the presence of 2% NGS and 0.1% Triton X-100 (TX). The
tissue was then washed and incubated for 2 hours with biotinylated goat anti-rabbit IgG
(1:500; Vector Labs, Burlingame, CA) followed by standard washes and incubation with
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an avidin-biotin-horseradish peroxidase complex (1:500; Vector Labs) for 1 hour.
Standard washes were done three times at room temperature in 0.1M PBS with 0.1% TX.
Finally, staining was visualized with a tris-buffered saline solution containing nickel
intensified diaminobenzadine (DAB, 0.5mg/ml; Sigma) and hydrogen peroxide (0.01%)
for 6-10 minutes. Nickel intensified DAB was prepared by adding 0.3mg/mL of nickel
ammonium sulfate to the DAB solution resulting in a dark blue stain.
Next, the tissue was washed and processed for BDNF immunoreactivity using
BDNF antiserum (1:500). Essentially, the tissue was processed as above, except that
after incubating with 0.3% H2O2 the tissue was blocked for 2 hours in 6% NGS. Tissue
was then washed (3 x 15 min. in 0.1M PBS-TX) before the secondary antibody
incubation as described above. Following a final washing step, this reaction was
developed with normal DAB (0.5mg/mL + 0.01% H2O2) to produce a brown reaction
product. After developing, the tissue was rinsed and mounted on glass slides. The
mounted sections were air-dried overnight at room temperature and the slides were
processed through a series of increasing alcohols, cleared with xylene, and coverslipped
with Permount (Fisher Scientific). Double-labeled cells were visualized by light
microscopy as cells containing a dark blue nucleus (ER) and a brown cytoplasm
(BDNF).
Fluorescent double-label immunocytochemistry on dissociated hippocampal cells
was essentially similar to that described above with some exceptions. After five days in
vitro, culture media was removed and the cells were fixed with 10% buffered formalin
for 10 minutes after which the cells were washed three times in PBS-TX. Following
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blocking and primary antibody incubations similar to that described above, the cells were
washed and incubated for two hours with Alexa Fluor 594 goat anti-rabbit IgG conjugate
(1:2000; Molecular Probes, Eugene, OR). Cells were then washed and incubated with
unlabeled goat anti-rabbit IgG (6% in PBS-TX) for an hour to block remaining binding
sites on ER antibodies. The cells were then processed for the second primary antibody as
described above with similar blocking, primary and secondary antibodies incubations.
Following another washing step, cells were incubated for one hour with Alexa Fluor 488
streptavidin conjugate (1:1,500; Molecular Probes). After a final washing step, the
coverslips were affixed to Superfrost Plus slides with Vectashield mounting medium
(Vector Laboratories). Cells were analyzed with a Zeiss Axioplan 2 imaging microscope
and images were captured with a Zeiss AxioCam digital camera.
Total RNA isolation and reverse transcription. Neonatal rat pups were decapitated, and
the brains quickly removed and the medial basal hypothalamus and hippocampal regions
CA1 and CA3 were dissected. Total RNA was isolated similar to the protocol of
(Chomczynski and Sacchi, 1987). Briefly, brain tissue was homogenized in 250l of
GIT buffer (4M guanidinium isothiocyanate/25mM NaCitrate, pH 7.0/0.5%sarcosyl/0.1M
-mercaptoethanol) on ice. Subsequently, 25l of 2M NaOAc (pH 4.0), 250l of buffersaturated phenol (pH 4.3) and 50l of chloroform/isoamyl alcohol (49:1) was added and
the mixture vortexed. The samples were then centrifuged at 14,000 x g for 20 minutes at
4ºC. The aqueous phase was recovered and the RNA was ethanol precipitated. The
resulting RNA was washed with ice-cold 70% ethanol, and reconstituted in 50l RNAse
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free water. The RNA content was measured with a spectrophotometer and only those
samples with a 260/280 ratio above 1.6 were used.
2 g of total RNA was reverse transcribed with Superscript II reverse
transcriptase (RT; Gibco/BRL, Rockville, MD) using oligo-dT primers,
deoxyribonucleotides (dNTPs; 100 mM each), 1st strand buffer (100 mM Tris-Cl/900 mM
KCl/1 mM MgCl2) and 2.5 mM dithiothreitol (DTT). The reaction was carried out at
room temperature for 10 minutes followed by 50 minutes at 42ºC. The RT was then
denatured at 95ºC for 10 minutes and stored at –80ºC until used.
Real-time quantitative polymerase chain reaction (PCR). Real-time quantitative PCR
was performed using the LightCycler System (Roche Molecular Biochemicals,
Indianapolis, IN). In this system, PCR occurs in borosilicate glass capillaries which have
a high surface-to-volume ratio to ensure rapid equilibration between the air and the
reaction components. A highly specific double-stranded (ds) DNA binding dye, SYBR
Green I (Molecular Probes, Eugene, OR), which only fluoresces when bound to dsDNA,
is used to determine the concentration of amplified products. SYBR Green I binds to the
minor groove of dsDNA and fluorescence is greatly enhanced by binding. During the
various stages of PCR, different intensities of fluorescence signals can be detected,
depending the amount of dsDNA that is present. The 530 nm fluorescence is recorded at
the end of the elongation phase, and increasing amounts of PCR product are monitored
from cycle to cycle. By comparing the amount of unknown cDNA to a curve of amounts
of a given cDNA amplified concurrently, real-time PCR eliminates the need for
competitive in-tube standards with identical primer sets as targets (Morrison et al., 1998).
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To prevent nonspecific amplification we used hot-start PCR with dNTPs, specific
primers, PCR buffer [100 mM Tris-Cl, 1.5 mM MgCl2, 0.5 units Taq polymerase, 0.5
units Taq antibody (Gibco/BRL) and 2 l of 10X stock SYBR Green I]. Specific primers
were as follows: BDNF (Genbank accession #M61178) forward primer position 245,
reverse primer position, 711; trkB (Genbank accession #M55291) forward primer 2091,
reverse primer 2406. Primers were developed using OLIGO software (v. 6.51; Molecular
Biology Insights, Cascade, CO). All samples were amplified at 40 cycles which is
approximately five to ten cycles beyond the beginning of the linear phase of
amplification. Specifically, an initial melting step was done at 95ºC for 2 minutes
followed for 40 cycles of 95ºC melting step for 1s, an annealing step (60ºC for trkB and
64ºC for BDNF) for 5s, and a 72ºC elongation step (13s for trkB and18s for BDNF). In
all experiments, samples containing no template were included to serve as negative
controls. To ensure that the standard and unknown samples amplified equivalently
additional control experiments were conducted in which a known amount of BDNF or
trkB cDNA (from the standard curve) was added to the unknown samples. These results
were then compared to the sum of those obtained from the known and unknown samples
amplified independently and were not significantly different (p = 0.797).
Construction of the BDNF and TrkB standard curve. To determine the absolute
concentration of the target transcript, conventional PCR for BDNF and TrkB was used to
generate a cDNA. The amplified cDNA was purified using the Qiagen PCR purification
kit (Qiagen, Valencia, CA) according to the manufacture’s directions. The purified PCR
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products were serially diluted at a range of 30ng-30fg and this curve was run in duplicate
alongside the unknown samples.
mRNA quantitative analysis. Following real-time PCR, the absolute concentration of
mRNA in each sample was determined by analysis with LightCycler Data Analysis
(LCDA) software. This software plots a standard curve of the crossing line intercepts of
the standards vs. the known concentrations of these standards. The crossing line intercept
is parallel to the x-axis on a graph of fluorescence intensity vs. cycle number and occurs
at the point where template amplification enters the logarithmic phase of the curve.
Samples with a higher concentration of starting material enter the logarithmic phase
earlier than samples with a lower concentration of starting material and therefore have a
smaller crossing point value. The crossing line intercept of an unknown sample is
subsequently compared with the standard curve to generate a quantitative amount of
starting material. In each case, the point at which the crossing line intercepts the loglinear region of each curve is used to generate the concentration of that sample.
Western Blot Analysis. Animals were sacrificed at ages described above and the brains
were quickly removed. The hippocampi were dissected and individually homogenized in
200l of 50mM Tris buffer (pH 7.2, 4ºC) containing 1mM EDTA, 1 mM
phenylmethylsulfonyl fluoride (PMSF), 1mM leupeptin, 1 g/ml antipain, and 1 g/ml
aprotinin. Protein concentrations were determined using the BCA protein assay (Pierce,
Rockford, IL). Homogenates were mixed 1:1 with sample buffer containing 10%
glycerol, 2% SDS, 5% -mercaptoethanol, and 0.05% bromphenol blue and boiled for 5
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minutes. For each age, 20g of protein were loaded into each well. The samples were
separated on 8% (trkB) or 12% (BDNF) SDS polyacrylamide gels along with biotinylated
molecular weight standards (Bio-Rad, Hercules, CA). Following electrophoresis, the
proteins were electrically transferred to nitrocellulose in 49.6mM Tris, 384 mM glycine,
0.01% SDS at 30V overnight followed by 80V for 1 hour. The gels then were stained
with Coomassie blue to confirm equal loading per lane. After transfer, blots were
incubated in tris-buffered saline with 0.1% Tween-20 (TBST) containing 5% non-fat
milk, 2% bovine serum albumin, and 0.1% sodium azide. Subsequently, blots were
incubated with either BDNF or trkB (1:500) antiserum for 48 hrs. at 4ºC in TBST
containing 2% non-fat milk and 0.1% sodium azide. Blots were also processed without
primary antibodies or antibodies that had been preabsorbed with the immunoreactive
peptide to serve as controls. Following primary antibody incubation, the blots were
washed (three times, 15 minutes each in TBST at 25ºC) and incubated with horseradish
peroxidase conjugated goat anti-rabbit antibodies (1g/mL, Vector Labs, Burlingame,
CA). Immunoreactive bands were visualized with an enhanced chemiluminescence
system (ECL, Amersham, Arlington Heights, IL) according to manufacturer’s directions.
To ensure that each lane was loaded with an equivalent amount of protein, the blots were
stripped with 0.2M NaOH and re-probed with anti-actin serum (1:10,000; Chemicon,
Temecula, CA) as described above. Following immunoblotting, digitized images of
immunoreactive bands for target (BDNF, trkB) and control (actin) products were
imported into NIH Image software (v. 1.62) and the average OD of each band was
measured (based on a grayscale of 0-256 arbitrary units, 0 being white and 256 being
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black). Additional background measurements were taken from each film and subtracted
from these values. A ratio of BDNF, trkB/actin was then determined and these values
were compared across development for statistical significance.
Statistical analyses. All analyses were performed using multi-way analysis of variance
(ANOVA, StatView, SAS Institute Inc.). Significant values were subsequently verified
with the Tukey-Kramer post hoc analysis.

Results

Estrogen receptor alpha, but not beta, co-localizes with BDNF in hippocampal pyramidal
cells in vivo and in vitro
In our initial studies we sought to determine if estrogen receptors alpha and/or
beta were co-localized with BDNF in neurons of the developing rat hippocampus using
double label immunocytochemistry. We demonstrated that ER and BDNF were highly
co-localized in pyramidal cells of the CA1 and CA3 hippocampal subregions of the intact
male and female rat on postnatal day 10 (Fig. 22). We chose this age based on our
previous experiments showing that while little or no ER positive cells are observed on
postnatal day 0, a transient increase in ER occurs from postnatal day 4 to 10 (Solum and
Handa, 2001a). Our results, presented here, demonstrate that ERand BDNF were colocalized in stratum pyramidale of the CA3 subregion and to a lesser extent in the CA1
subregion. Double-labeled neurons are visualized as cells with a dark blue nucleus and a
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brown cytoplasm. Additionally, a few scattered ERimmunoreactive neurons were also
observed in stratum radiatum and oriens. However, these cells did not express BDNF as
well, and are likely non-pyramidal interneurons.
Next we examined whether ER was also co-localized with BDNF in the
developing rat hippocampus. While we observed a few neurons in which ER and
BDNF were co-localized in the neonatal hippocampus, the majority of BNDF
immunoreactive cells were ER negative (Fig 22). In all of the samples we examined,
the intensity level of ER immunoreactivity was much less than that for ER.
Additionally, in each of these experiments we did not observe an obvious sex difference
in the number or intensity of immunoreactivity for ER ( and ) or BDNF.
It is difficult, however, to determine the extent to which cells are double-labeled
due to the fact that BDNF expressing pyramidal cells are densely packed in stratum
pyramidale of the hippocampus. Because of this, we examined whether BDNF and ERs
are co-localized in primary hippocampal cells grown at moderate density in vitro for
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Figure 22 Legend: Double-label immunocytochemistry of estrogen receptor ( and )
and BDNF in the neonatal hippocampus. Double-label immunocytochemistry in the P10
male hippocampus was used to co-localize ER and BDNF to pyramidal neurons in the
CA1 (A) and CA3 (B) hippocampal subregions. ER immunoreactivity is visualized as a
blue nuclear stain, while BDNF immunoreactivity is visualized as a brown cytoplasmic
stain. The majority of immunopositive cells were ER+/BDNF+ (arrows and inset)
although some ER-/BDNF+ cells (arrowheads) cells were also observed. ER and
BDNF were not appreciably co-localized in either the CA1 (C) or CA3 (D) hippocampal
subregions of the intact P10 male rat. A few ER+/BDNF+ (arrows) cells were observed
but the majority were ER-/BDNF+ (arrowheads). Scale bar = 50m
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Figure 22
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Figure 23

Figure 23 Legend: Co-localization of ERs with BDNF and GABA in primary cultures of
hippocampal cells. Double-label fluorescent immunocytochemistry in embryonic
hippocampal cell cultures grown in vitro for five days was used to co-localize ER, but
not ER, and BDNF. Each figure is an overlay of ER or  and BDNF or GABA
immunocytochemistry. ER immunoreactivity is visualized as red immunofluorescence,
while BDNF or GABA immunoreactivity is green. (A) The majority of immunopositive
cells were ER+/BDNF+ (arrows), although some BDNF+ cells were observed which
expressed little or no ER-ir (arrowheads). (B) Essentially no ER immunoreactivity
was observed to be co-expressed with BDNF and the nuclei of these cells are essentially
unstained (arrowheads). (C) No cells were observed that express ER and GABA,
although ER positive cells (arrowheads) and GABAergic processes (arrows) clearly
visible. Scale bar = 25m
five days. Additionally, we double labeled primary hippocampal cultures with ER and
GABA to confirm our previous findings in vivo showing ER is primarily located in
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pyramidal cells, not interneurons. These experiments confirmed our findings in vivo and
demonstrated that ER but not ER, was co-localized with BDNF in hippocampal
pyramidal cells grown in vitro (Fig. 23). In this experiment, the majority of
immunopositive cells were ER+/BDNF+, although some ER-/BDNF+ cells were also
present. We did not observe any ER+/BDNF-, ER+/BDNF+ or ER+/GABA+ cells.

BDNF mRNA levels are decreased in the hippocampus following neonatal gonadectomy
and this effect can be reversed by a single injection of estrogen
Using quantitative real-time RT-PCR we examined the expression of BDNF
messenger RNA in the CA1 and CA3 hippocampal subregions of the intact male rat
during development and compared these values to those from males that had been
castrated on postnatal day 0 and immediately given a single injection of oil vehicle or
estradiol benzoate (Fig. 24). Because injected estrogen levels have a longer half-life in
newborn rats than in older animals (MacLusky et al., 1979), we used this experimental
protocol to mimic the increase in brain estrogen levels observed early in postnatal life.
This allowed us to examine the direct organizational effects of estrogen on BDNF, rather
than indirect effects resulting from the aromatization of testosterone. Our results
demonstrate that the level of BDNF mRNA expression increases in the intact animal
from P4 to P7 in the CA1 region, and P4 to P10 in the CA3 region (p < 0.001), and then
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is maintained through adulthood. However, when males are castrated at birth, developing
levels are significantly attenuated in these hippocampal subregions. Beginning on P4,
and continuing through P10, the levels of BDNF mRNA are significantly less in the
hippocampus of castrated males compared to intact controls (CA1, p = 0.002; CA3, p =
0.003). By P15, the levels of BDNF mRNA from castrated animals are no longer
significantly different from intact males in either the CA1 or CA3 subregion, and this
remains the case into adulthood. When neonatally castrated males are given a single
injection of estradiol benzoate, the levels of BDNF mRNA expression are significantly
higher in the CA1 and CA3 hippocampal subregions from castrated males given vehicle
alone (p < 0.001). Moreover, the levels of BDNF mRNA expression are not different
from intact animals (CA1, p = 0.609; CA3, p = 0.536). Even so, in each of these
treatment groups, a developmental trend similar to intact animals was observed where
BDNF mRNA levels increased during the first two postnatal weeks at which point they
were not different from adults. Also important to note is that the time course for
estrogen’s effects on BNDF mRNA expression are very similar to the transient increase
in estrogen receptors in the hippocampus that we have previously reported. These data
demonstrate that estrogen significantly increases BDNF mRNA levels in the
hippocampus during development and this effect is likely mediated through estrogen
receptor alpha.
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Estrogen effects BDNF mRNA expression in vitro in a dose dependent manner
To determine at what concentration estrogen effects on BDNF mRNA expression
are observed we treated primary hippocampal cells with various doses of estrogen
ranging from 0.01nM to 100nM (Fig. 25). Following estrogen treatment we examined
BDNF mRNA expression with quantitative real-time PCR. Our results demonstrate that
estrogen regulates BDNF mRNA expression in a dose dependent manner. Very low
doses (0.01nM) of estrogen had no effect, while increasing doses resulted in an
upregulation of mRNA levels. Treatment with 10nM estrogen resulted in a significant
increase in BDNF mRNA over control levels, and this was only slightly elevated with
higher concentrations. These results confirmed our findings in vivo and demonstrate that
estrogen significantly upregulates BDNF mRNA levels in hippocampal cultures.
Additionally, these experiments provide evidence to support the utilization of primary
hippocampal cultures as a model for studying effects of estrogen on BDNF expression.

BDNF mRNA levels in the hypothalamus are unaffected by gonadectomy or estrogen
replacement
Previous studies have shown that the effect of estrogen on BDNF mRNA
expression in the adult varies depending on the brain region examined (Jezierski and
Sohrabji, 2000). To determine whether estrogen affects BDNF mRNA levels in a brain
region specific manner during development, we examined the medial basal
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hypothalamus in addition to the hippocampus. The existence and distribution of BDNF
mRNA within the adult rat hypothalamus has been well established (Marmigere et al.,
1998). Using quantitative real-time PCR we examined the expression of BDNF mRNA
in the developing hypothalamus of intact male rats and neonatal male rats castrated at
birth and given a single dose of either 10g estradiol benzoate or vehicle. Our results
demonstrate that BDNF mRNA levels in the hypothalamus of developing male rats were
unaffected either by neonatal castration or castration plus estrogen replacement (Fig. 26).
Interestingly, we did not observe a significant change across development and the level of
BDNF mRNA expression was generally lower in the hypothalamus when compared to
the hippocampus. These findings are similar those observed in the avian hypothalamus,
where neither acute nor chronic treatment of 17-estradiol had an effect on BDNF
mRNA levels (Viant et al., 2000).

Neonatal gonadectomy increases BDNF protein levels in the developing hippocampus
and this effect can be reversed by a single injection of estrogen
After observing an effect of estrogen on BDNF mRNA expression in the
developing hippocampus, we next examined whether estrogen had an effect on BDNF
protein levels in this brain region as well. We used Western blot analysis to compare the
effect of estrogen on BDNF expression in the developing hippocampus of normal males,
males castrated at birth and castrated animals given an injection of estradiol benzoate at
the time of castration. These data are presented in Fig. 27. In the intact
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Figure 27 Legend: Estrogen regulation of BDNF levels in the developing hippocampus.
BDNF levels were measured using western blot analysis. (A) A single band of
approximately 14kDa was detected in hippocampal protein samples from intact,
gonadectomized (GDX) and estrogen treated males during various stages of postnatal
development. Males were GDX on postnatal day 0 and immediately treated with a single
injection of oil vehicle or estradiol benzoate. (B) Following Western blot analysis of
BDNF and actin in the developing hippocampus of intact and hormone manipulated
males, mean optical densities of immunoreactive bands were determined. Background
levels were subtracted from these measurements and a ratio of BDNF/actin was
determined to give a mean net density for each age. Each bar represents the mean ±
S.E.M. of three independent experiments. (*) Significantly greater than other treatment
groups at that age (p < 0.001).
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animal we observed a developmental trend in BDNF protein levels similar to that of
BDNF mRNA where levels increased from P0 to P10 (p < 0.003). However, contrary to
our expectations, neonatal castration did not decrease BDNF protein levels as it had with
mRNA levels. Quite the opposite, from postnatal day 4 to 7, BDNF levels in the
hippocampus were significantly increased following castration at birth (p < 0.001).
Moreover, when castrated animals were given a single injection of 10g estradiol
benzoate, BDNF protein levels were no longer significantly different from intact males.
To ensure that the immunoreactive bands that we observed were specific for BDNF, we
conducted two control experiments including elimination of the primary antibody and
preadsorption of the antiserum with the immunoreactive peptide (100ng/ml; sc-546P,
Santa Cruz Biotech). Both of these control experiments completely eliminated the
immunoreactive band (data not shown).

Estrogen does not effect trkB mRNA or protein expression in the developing
hippocampus
To determine whether estrogen alters neuronal sensitivity to BDNF by influencing
BDNF receptor concentration, we examined the mRNA and protein expression for trkB,
the high affinity BDNF receptor. Using quantitative PCR and Western blot analysis we
did not observe any differences in mRNA (Fig. 28) or protein (Fig. 29) expression in the
hippocampus across development when comparing normal males with castrated males
treated with estradiol benzoate or vehicle. We analyzed trkB mRNA in both the CA1 and
CA3 hippocampal subregions from postnatal days 4 to
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Similar to earlier reports using a different technique (Fryer et al., 1996), we detected very
little change in expression during the first two postnatal weeks, where the levels of
mRNA for full length trkB are no different from adult levels (Fig. 7). Additionally, we
did not observe a significant difference between any treatment group at each timepoint (p
= 0.680).
Next, we examined trkB protein expression from postnatal days 4 to 15 in similar
treatment groups (Fig. 8). After immunoblotting with anti-trkB serum, we observed an
immunoreactive doublet at approximately 145kDa. The larger band of this doublet
represents the predominant full-length receptor, while the smaller band likely represents
phosphorylated trkB receptors that have been previously described (Kang et al., 1997).
Similar to our findings with trkB mRNA, our data demonstrated that estrogen does not
regulate the level of trkB protein expression in the developing rat hippocampus. We did
not observe any significant differences between intact males and castrated males given
estrogen or vehicle. Also, consistent with our finding concerning trkB mRNA, we did
not observe any developmental changes in trkB protein levels. These results suggest that
estrogen is not acting by modulating trkB, but rather on BDNF directly.
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Figure 29 Legend: trkB protein levels in the hippocampus of the developing male rat
following castration and estrogen replacement. trkB levels were measured using Western
blot analysis. (A) An immunoreactive doublet of approximately 145kDa was detected by
Western blotting of hippocampal protein samples from intact, gonadectomized (GDX)
and estrogen treated males during various stages of postnatal development. Males were
GDX on postnatal day 0 and immediately treated with a single injection of oil vehicle or
estradiol benzoate. (B) Following Western blot analysis of trkB and actin in the
developing hippocampus of intact and hormone manipulated males, mean optical
densities were determined of immunoreactive bands. Background levels were subtracted
from these measurements and a ratio of trkB/actin was determined to give a mean net
density for each age. Each bar represents the mean ± S.E.M. of three independent
experiments. The levels of trkB expression following GDX were not significantly greater
than the intact, or GDX + E treatment groups (p > 0.68).
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Discussion
In this study we examined the effect of early steroid environment on BDNF gene
expression and demonstrated that neonatal gonadectomy and subsequent estrogen
replacement regulates BDNF mRNA and protein expression in the developing rat
hippocampus. A quantitative analysis of BDNF mRNA levels in the hippocampus
following neonatal gonadectomy and subsequent estrogen replacement revealed a
significantly increase in BDNF mRNA from postnatal days 4-10. Surprisingly, estrogen
induced increases in BDNF mRNA were accompanied by a decrease in BDNF protein
levels. However, there was no effect on trkB mRNA or protein expression. Thus, during
development, estrogen could influence neuronal differentiation through regulation of
BDNF.
Estrogen and numerous growth factors, including the neurotrophins, are
associated with neuronal differentiation and survival. Estrogen is important during brain
development influencing the maturation of neural systems and affecting the sexual
differentiation of brain structures and functions. Estrogen affects both hypothalamic and
hippocampal neuronal physiology and plasticity and promotes growth of the developing
nervous system (Arnold and Gorski, 1984; Toran-Allerand, 1984). Unfortunately, the
mechanisms by which estrogen affects the developing hippocampus are ill-defined.
The neurotrophins play important roles in neuronal survival and differentiation
(for review, see Thoenen, 1995) and promotes neuronal survival during development and
after various brain insults (Lindvall et al., 1994; Tucker et al., 2001). Studies have shown
that neuronal cultures established during the early stages of neurogenesis are supported
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by BNDF, whereas older neurons survive with NGF treatment (Enokido et al., 1999).
Additionally, BDNF has been shown to induce the formation of both excitatory and
inhibitory synapses of embryonic hippocampal cells (Vicario-Abejon et al., 1998),
providing evidence that BDNF is essential during development.
BDNF has been postulated to be an important signaling molecule in regulating
synaptic strength and overall circuit activity in the adult. Accordingly, chronic treatment
with BDNF potentiates neurotransmission in the hippocampus (Bolton et al., 2000).
BDNF and its receptor trkB regulate both short-term synaptic functions and long-term
potentiation (LTP; McAllister et al., 1999). Estrogen has similarly been shown to
enhance LTP (Warren et al., 1995; Foy et al., 1999; Good et al., 1999) and may regulate
neural processes underlying learning and memory. The mechanisms by which estrogen
modulates LTP are essentially unknown, but one possibility could be through interactions
with the BDNF gene.
The co-localization of estrogen receptors with the neurotrophin receptors,
p75NGF, trkA and trkB, in the adult basal forebrain established an interaction between
estrogen and the neurotrophins (Toran-Allerand et al., 1992; Miranda et al., 1993a).
Subsequent work demonstrated the presence of an estrogen response element in the
BDNF gene (Sohrabji et al., 1995) providing a direct link between estrogen and BDNF.
Moreover, estrogen regulates BDNF gene expression in a developmental stage- and brain
region-specific manner (Jezierski and Sohrabji, 2000), and this may play important roles
in region and stage specific regulation of brain development. Similar to our findings in
neonates, it has recently been demonstrated that estrogen significantly affects BDNF
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mRNA and protein levels in a bi-directional manner within the adult rat hippocampus
(Gibbs, 1999). Furthermore, other published reports have shown that estrogen (Liu et al.,
2001) and phytoestrogens (Pan et al., 1999) significantly upregulate BDNF mRNA levels
in adult mammals.
In addition to its effects on BDNF, estrogen has been shown to influence the
expression of neurotrophin receptors. For instance, estrogen up-regulates mRNA for the
NGF receptor, trkA (Sohrabji et al., 1994a; Sohrabji et al., 1994b), and increases trkB in
the olfactory bulb (Jezierski and Sohrabji, 2000). However, consistent with the study of
Gibbs (1998) in the adult hippocampus, we did not observe an effect of estrogen on trkB
mRNA or protein during development. It is possible that estrogen regulates the trk
receptors differently depending on the brain region or developmental period examined.
Additional studies are needed to examine these differences.
Neurotrophic factors are assumed to provide trophic support via a target-derived,
retrograde mechanism. Recent studies have demonstrated that BDNF can also act
anterogradely similar to neurotransmitters (Smith et al., 1997; Altar and DiStefano,
1998). It is possible that BDNF produced in hippocampal neurons is transported to
downstream targets, such as the basal forebrain and entorhinal cortex, and this transport
could be influenced by estrogen as has been suggested for other brain regions (Jezierski
and Sohrabji, 2000). This could account for the increased BDNF mRNA and decreased
protein levels following estrogen treatment. This conclusion is supported by a recent
report demonstrating an estrogen induced increase in BNDF levels in hippocampal
targets (Liu et al., 2001). Alternatively, differential changes in turnover rates for BDNF
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mRNA and protein or increases in BDNF levels following neonatal GDX due to
retrograde uptake and storage from non-hippocampal sites could explain the differences.
Estrogen may also act to regulate BDNF expression in different brain regions, or periods
of development. For instance, Jezierski and Sohrabji (2000) recently demonstrated that
estrogen increased BDNF levels in the olfactory bulb and DBB, but decreased them in
the cingulate cortex. It appears that estrogen’s effects on BDNF are complex and likely
dependent upon the brain region or age examined.
Similar to our results in vivo, Murphy et al. (1998) showed that estrogen acts to
down-regulate BDNF levels in hippocampal neurons grown in vitro. These authors
suggested that estrogen acts through GABAergic interneurons to regulate BDNF
expression. This was based on the findings of Weiland et al., (1997) showing ER in
interneurons of the adult rat. However, we have recently shown that during development,
the highest concentration of ER is in CA1 and CA3 pyramidal neurons, and doublelabeling experiments demonstrated these cells did not express GABA (present findings
and Solum and Handa, 2001). Based on our current findings showing that ER is colocalized with BDNF in hippocampal pyramidal neurons and studies showing that BDNF
is not expressed in interneurons (Pascual et al., 1999) we conclude that there is a direct
action of ER on the BDNF gene in pyramidal cells. Even so, it is possible that estrogen
regulates the expression of BDNF indirectly through a step involving other transcription
regulating factors. For instance, Murphy et al. (1998) have suggested that BNDF levels
could be regulated by CREB phosphorylation. Even so, this is consistent with our
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findings, as estrogen has been shown to enhance CREB expression in the hippocampus
(Panickar et al., 1997).
The discovery of ER (Kuiper et al., 1996) raised the possibility that some of
estrogen’s effects could be mediated by this receptor. While it has been shown that ER
mRNA exist in the adult hippocampus (Shughrue et al., 1997; Shughrue and
Merchenthaler, 2001), ER mRNA does not appear to be translated at significant levels
(Shughrue and Merchenthaler, 2001). Although ER has been described in the
developing mouse hippocampus (Ivanova and Beyer, 2000), it has not been demonstrated
whether ER protein exists during development. Here we have shown that ER is indeed
found at low levels in the developing hippocampus but it is not co-localized with BDNF,
suggesting the predominant interaction is through ER. Studies examining splice
variants of ER mRNA have suggested that the predominant form in the hippocampus is
a variant that does not bind estrogen (Price et al., 2001). Since the two estrogen receptor
types can activate different signaling pathways (Webb et al., 1999), it is possible these
receptor types may differentially influence the extent and direction of BDNF expression.
While the mechanism underlying estrogen effects on BDNF gene expression remains
unclear, differences in ER and ER signaling mechanisms (Jones et al., 1999), and
regional expression patterns (Shughrue et al., 1997) may help explain these differences.
Our studies used real-time PCR to analyze the expression of BDNF and trkB
mRNA following neonatal gonadectomy. Using a traditional thermal cycler, which relies
on end-point quantitation, there is theoretically a quantitative relationship between the
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amount of starting target sequence and amount of product following amplification.
Unfortunately, quantitation relies on carefully titrating the product to the linear part of the
amplification curve which is, in reality, a very narrow range. Furthermore, replicate
reactions often yield different amounts of PCR product unless elaborate, time-consuming
controls are used. Real-time PCR has reduced the variability and expanded the linear
range for quantitation by monitoring the product amount after each cycle (Wittwer et al.,
1997). Therefore, the optimum cycle number does not need to be determined
empirically. This technique has been proven to be a sensitive and quantitative way to
assess gene expression in normal development and during pathophysiological conditions
(Li and Wang, 2000; Wang et al., 2000) as well as to quantify steroid hormone receptor
mRNA levels (Latil et al., 2001).
In summary, previous work in this laboratory has shown that in the neonatal
hippocampus, ER is highly expressed during development. In this study, we have
demonstrated that estrogen regulates the expression of BDNF mRNA and protein in the
developing rat hippocampus. It is possible then, estrogen, by binding the ER receptor,
directly alters BDNF gene expression. These findings may contribute to our
understanding of the mechanisms by which steroid hormones influence the differentiation
of developing neurons.

CHAPTER 6
DEVELOPMENTAL EXPRESSION OF THE p160 COACTIVATORS IN THE
RAT BRAIN

Abstract
During development, steroid hormones permanently impact the morphology and
physiology of neurons. These effects are mediated by nuclear hormone receptors which,
following ligand binding, regulate gene transcription and neuronal function.
Additionally, The control of target gene expression by steroid hormone receptors requires
the recruitment of multiple cofactors for efficient transcriptional activity. Here we
describe the developmental expression of messenger RNA for the p160 steroid receptor
coactivators (SRCs), including SRC-1/N-CoA1, SRC-2/GRIP-1/TIF2 and SRC3/AIB1/p/CIP in several regions of the rat brain using quantitative real-time PCR.
Messenger RNA expression levels were quantitated in the medial basal hypothalamus,
prefrontal cortex and the CA1 and CA3 regions of the hippocampus from postnatal (P)
day 0, 4, 7, 10, 15, 20 and adult rats. Our results demonstrate that these coactivators
show significantly different levels of mRNA expression, with SRC-1 generally expressed
at the highest levels, and SRC-2 at the lowest in all brain regions examined. The level of
expression for SRC-3 was more variable depending on the brain region examined, but
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was usually less than SRC-1. The developmental timecourse of mRNA expression was
also variable for these coactivators. SRC-1 was expressed at high levels at all ages
examined. SRC-2 and 3, in contrast, showed changes in expression patterns over the
course of development. For example, in the hippocampus, the levels of SRC-2 were
undetectable at P0, and increased transiently to their highest levels at P15. SRC-3, on the
other hand, was generally expressed at low levels early in development, with a gradual
increase in expression over development. This pattern was similar for all brain regions
examined. These findings suggest that the p160 coactivators play differening roles
during brain development to enhance transcriptional activation of steroid hormone
receptors.

Introduction
Steroid hormones influence transcriptional activation through specific nuclear
receptors (NRs), including the estrogen receptor (ER) and progesterone receptor (PR).
These receptors function as ligand-activated transcription factors and work in conjunction
with a variety of coregulatory proteins. Ligand activated nuclear hormone receptors bind
to specific DNA sequences in the enhancer region of hormone-responsive genes, termed
hormone response elements, where they serve to stimulate or repress transcription of
hormone responsive genes. Nuclear hormone coactivators and corepressors are
molecules that form a bridge (either function or physical) between the receptor and the
RNA II polymerase holoenzyme complex. Coregulatory proteins include members of the
p160 family of steroid receptor coactivators. Coactivator proteins are often part of

154
multiprotein complexes that enhance the activity of NRs and other transcription factors
(Horwitz et al., 1996; McKenna et al., 1999a; Glass and Rosenfeld, 2000). The
recruitment of coactivator proteins to the basal transcription machinery by steroid
hormone receptors when complexed with their respective ligands is correlated with
transcriptional activity. While very little attention has been given to the role of
coactivator proteins in the brain, some studies have demonstrated that some coactivator
proteins are located in neurons (Martinez de Arrieta et al., 2000; Meijer et al., 2000;
Ogawa et al., 2001), and may influence the function of receptors in brain functions such
as the sexual differentiation of the brain (Auger et al., 2000).
Over 30 potential coactivator proteins have been identified based on their ability
to bind various receptor domains and to alter the transcriptional activity of NRs
(McKenna et al., 1999a; Glass and Rosenfeld, 2000). These coactivator proteins function
as signaling intermediates between the receptors and the general transcriptional
machinery to affect gene transcription (Horwitz et al., 1996; Katzenellenbogen et al.,
1996). Distinct classes of ligand-dependent transcriptional cofactors have been
described, including CBP/p300 and the p160 family (Xu et al., 1999). At present, the
p160 family contains three members including SRC-1/N-CoA1 (Onate et al., 1995;
Kamei et al., 1996), SRC-2/GRIP-1/TIF2 (Hong et al., 1996; Voegel et al., 1996; Torchia
et al., 1997) and SRC-3/AIB1/p/CIP/RAC3 (Li et al., 1997a; Torchia et al., 1997; Suen et
al., 1998). The p160 family is defined by an overall sequence similarity of 40% between
the three proteins, distinguishing its members from other coregulator classes. The highest
degree of homology is in the N-terminal domain, where the basic helix-loop-helix
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(bHLH) domain exhibits a high degree of similarity. This bHLH domain is responsible
for mediating protein-protein interactions with other transcriptional machinery, including
CBP/p300 and RNA polymerase II.
How coactivator proteins function to enhance transcriptional activation is
currently speculative, but attention centers on their interactions with the basal
transcription machinery and on their associated histone acetyltransferase (HAT) activity
(Bannister and Kouzarides, 1996; Chen et al., 1997). For example, coactivator proteins
play a role in chromatin remodeling, a process that allows the binding of other
transcription factors (Kadonaga, 1998). Subsequently, coactivators interact with
transcription machinery, such as RNA polymerase II, to transcribe target genes. Thus,
the specific recruitment of a protein with histone acetyltransferase activity to a gene
promotor region may play a critical role in transcriptional activation by a hormone
receptor. Moreover, in the absence of coactivator proteins, significant transactivation of
steroid receptors is unlikely to occur.
Steroid receptor coactivator 1 (SRC-1; also N-CoA1) is a 160kDa protein that has
been shown to enhance transcription mediated by steroid hormone receptors, including
PR and ER (Onate et al., 1995) in addition to functioning with the coactivator CBP/p300
(Kamei et al., 1996; Smith et al., 1996). SRC-1 enhances the activity of ligands that have
pure agonist activity (Llopis et al., 2000) as well as those with mixed agonist/antagonist
properties (Katzenellenbogen et al., 1996). For instance, 17b-estradiol has been shown to
create a strong association between ERa and SRC-1, and this interaction is disrupted by
the antagonist ICI 182,780 (Stenoien et al., 2000). It has been demonstrated that
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peripheral steroid target organs of mice containing a targeted disruption of the SRC-1
gene have a decreased response to steroid hormones such as estrogen and progesterone
(Xu et al., 1998), demonstrating its importance in steroid hormone receptor action.
Additionally, the distribution of SRC-1 has been shown to be extensive in both
peripheral (Onate et al., 1995; Misiti et al., 1998) and nervous tissues (Martinez de
Arrieta et al., 2000; Meijer et al., 2000; Ogawa et al., 2001), although little is known
about its expression during development.
Steroid receptor coactivator 2 (SRC-2; also GRIP1/TIF2) has significant
homology to SRC-1 (Hong et al., 1996; Voegel et al., 1996) and mediates transcriptional
activation by members of the steroid receptor superfamily. SRC-2 interacts in a ligandregulated manner with the hormone binding domain of the glucocorticoid receptor (GR)
and androgen receptor (AR) as well as ER (Hong et al., 1996). While very few studies
have examined the expression of SRC-2 in brain tissue, its distribution appears to be
much more restricted than SRC-1 (Xu et al., 1998; Meijer et al., 2000).
Like the other two p160 coactivator family members, steroid receptor coactivator
3 (SRC-3; also AIB1/p/CIP/RAC3) interacts with a wide variety of nuclear receptors in a
ligand dependent manner (Anzick et al., 1997). Similar to SRC-2, SRC-3, has a variable
expression pattern in peripheral tissues, and its distribution appears to be more restricted
than SRC-1 in brain (Suen et al., 1998; Xu et al., 2000). SRC-3 has the ability to enhance
the transcription mediated by the progesterone receptor (PR), and selectively enhances
the transcriptional activity of the ER subtype over ER (Suen et al., 1998). The
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receptor selectivity observed with SRC-3 may subsequently underlie regional or tissue
differences in receptor activation.
In this study, we examined the developmental expression of mRNA for steroid
receptor coactivators in multiple regions of the rat brain using quantitative real-time PCR.
We show that mRNAs for p160 steroid receptor coactivators are variably expressed in
different brain regions, and that the developmental time course for their expression is also
variable depending on the brain region examined. Thus, the differential expression of
these coactivators may underlie the diversity of steroid receptor mediated signals in the
developing brain.

Material and Methods
Animals. Neonatal male and female rats of various ages taken from timed-pregnant
Sprague-Dawley females and male and female adult rats were obtained from Charles
River Laboratories (Portage, MI). Animals were housed under a 12/12 h light dark cycle
(lights on at 07.00 h) with food and water available ad libitum. Upon parturition, litters
were sexed and thinned to 8 pups (4 males and 4 females). Adult females were sacrificed
at 3-4 months of age. All animal protocols were previously approved by the Animal Care
and Use Committee at Colorado State University.
Total RNA isolation and reverse transcription. Neonatal rat pups were
decapitated, and the brains quickly removed. Medial basal hypothalamus, cortex, and
hippocampal regions CA1 and CA3 were then rapidly dissected. Total RNA was isolated
according to the protocol of Chomczynski and Sacchi (1987). Briefly, brain tissue was
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homogenized in 250l of GIT buffer (4M guanidinium isothiocyanate/25mM NaCitrate,
pH 7.0/0.5%sarcosyl/0.1M -mercaptoethanol) on ice. Subsequently, 25l of 2M NaOAc
(pH 4.0), 250l of buffer-saturated phenol (pH 4.3) and 50l of chloroform/isoamyl
alcohol (49:1) was added and the mixture vortexed. The samples were then centrifuged
at 14,000 x g for 20 minutes at 4ºC. The aqueous phase was recovered and the RNA was
ethanol precipitated. The resulting RNA was washed with ice-cold 70% ethanol, and
reconstituted in 50l RNAse free water. The RNA content was measured with a
spectrophotometer and only those samples with a 260/280 ratio between 1.6 and 2.0 were
used.
2 g of total RNA was reverse transcribed with Superscript II reverse
transcriptase (RT; Gibco/BRL, Rockville, MD) using oligo-dT primers,
deoxyribonucleotides (dNTPs; 100 mM each), 1st strand buffer (100 mM Tris-Cl/900 mM
KCl/1 mM MgCl2) and 2.5 mM dithiothreitol (DTT). The reaction was carried out at
room temperature for 10 minutes followed by 50 minutes at 42ºC. The RT was then
denatured at 95ºC for 10 minutes and stored at –80ºC until used.
Real-time quantitative polymerase chain reaction (PCR). Real-time quantitative
PCR was performed using the LightCycler System (Roche Molecular Biochemicals,
Indianapolis, IN) as previously described (Solum and Handa, 2001b). In this system, A
highly specific double-stranded (ds) DNA binding dye, SYBR Green I (Molecular
Probes, Eugene, OR), which only fluoresces when bound to dsDNA, is used to determine
the concentration of amplified products. SYBR Green I binds to the minor groove of
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dsDNA and fluorescence is greatly enhanced by binding. During the various stages of
PCR, different intensities of fluorescence signals can be detected, depending the amount
of dsDNA that is present. The 530 nm fluorescence is recorded at the end of the
elongation phase, and increasing amounts of PCR product are monitored from cycle to
cycle. By comparing the amount of unknown cDNA to a curve of amounts of a given
cDNA amplified concurrently, real-time PCR eliminates the need for competitive in-tube
standards with identical primer sets as targets (Morrison et al., 1998).
To prevent nonspecific amplification we used hot-start PCR with dNTPs, specific
primers, PCR buffer (100 mM Tris-Cl, 1.5 mM MgCl2), 0.5 units Taq polymerase, 0.5
units Taq antibody (Gibco/BRL) and 2 l of 10X stock SYBR Green I. Specific primers
were as follows: SRC-1 (Genbank accession #NM 010881) forward primer position
3433, reverse primer position, 3954; SRC-2 (Genbank accession #AF136943) forward
primer 3179, reverse primer 3596 and SRC-3 (Genbank accession #AF322224) forward
primer position 167, reverse primer position 500. Primers were developed using OLIGO
software (v. 6.51; Molecular Biology Insights, Cascade, CO). All samples were
amplified at 40 cycles, which is approximately five to ten cycles beyond the beginning of
the linear phase of amplification. Specifically, an initial melting step was done at 95ºC
for 2 minutes followed for 40 cycles of 95ºC melting step for 1s, an annealing step (60ºC
for SRC-1 and 64ºC for SRC-2 and 3) for 5s, and a 72ºC elongation step (21s for SRC-1,
16s for SRC-2 and13s for SRC-3). In all experiments, samples containing no template
were included to serve as negative controls.
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Construction of cDNA standard curves. To determine the absolute concentration
of the target transcript, conventional PCR for SRC1-3 was used to generate a cDNA. The
amplified cDNA was purified using the Qiagen PCR purification kit (Qiagen, Valencia,
CA) according to the manufacture’s directions. The purified PCR products were serially
diluted at a range of 30ng-30fg and this curve was run in duplicate alongside the
unknown samples.
mRNA quantitative analysis. Following real-time PCR, the absolute
concentration of mRNA in each sample was determined by analysis with LightCycler
Data Analysis (LCDA) software. This software plots a standard curve of the crossing
line intercepts of the standards vs. the known concentrations of these standards. The
crossing line intercept is parallel to the x-axis on a graph of fluorescence intensity vs.
cycle number and occurs at the point where template amplification enters the logarithmic
phase of the curve. Samples with a higher concentration of starting material enter the
logarithmic phase earlier than samples with a lower concentration of starting material and
therefore have a smaller crossing point value. The crossing line intercept of an unknown
sample is subsequently compared with the standard curve to generate a quantitative
amount of starting material. In each case, the point at which the crossing line intercepts
the log-linear region of each curve is used to generate the concentration of that sample.
Statistical analyses. All analyses were performed using analysis of variance
(ANOVA, StatView, SAS Institute Inc.). Significant values were subsequently verified
with the Tukey-Kramer post hoc analysis.
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Results
Expression of steroid receptor coactivator mRNA in the hypothalamus
We first examined the expression of messenger RNA for the p160 steroid receptor
coactivators (SRCs 1-3) in the medial basal hypothalamus of intact female rats during
development from postnatal day 0 through adulthood (Fig 30). Steroid receptor
coactivator 1 (SRC-1) mRNA is expressed at relatively high levels in the hypothalamus,
and these levels do not change significantly from birth to adulthood. The coactivator
SRC-2, on the other hand, has the lowest level of expression of the three coactivators
examined. Moreover, the level of expression did not change significantly throughout
development. The last coactivator examined, SRC-3, maintained a level of expression
that while only slightly and insignificantly greater that SRC-2 at most ages, was much
less than SRC-1 at all time points. Even so, the expression of SRC-3 mRNA levels
showed a trend toward gradually increasing concentrations, such that by adulthood the
levels were significantly greater that those at birth (p < 0.03). The results of these studies
demonstrate that while significant differences in the levels of mRNA expression for these
coactivators exist in the medial basal hypothalamus, they are all present during postnatal
development. Moreover, the levels of expression for these coactivators are high enough
to suggest they play some role in the transcriptional modulation of steroid responsive
genes in the developing hypothalamus.
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Expression of p160 steroid receptor coactivator mRNA in the hippocampus
The presence of p160 coactivators in the hypothalamus during development and
adulthood subsequently raised additional questions concerning their expression in other
brain regions. Therefore, we examined the expression of messenger RNA for steroid
receptor coactivators (SRCs 1-3) in hippocampal subregions CA1 and CA3 of intact
female rats during normal development (Fig 31). Similar to our findings in the
hypothalamus, SRC-1 expression levels in the hippocampus were very high during
development in both CA1 and CA3, and these levels did not change with increasing age
from birth through adulthood. In contrast to SRC-1, the pattern of SRC-2 mRNA
expression showed a much different pattern during development. At birth, the levels of
SRC-2 mRNA were not detectable. Beginning on postnatal day 4, the levels increased to
peak by P10, then declined gradually to lower levels which were observed in adult
animals. The decline in expression from P10 to adulthood was much more pronounced in
the CA3 subregion. In fact, in the CA1 subregion, the levels at postnatal day 15 and 20
were not different from those at P10, but in the CA3 region the levels of SRC-2 were
significantly reduced by P20. SRC-3 mRNA levels were barely detected on P0, but in
each subsequent age examined, the levels of expression increased. This remained the
case until P20, at which point mRNA levels were not different from adults. The
developmental changes in mRNA levels for SRC-3 was essentially the same in both the
CA1 and CA3 hippocampal subregions.
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Figure 31 Legend: Expression of p160 steroid receptor coactivator mRNA in the
hippocampus. Quantitative real-time PCR was used to examine the expression of SRC13 mRNA in the CA1 (A) and CA3 (B) hippocampal subregions during development. All
values are reported in picograms of cDNA. Each bar represents the mean ± S.E.M. of
three independent experiments. No significant changes were observed for SRC-1 over
development (p > 0.76). In both the CA1 and CA3 subregions, the level of expression for
SRC-2 increased from P0 to peak at P10. These levels decreased, and in the CA3
subregion, the levels in adults were significantly less than at P10 (P < 0.01). The levels
of SRC-3 mRNA were very low shortly after birth, and increased gradually over
development to reach their highest in adulthood. In fact beginning on P7 the levels of
SRC-3 mRNA were significantly greater than at birth. Unlike SRC-2, the levels for
SRC-3 did not drop after the second postnatal week. (*) Significantly less than P10.
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Figure 311
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Expression of steroid receptor coactivator mRNA in the prefrontal cortex
In the cortex, the levels of expression for SRC-1 followed a pattern of expression
similar to that of the hypothalamus and hippocampus with one notable exception. That
is, while the level of expression of SRC-1 did not change over development in the cortex,
they were much greater than the hypothalamus and hippocampus at all ages examined
(Fig 32). In fact, at some ages the levels of cDNA were nearly double of those observed
in the other brain regions examined. The physiological significance of this finding is
unknown. The levels of SRC-2 were significantly less than those for SRC-1, and slightly
less than those of SRC-3 at most ages examined. These overall differences in expression
were maintained throughout development. Moreover, In contrast to the hypothalamus
and hippocampus no developmental changes were observed for any of p160 coactivators
in the cortex. This was a surprising finding considering that many substantial changes
are taking place in the cortex during the developmental period examined. Nevertheless,
the SRCs are expressed at levels high enough to suggest that, if translated, they would
play important roles in steroid hormone action.
Localization of SRC-1 in the developing rat brain
Next, we used immunocytochemistry to determine whether SRC-1 expression
was similar to that of its messenger RNA. Our results demonstrated a pattern of
expression for SRC-1 that was consistent with that of its messenger RNA (Fig. 33).
Analysis of the distribution of SRC-2 and SRC-3 was hindered by the inability of
currently available antibodies to recognize these proteins in brain tissue. At all ages
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Figure 33
Figure 33 Legend: Expression of SRC-1 in the developing brain. SRC-1 is highly
expressed in the hippocampus, hypothalamus and cortex of the developing rat. In the
hippocampus, the majority of staining is observed in the CA3 region, with CA1 and
dentate gyrus lower. In the cortex, layers 2-6 are heavily stailed while in the
hypothalamus a large number of cells in the arcuate and ventral medial nuclei are
immunopositive.
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examined, SRC-1 immunoreactivity was concentrated to the nucleus of cells in the
hypothalamus, hippocampus and cortex. Moreover, in these studies we never observed
cytoplasmic staining for this coactivator, and within the nucleus, the intensity of staining
was usually quite high. In the hypothalamus, SRC-1 immunoreactivity was moderately
expressed, with the arcuate and ventral medial nuclei consistently stained darkly. The
supraoptic nucleus was also notably immunopositive. In the hippocampus,
immunoreactivity was very strong in stratum pyramidale of both CA1 and CA3
subregions. SRC-1 immunoreactivity in the cortex was most intense in layers 4-6, but
cells in layers 2 and 3 were also immunopositive. Similar to our findings on the
expression of SRC-1 mRNA in the developing brain, the levels of immunoreactivity did
not change drastically with increasing age. In general, the number and intensity of
immunoreactive cells was high beginning on P0, and in each subsequent age examined,
the number and intensity of SRC-1 immunoreactive cells remained high.

Discussion
Steroid hormones, including estrogen, exert important roles in the development of
the central nervous system by acting in cell and temporally-specific ways. However, the
estrogen receptors and other NRs are much more than simple switches that translate the
presence of hormones into changes in gene expression. The responses of steroid
hormones depend on multiple cofactors, such nuclear receptor (NR) coactivator proteins.
Following a quantitative analysis of messenger RNA levels for the p160 coactivators in
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the developing rat brain, we observed a unique developmental and regional pattern of
expression for these coactivators. These distinct patterns of expression for the p160
coactivators may subsequently underlie tissue or ontogenetic differences in the ability of
these proteins to influence transcriptional activation in the brain. Additionally, we have
demonstrated that like its mRNA, SRC-1 protein is highly expressed in the hippocampus,
and is colocalized with ER in neurons from this brain region. SRC-1 is also highly
expressed in the developing cortex, and to a lesser extent in the medial basal
hypothalamus. To our knowledge, this is the first report to describe the developmental
expression of the p160 coactivator messenger RNAs in brain tissue.
The nuclear receptors are transcriptional regulators that activate gene transcription
upon binding of their respective ligands. While there is considerable evidence that
nuclear receptors can contact some of the basal factors of the preinitiation complex
directly, without the need for intermediary coregulatory proteins, evidence for additional
factors is supported by observations that different classes of receptors can interfere with
one another’s transcriptional activity by squelching limiting factors that are not
components of the basal transcription machinery (Meyer et al., 1989). Studies aimed at
understanding the mechanism by which NRs regulate target gene transcription have
discovered several novel coactivators that increase the ability of the receptors to activate
transcription (Horwitz et al., 1996). It has been suggested that these cofactors act as a
bridging apparatus between the receptor and the transcriptional machinery (Chiba et al.,
2000; Glass and Rosenfeld, 2000). Additionally, ligand dependent recruitment of p160
coactivators, in concert with other factors such as CBP and p300, bring acetyl transferase
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activity to NR complexes. The coactivator proteins, then, coordinate the interactions of
steroid receptors, their ligands, and transcriptional machinery to initiate gene
transcription.
In this report, we find expression patterns that are specific for each p160
coactivator, suggesting different roles for these three genes and differences in regional
sensitivity for steroid signaling in the developing brain. Such differences in expression
levels might indicate cell specificity of NR-mediated transcriptional regulation, and
might partially explain how the same gene can be regulated differentially in different cell
types (Jain et al., 1998). This idea is further supported by the SRC-1 and SRC-2 knock
out mice which demonstrate distinct NR coactivators may have specific physiological
functions based on the different phenotypes these mice exhibit (Xu et al., 1998; Xu et al.,
2000). While mice lacking p160 coactivators are viable and grossly normal, SRC
deletions resulted in steroid and thyroid hormone resistance, suggesting that such states
could be manifestations of dysfunctional NR coactivators. It appears then, that the p160
coactivators play a more important role in the tissue specific effects of steroid hormones
than just to provide a functional redundancy for the other class members.
While some coregulatory proteins function as coactivators for a variety of
transcription factors, the p160 family, including the SRCs, appears to be restricted to the
nuclear receptor family (Torchia et al., 1997; Korzus et al., 1998). Not only do SRCs
enhance transactivation by steroid hormones, but also in certain circumstances,
significant transactivation mediated by steroid hormones is not likely to occur in their
absence (Llopis et al., 2000). For instance, studies with the estrogen receptor have
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demonstrated that SRC-1 is required for transcriptional activation, and this activation is
enhanced in a ligand dependent manner (Onate et al., 1995; McKenna et al., 1999b;
Llopis et al., 2000).
The developing brain is a sensitive target for steroid hormones, which mediate
several events and have lasting effects on adult physiology and behavior (Harris and
Levine, 1962). Additionally, steroid hormones, including estrogen and thyroid hormone,
act during a perinatal sensitive period of development to influence the development of
brain structures (Hajos et al., 1973; McEwen, 1983).
Similar to our findings presented here, other studies have shown that the
abundance of transcripts for SRC-1 is of the same order for many brain regions (Meijer et
al., 2000). However, this finding may be specific to the brain region examined as
another recent report demonstrated a developmental increase in the levels of SRC-1
mRNA levels in the cerebellum (Martinez de Arrieta et al., 2000), a brain region not
examined in the present study.
In contrast to our results presented here, Meijer and colleagues (2000) reported
that they were unable to detect SRC-2 mRNA in brain tissue. This is possibly due to the
fact that Meijer et al. (2000) used in situ hybridization with end-labeled oligonucleotides,
a technique with much less sensitivity than RT-PCR. This technique would be unlikely
to detect small concentrations of mRNA such as what we have reported here for SRC-2
mRNA. Nevertheless, in experiments using adult mice, it was demonstrated that SRC-3
gene expression is restricted in a tissue and cell type-specific manner (Xu et al., 2000),
supporting our findings with SRC-3 mRNA in the developing rat. The present findings,
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taken together with earlier reports examining the distribution of p160 coactivators,
underscore the variability associated with the expression patterns of these genes. Clearly,
additional studies need to be conducted to elucidate the significance of the p160
coactivators in the developing brain.
In summary, p160 coactivator genes appear to be developmentally regulated in
the rat brain, with each gene following a unique pattern of expression throughout
development. SRC-1 was generally expressed at the highest levels in all brain regions
examined, including the hippocampus, hypothalamus and cortex, with lower levels of
SRC-3 and SRC-2 consistently observed. The presence of these genes in the developing
brain suggest they play an important role in the coordination of transcriptional activation
by steroid receptors.

CHAPTER 7
OVERALL DISCUSSION

In recent years, the knowledge of how estrogen influences mammalian brain
functions and development has broadened substantially. In the adult brain, estrogen is
not only involved in the neuroendocrine feedback regulation at the hypothalamic and
pituitary level but also in the control of cognitive functions (Sherwin, 1997). More
recently, estrogen was suggested to act as a neuroprotective factor for neurodegenerative
disorders such as Parkinson’s and Alzheimer’s disease (Henderson et al., 1996; Leranth
et al., 2000). In addition to these regulatory and protective functions, estrogen plays an
important role during development. After the demonstration that the estrogensynthesizing enzyme aromatase (Harada and Yamada, 1992) and both nuclear estrogen
receptors (Jakab et al., 2001 ; DonCarlos, 1996; Yokosuka et al., 1997; Ivanova and
Beyer, 2000) are expressed in many brain regions during ontogeny, it was soon realized
that estrogen modulates neuronal differentiation, notably by influencing cell survival and
death, and synaptic plasticity of neurons. These effects were initially seen in the classical
target area for estrogen, the hypothalamus, but successive studies revealed the
neurotrophic potential of estrogen in other brain regions as well. One example of an
extrahypothalamic brain region that is influenced by steroid hormones is the
hippocampus. This brain region is involved with learning and memory tasks, cognition,
174
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and stress responsivity, all of which show sexual dimorphisms (Williams et al., 1990;
Williams and Meck, 1991; Kellogg, 1999; Lavenex et al., 2000). The mechanisms by
which estrogen exerts its neurotrophic and neuroprotective roles are essentially unknown,
but an attractive hypothesis involves an interaction with brain-derived neurotrophic factor
(BDNF). BDNF has been shown to be important in both of these roles; that is, it is
neuroprotective in adulthood, and neurotrophic during development (Barde, 1989;
Davies, 1994). Although the exact mechanism by which estrogen interacts with BDNF is
not known, there are several possibilities. One involves a direct interaction of wildtype
estrogen receptors with the estrogen response element in the BDNF gene. This is the
simplest and most likely possibility. Alternatively, estrogen’s effects could be mediated
by a 3 variant of ER that doesn’t bind efficiently to EREs, but does initiate
transcription at AP-1 response elements. Alternatively, estrogen may be acting indirectly
through second messenger systems such at the MAP kinase pathway. Finally, the effects
of estrogen on BDNF could be mediated through protein-protein interactions with
coactivator proteins such as the p160s and CBP/p300, which bind to the CREB response
element in the BDNF gene promotor.
In the studies presented in this dissertation, some potential mechanisms by which
estrogen influences the hippocampus during early postnatal development have been
examined utilizing both in vivo and in vitro models. This project was conceived based on
the data presented in chapter three which describes the developmental expression of
estrogen receptor alpha in the hippocampus. Our findings suggested that estrogen might
be acting very differently than had been described in the literature based on the location
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of ER we observed in the developing hippocampus. For instance, I demonstrated that
during postnatal development, ER was predominantly localized to pyramidal neurons of
the CA1 and CA3 subregions of the hippocampus, and not restricted to spiny
interneurons as had been previously described in adults (Weiland et al., 1997).
Interestingly, it had been demonstrated in the adult that hippocampal pyramidal cells
display a robust response to estrogen treatment and to fluctuations in ovarian hormones
across the estrous cycle (Gould et al., 1990; Woolley and McEwen, 1992). Furthermore,
during the second postnatal week, a time when we observe the highest concentration of
ER, the plasma levels of estradiol are also high (Meijs-Roelofs et al., 1973; Dohler and
Wuttke, 1975). Therefore, our results were exciting considering the distribution of ER
we observed which coincided with the transient increase in plasma estrogen levels and
suggested that estrogen might be acting directly on the excitatory principle cells of the
hippocampus rather than through an indirect mechanism involving the inhibitory
neurotransmitter -amino butyric acid.
The data presented in this dissertation also raise another interesting question
concerning the time frame for the organizational effects of steroid hormones in different
brain regions. Studies in the hypothalamus showed gonadal hormones influence sexual
differentiation from embryonic day 18 through about the second week after birth
(MacLusky and Naftolin, 1981), and these effects are likely mediated through the
estrogen receptor. Our results, showing the peak of ER expression at P10 in the
hippocampus, which is relatively late in relationship to the “critical period” of the
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hypothalamus, could suggest that the hippocampus possesses a critical period that is later
than the hypothalamus. This is a reasonable hypothesis considering the hippocampus
finishes developing at a later age than the hypothalamus (Bayer, 1980; Jacobson and
Gorski, 1981a; Seress, 1985). Alternatively, it may be that the transient expression of
ERs in the hippocampus is not related to sexual differentiation at all, but rather play a
different role in the development and synaptogenesis of hippocampal neurons.
After describing the distribution of ER in the developing hippocampus, we
asked whether the second form of estrogen receptor, ER, was present in the
hippocampus and played a role in the development of this brain region as well. ER
possesses all the properties of a physiological relevant estrogen receptor (Kuiper et al.,
1996; Mosselman et al., 1996a; Kuiper et al., 1997) and has been shown to be highly
expressed in prostate and ovary with lower expression in brain, uterus, and testis
(Mosselman et al., 1996b; Kuiper et al., 1997; Shughrue and Merchenthaler, 2001). The
potential role of these different ER subtypes in developmental neurobiology has been
established by studies providing clear evidence that, in a given target cell, ER and 
play distinct biological roles (Patrone et al., 2000) suggesting that estrogen can activate
selected intracellular signaling pathways depending on the receptor subtype bound. The
possibility that ER played a role in the developing hippocampus was supported from
recent studies using mice lacking ER and suggested that ER may mediate the effects
of steroid hormones in a spatial learning task (Cunningham et al., 1998). Additionally,
unlike ER, ER mRNA has been shown to be variably spliced resulting in correctly
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processed and exon-skipped transcripts that disrupt the normal domain structure of the
receptor (Petersen et al., 1998; Inoue et al., 2000; Price et al., 2000). Interestingly, an
mRNA splice variant missing exon four has been described in the hippocampus, and
cortex, but is absent in nearly all other brain regions examined, including the
paraventricular and supraoptic nuclei of the hypothalamus (Price et al., 2000). Thus, the
possibility arises that within the developing hippocampus particular ER mRNA splice
variants are expressed at sufficient levels to significantly influence estrogen mediated
transcriptional activation. For example, in transient transfection studies, these splice
variants have been shown to be transcribed into functional proteins that have an altered
subnuclear localization and transcriptional activities (Price et al., 2001). However,
whether ER mRNA splice variants exist in vivo or not is still unclear, as the tools to
analyze the individual variants currently do not exist. Nevertheless, it is enticing to
consider the possibility that various ER mRNA splice variants could act alone or with
the wildtype ER and ER forms resulting in a very specific way by which estrogen
influences gene transcription in a particular cell.
Another interesting possibility involves the role of nontraditional ligands that may
have ER subtype-selective activity. For instance, the ER2 mRNA splice variant has an
in-frame insertion of 18 amino acids that disrupts the normal estrogen binding pocket of
the receptor. As predicted, this particular ER isoform binds 17- estradiol, the classical
ER agonist, with much lower affinity than the wildtype receptor (Petersen et al., 1998).
Moreover, a variety of different ligands have been identified to date, which show altered
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activity at the various receptor types (Sun et al., 1999). It is possible that during
development in the hippocampus, when ER2 isoforms are highly expressed, specific
ligands may act to create a unique pattern of gene expression required for differentiating
neurons. The development of novel ligands for the nuclear receptors has extended
beyond neuroendocrinology and has yielded important therapeutic treatments, among
them the use of tamoxifen for endocrine therapy of breast cancer (Katzenellenbogen et
al., 1995). Curiously, in certain tissues, and after long-term treatment in patients with
breast cancer, tamoxifen exhibits unexplained partial agonist activity. Various agents
that raise intracellular cAMP levels or stimulate the ras/MAP kinase pathway can
similarly cause estrogen receptor activation in the presence of tamoxifen or the absence
of any activating ligand (El-Tanani and Green, 1997). It is possible that these molecules,
classically considered antagonists can regulate the association with coregulatory
molecules with nuclear receptors, including the nature of the ligand, the levels of
available coregulator molecules, and the action of diverse protein kinase signaling
cascades that modulate the switch from transcriptional repression to activation. In
support of the idea that antagonists can influence the action of ERs, we have shown in
primary hippocampal cells, ER, which is often localized to the cytoplasm, can be
translocated to the nucleus following tamoxifen treatment (Fig. 34). However, this effect
does not result from estradiol treatment. In chapter four we demonstrated that several
ER splice variants exist in the developing hippocampus, including a variant missing the

180
fourth exon. Based on the deletion in this splice variant, it is likely that it is unable to
translocated to the nucleus due to a

Figure 34

disrupted nuclear localization signal. The possibility that tamoxifen can initiate
translocation of ER raises a variety of questions concerning the role of estrogen
receptors in the developing hippocampus.

The Role of Brain-Derived Neurotrophic Factor
More than twenty five years ago, Dominique Toran-Allerand (1976) found that
estrogen enhances the growth and arborization of axons and dendrites in hypothalamic
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neurons grown in organotypic cultures. In the following years, these initial finding were
extended, and growth-promoting effects of estrogen were described in the hippocampus
(Gould et al., 1990), midbrain (Reisert et al., 1987), cortex (Garcia-Segura et al., 1989),
pituitary (Chun et al., 1998) and spinal cord (VanderHorst and Holstege, 1997). Thus it
appears that estrogen has the ability to regulate a wide variety of differentiation processes
in neurons that are necessary for the proper development of many different brain
structures and connections. However, the mechanisms by which estrogen influences the
differentiation of neurons is not entirely clear. One possible mechanism is through an
interaction with the neurotrophins. A number of recent studies have demonstrated that
neurotrophins play important roles in early development as well as in the later activitydependent processes important for the final shaping of neural connections (see Barde,
1989; Davies, 1994). Thus, the neurotrophins may play a role in linking functional
modifications of synapses to the morphological effects of synaptic stabilization and
rearrangement, as observed in the hippocampus. In view of its importance and broad
range of activities in neuron populations, brain-derived neurotrophic factor, a member of
the neurotrophin family, has gained attention as a potential therapeutic agent for
neurological diseases (Lindsay, 1994). Interestingly, estrogen is also an important
regulator for BDNF expression in adult rat brain. For example, the level of BDNF
mRNA in the hippocampal formation fluctuates across the estrous cycle (Gibbs, 1998)
and increases in response to acute estrogen replacement (Singh et al., 1995). It was with
these early studies in mind that we chose to examine the effects of estrogen treatment on
BDNF gene expression during hippocampal development in the rat.
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Over the course of the hormone manipulation studies included in this dissertation,
we observed a very curious result concerning the effects of estrogen on BDNF gene
expression. This finding is presented in chapter five and demonstrates that following
hormone removal resulting from neonatal castration of males, the levels of BDNF mRNA
are significantly reduced or even developmentally delayed. Interestingly, in what seemed
to be a paradox, estrogen induced decreases in mRNA expression were accompanied by
an increase in protein levels. A single injection of estrogen given at the time of castration
induces a reversal of this effect such that the levels are returned to those observed in
intact animals. The fact that hormone replacement produced an increase in BDNF mRNA
and a decrease in BDNF protein in the hippocampus, suggests either an uncoupling of
BDNF transcriptional and translational mechanisms, an increase in BDNF protein
degradation, or an increase in BDNF release which is then either degraded or transported
away, resulting in lower levels of BDNF in the hippocampus. The most likely
explanation for the differential effects on BDNF mRNA and protein expression involves
evidence demonstrating that BDNF can be transported anterogradely in axons and is
released from nerve terminals in a similar fashion to neurotransmitters. However, it is
unlikely that the BDNF transport is an estrogen mediated event, as we did not observed
any changes in the
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Figure 35: Schematic diagram demonstration the activation of BDNF through a classical
estrogen response element via wildtype ER and/or . This diagram represents ER
and/or  in an inactivated state [unliganded or in the presence of an antagonist such as
tamoxifen (T)] where the corepressor NCoR with its associated HDAC activity acts to
silence BDNF transcriptional activation (panel A). Following estrogen (E) binding the
ER undergoes a conformational change which releases NCoR and allows binding of p160
coactivators (B). Coactivator binding subsequently recruits additional coregulatory
proteins such as CBP with HAT activity. This complex finally recruits the TRAP/DRIP
complex which promotes transcriptional activation of BDNF. levels of mRNA or protein

184
for the BDNF receptor, trkB, over development or following hormone manipulation.
With these possibilities in mind, it is then possible to consider that BDNF may even
regulate its own production by binding to receptors on pyramidal cells resulting in
negative feedback and down regulation of the ligand.
The data presented in this dissertation demonstrate that estrogen significantly
affects the levels of BDNF mRNA and protein in the developing hippocampus, and these
effects are brain region specific. Given the mounting evidence for effects of BDNF on
neuronal connectivity and activity-dependent synaptic plasticity in the brain, it is
reasonable to hypothesize that the hormonal effects on BDNF gene expression can
contribute to changes in brain structure and function. These influences may, in turn,
contribute to the effects of estrogen replacement on cognitive processes, as well as to the
ability of estrogen treatment to reduce the risk and severity of Alzheimer’s Disease
related cognitive decline that have been reported in adult humans.

Nuclear Receptor Coregulators
In recent years, molecular genetics and biochemistry have identified many
intermediary components, co-activators, and co-repressors, involved in both liganddependent and ligand-independent transcriptional activation following interaction with
nuclear receptors (McKenna et al., 1999a; Glass and Rosenfeld, 2000). Recent data show
that nuclear receptors, including the estrogen receptors, enhance or inhibit transcription
by recruiting an array of these coregulatory proteins to the transcription complex (see
Horwitz et al., 1996). Moreover, as the number of putative coactivators and/or
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corepressors grows and as functional activities are identified (e.g. histone
acetyltransferase or methylation activity), the interplay among the NRs, coactivators
and/or corepressors, integrators, and the basal transcriptional apparatus will facilitate, at
least in part, an understanding of tissue- and developmental specific gene expression
mediated by ligand-activated estrogen receptors. Different cell types may have different
relative compositions of these coregulators associated with the nuclear receptors (Misiti
et al., 1998). Accordingly, we have investigated the developmental
expression of the p160 coactivators, including
steroid receptor coactivators (SRC) 1-3, in the rat
brain. Interestingly, the expression pattern for the
p160 coactivators in the developing brain is highly
variable, suggesting that while the coactivators are
widely expressed, their relative expression is
dependent upon the brain region and ontogenetic
period examined. In this dissertation, we have
demonstrated that estrogen receptors and steroid
receptor coactivators are each expressed in the
developing hippocampus. Indeed, the interaction
between these proteins is further supported in figure
36 demonstration that over 81% of primary

Fig. 36
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hippocampal cells containing SRC-1 (red) also contain ER(green). It appears then,
that within the developing brain, a highly complex system for transcriptional regulation
exists. This complex includes steroid responsive genes, nuclear receptors, coregulatory
proteins and the general transcriptional machinery.
How estrogen receptors interface with the p160 coactivator system, for example,
is an intriguing question, but given that nuclear receptors do not contain histone
acetyltransferase activity, one could envision a two-step process. In this hypothetical
model, chromatin remodeling coactivators such as CBP and p300, either bound directly
to steroid receptors or through ligand-recruited coactivators such as the p160 coactivators
could open up the chromatin to then allow the nuclear receptors to act directly on the
preinitiation complex. Thus, the specific recruitment of a complex with histone
acetyltransferase activity to a promotor may play a critical role in overcoming repressive
effects of chromatin structure on transcription (Struhl, 1998). It is even more intriguing
to speculate that coactivator proteins could interact in a ligand independent fashion with
the AF-2 domain of the estrogen receptor to influence transcriptional activation. For
instance, concerning the BDNF gene, it is convenient to think that following ligand
binding and recruitment of specific coactivator proteins, the wildtype estrogen receptors
bind to the estrogen response element in the BDNF promotor to initiate transcription (Fig
35). An alternative, albeit much more complex, scenario involves the ligand independent
interaction of an ER splice variant, likely ER2 or ER23, following the
phosphorylation of the AF-1 domain via activation of the AKT or ERK pathway.
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Following this phosphorylation event an array of coactivator proteins including the p160s
and CBP could be recruited the estrogen receptor. Finally, the CBP

23
23 23

Figure 37: A schematic diagram showing the activation of BDNF through a non-classical
pathway involving nuclear receptor coactivators. This hypothetical diagram represents a
scenario in which ER splice variants could activate BDNF transcription in an agonist
independent (or antagonist stimulated) fashion. Following phosphorylation of ER
activation domains, steroid receptor coactivators can interact with the receptor. Through
a subsequent series of protein-protein interactions, additional coregulatory proteins could
be recruited resulting ultimately in gene activation. In this particular example, CREB
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(cAMP response element) is the requisite transcription factor for transcriptional
activation.

bound complex could interact with the CBP responsive element in the BDNF promotor to
initiate transcription (Fig 37). However, concerning this alternative scenario, it should be
noted that no evidence of ligand independent activation of ER2 splice variants has been
reported, making the first hypothetical situation even more attractive.
A further understanding of which intermediary factors are involved in the
transcriptional control of particular target genes, including BDNF, will require a detailed
analysis of genes in a chromatin complex within cells. These studies will need to be
conducted in concert with the continued development of transcription systems that
respond to multiple activators in a chromatin context in vitro. When combined, these
types of experiments will allow for further identification of novel cofactors involved in
gene transcription. They will also assist in the dissection and elucidation of the direct
biochemical functions of particular chromatin modifying, remodeling, or general
cofactors in coordinating the action of nuclear receptors and other classes of activators
and repressors at complex promoters. In addition to potential enhancer-induced
cooperativity, such experiments may also reveal novel activator specific or gene-selective
mechanisms of transcriptional control in response to multiple stimuli and, taken together,
should increase our understanding of cellular proliferation and differentiation.
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Conclusion
Brain development involves a precise program of gene activation that establish
specific neuronal phenotypes and the intricate patterns of connections between them.
Understanding the mechanisms underlying these selective programs of gene activation
and repression that define the maturation of neurons represent a fundamental question in
neurobiology. However, despite considerable evidence that gonadal hormones influence
the function and organization of circuits in the brain, the molecular signals that regulate
the structural and functional changes in connections during development remain largely
obscure. Estrogen affects the nervous system in ways that extend beyond its essential
actions of regulating gonadotropins and prolactin secretion and modulating sexual
behavior. The diversity of these effects implies an involvement of brain regions outside
of the hypothalamus, a traditional site for the study of estrogen receptors and their role in
the control of reproductive function. Such extrahypothalamic sites include, for example,
the hippocampus, basal forebrain and cerebral cortex. These non-hypothalamic brain
regions are also particularly susceptible to damage resulting from stroke or
neurodegenerative disease. Moreover, in humans, epidemiological studies and clinical
experiments have suggested that estrogen replacement therapy reduces the risk for
neurodegenerative diseases that target hippocampal neurons, such as Alzheimer’s disease
(Henderson et al., 1996; Asthana et al., 2001). Additional studies have shown that
estrogen treatment has positive outcomes on cognition and memory (see Sherwin, 1994;
Fink et al., 1996; Sherwin, 1997). Both of these effects are possibly mediated through
interactions with the neurotrophins. Thus, the implications of the studies presented in
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this dissertation extend beyond endocrine neurobiology alone. They demonstrate that
estrogen not only plays an important role in the hippocampus, but that the influences of
this steroid hormone are mediated during development at a critical time when
hippocampal neurons are differentiating and undergoing synaptogenesis.
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